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Abstract 
Blood vessel patterning during angiogenesis is a guided process. Endothelial tip cells 
located at the end of vascular sprouts are important for vessel guidance. One of the 
aims of my studies is to determine how endothelial tip cell formation is regulated. 
Previous  studies  have  shown  that  the  Notch  ligand,  Delta-like  4  (Dll4),  is 
prominently expressed in tip cells, therefore suggesting a role of Notch signalling in 
its regulation. In the mouse, suppression of Notch signalling by pharmacological 
inhibition of γ-secretase or genetic deletion of one Dll4 allele resulted in excessive 
endothelial tip cell formation and a poorly-patterned, hyperdense vessel network. 
Induction of Notch signalling by Jagged1 peptide treatment led to a decrease in tip 
cell  formation  and  a  sparse  vessel  network.  Thus,  the  Notch  pathway  negatively 
regulates tip cell formation to promote a non-sprouting endothelial stalk cell.  
  The Notch-regulated ankyrin repeat protein, Nrarp, is a Notch target gene 
that  is  highly  expressed  in  stalk  cells  and  endothelial  cells  located  at  vessel 
branchpoints. Deletion of Nrarp in mouse and morpholino knockdown of nrarp-a 
and  nrarp-b  in  zebrafish  resulted  in  decreased  endothelial  cell  proliferation  and 
junctional instability, leading to ectopic vessel regression and the formation of a 
sparse vessel network. In endothelial cells, loss of Nrarp function increased Notch 
signalling but decreased Wnt signalling, thereby confirming its role as a negative and 
positive  modulator  of  Notch  and  Wnt  signalling,  respectively.  Mice  null  for 
Lymphoid enhancer factor 1 (Lef1) or deficient in endothelial Ctnnb1 also displayed 
increased  vessel  regression  and  decreased  vessel  density,  suggesting  a  role  of 
canonical Wnt/β-catenin signalling in maintaining vessel stability. 
  In conclusion, my studies show that Notch signalling regulates endothelial tip 
cell  formation  and  vessel  stability  to  fine-tune  vessel  patterning.  Furthermore,  I 
demonstrate that Nrarp provides a molecular link to Wnt signalling to regulate vessel 
stability.  
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ZO-1  Zonula occludens-1   15  1    Introduction   1.1   T HE  V ASCULAR  S YSTEM   The  cardiovascular  system  is  the  first  organ  to  develop  during  vertebrate  embryogenesis.  The  generation  of  a  closed  circulatory  system  is  essential  for  efficient delivery of oxygen and n utrients to growing tissues and organs with high  metabolic demands, and also for efficient clearance of waste products. The vascular  system  is  also  a  conduit  through  which  immune  cells  such  as  leukocytes  are  transported to sites of infection. Two separate  vascular systems exist in vertebrates:  the  blood  vessels,  which  are  the  subject  of  my  PhD  studies,  and  the  lymphatic  vessels.  These  distinct  vascular  systems  are  interconnected  through  the  largest  lymphatic vessel, the thoracic duct, which drains lymph int o the blood circulation.      Blood  vessels  develop  from  a  common  precursor  cell,  the  angioblast.   Angioblasts  are  mesoderm - derived  endothelial  precursor  cells  that  are  not  fully  differentiated. They aggregate to form multi - cellular structures called blood is lands  and later differentiate into endothelial cells (ECs) that coalesce to form cord - like  structures, giving rise to a primitive vascular plexus with lumen ( Figure  1 ). This  process is known as vasculogenesis. The l ongitudinal axial vessels of vertebrates,     Figure  1 .  The  formation  of  the  primary  vascular  plexus  occurs  through  vasculogenesis.   Mesodermal cells in th e early embryo (E7) differentiate into endothelial precursor  cells or angioblasts and form aggregates of blood islands. Angioblasts subsequently  differentiate into endothelial cells (ECs). Coalescence of blood islands leads to the  formation of honeycomb - sh aped primary capillary plexus in the yolk sac and the  embryo proper.    16     Figure  2 . The vascular system is composed of a hierarchical network of arteries,  veins and capillaries.   Arterial,  venous  and  capillary  endothelial  and  mural  cells  are  morphologically  dis tinct. Arterial ECs have a spindle - like morphology, align in the direction of blood  flow and have low proliferation. Arteries are surrounded by extensive extracellular  matrix (ECM), elastic fibres and layers of contractile vascular smooth muscle cells  (vSM Cs). The wall of mature arteries (such as the aorta) is composed of the inner  tunica intima (ECs and basement membrane), the central tunica media with multiple  alternating layers of matrix and vSMCs, and the outermost layer tunica adventitia,  which is rich  in collagen and fibroblasts. Veins have less extensive vSMC coverage  and  contain  valves.  Haemodynamic  factors  control  arterial - venous  differentiation  and morphological changes in ECs and vSMCs. The mural cells that cover arteries,  veins and capillaries ar e derived from mesenchymal or neural crest cell precursors,  and possibly, from circulating cells. vSMCs undergo several steps of differentiation  before they acquire their mature morphology and gene - expression profile.  (Adams  and Alitalo, 2007)     the  dorsal  aorta  and  the  cardinal  vein,  are  the  first  vessels  to  form  during  embryogenesis through vasculogenesis. Vessel branches emanate from th is primitive  plexus through a separate process called angiogenesis, which will be covered in more  detail in the following pages.   
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During  blood  vessel  development,  a  hierarchical  network  comprising  of 
arteries, veins and capillaries arises. Functionally, arteries (except for the pulmonary 
artery) carry oxygenated blood away from the heart under high pressure while veins 
return deoxygenated blood to the heart at lower pressure. The core component of 
blood vessels is the endothelial cell, which forms the lining of the vessel lumen. 
Additionally, mural cells envelop blood vessels. Mural cells consist of pericytes, 
which wrap around small vessels such as capillaries, and vascular smooth muscle 
cells (vSMCs), which are found around bigger vessels such as arteries and veins. 
Morphologically, arteries develop more extensive layers of elastic fibres and vSMCs 
compared to veins in order to support and regulate high blood flow and pressure. In 
addition, veins posses specialized structures, such as valves, to ensure uni-directional 
blood flow (Figure 2). 
 
1.2  ANGIOGENESIS 
Angiogenesis, in the simplest of definitions, is the formation of new blood vessels 
from  a  pre-existing  network  of  vessels.  This  process  is  highly  complex  and 
comprises a multitude of cellular and morphogenic events. Angiogenesis occurs in 
two  fundamental  ways,  either  by  sprouting  angiogenesis  or  by  intussusceptive 
growth. Intussusceptive angiogenesis is the splitting of two existing vessels. This 
event is initiated by the formation of a vascular pillar, which is a slender endothelial 
cell cylinder that stretches through the lumen from one part of the wall to the other. 
The pillar subsequently widens as a result of in-growth of mural cells, fibroblasts and 
extracellular matrix so that one vessel is split into two parallel vessels (Burri and 
Djonov, 2002).  
One of the interests of my studies is angiogenic sprouting, and in this section 
of the introduction, I will briefly illustrate the morphogenic events that occur during 
sprouting  angiogenesis:  the  initial  phase  of  new  vessel  formation,  the  process  of 
vessel  morphogenesis  when  endothelial  cells  form  functional  tubes,  vessel 
stabilization and the process of vessel regression during vascular remodelling. 
1.2.1    VASCULAR SPROUTING AND PATTERNING 
The  final  vascular  network  established  in  a  given  tissue  or  organ  is  a  highly 
organized one. The pattern that forms differs extensively between organs to suit the  
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anatomical  and  physiological  needs  of  each  organ.  How  does  such  an  organized 
vessel network arise? There are two possible mechanisms that may lead to organ-
specific vascular patterns. Firstly, a primary vascular plexus may be formed by a 
random process and this is followed by  specific branch regression or pruning to 
establish the final plexus. Secondly, angiogenic sprouting is triggered by selective 
cues and  sprouting and fusion of vessels may be a guided process with directed 
collective  cell  motility.  This  would  create  specific  primary  vascular  patterns. 
Although vessel regression does play a role in establishing the final organization of 
the  vascular  plexus,  there  is  a  wealth  of  evidence  demonstrating  that  vessel 
patterning is a guided process.  
1.2.1.1  A specialized endothelial tip cell guides new vessel sprouts. 
Endothelial cells that compose an angiogenic sprout are not homogenous. Rather, 
there  are  different  subpopulations  of  endothelial  cells  with  unique  morphologies 
within a sprout (Gerhardt et al., 2003). The tip of vascular sprouts consists of a single 
endothelial cell that extends multiple long filopodia in a polarized manner. This cell 
is active with motile and invasive behaviour and is referred to as an endothelial tip 
cell. Endothelial cells that trail the tip cell within the vascular sprout display fewer 
filopodia and are referred to as endothelial stalk cells. In addition, stalk cells form 
and line the vascular lumen, whereas tip cells do not. Endothelial tip and stalk cells 
also differ in their gene expression profile. Although a tip cell-specific marker has 
not yet been identified, tip cells express Pdgfb, Dll4, Unc5b, Kdr and Flt4 more 
strongly than stalk cells (Gerhardt et al., 2003; Claxton and Fruttiger, 2004; Lu et al., 
2004; Siekmann and Lawson, 2007; Tammela et al., 2008).  
The  differences  in  cell  morphology  and  gene  expression  suggest  that 
endothelial tip and stalk cells have  specialized functions. Indeed, as discussed in 
more detail below, tip cells function to guide the migration of nascent blood vessels 
into an avascular tissue so that an organized vessel network is formed. Stalk cells 
proliferate more frequently so that blood vessels grow in length and diameter. In 
addition,  stalk  cells  undergo  positional  rearrangements  within  a  vessel  to  form 
lumen.    19   1.2.1.2   Vessel patterning is regulated by attractive cues    Vascular endothelial growth factor - A (VEGF - A) is one of  six members of the VEGF  family,  whose  other  members  include  placental  growth  factor  (PLGF),  VEGF - B,  VEGF - C, VEGF - D and the viral VEGF - Es encoded by strains  D 1701 ,  NZ 2  and  NZ 7  of  the  parapoxvirus  Orf  (Holmes  and  Zachary,  2005) .  VEGF - A  consists  of  two  monomers,  which  are  arranged  head - to - tail  in  a  homodimer  with  two  interchain  disulphide bridges. Each monomer contains a cystine knot motif, which consists of  eight conserved cysteine re sidues held together by three intrachain disulphide bonds  (Muller  et  al.,  1997) .  The  expression  and  functions  of  VEGF - A  are  critically  important  for  haematopoiesis  and  cardiovascular  development.  In  vascular  dev elopment, VEGF - A is required for chemotaxis and differentiation of angioblasts,  endothelial  cell  proliferation,  vasculogenesis  and  angiogenic  remodelling.  Inactivation of a single  Vegfa  allele in mice results in early embryonic lethality (E11 - 12)  as  a  resu lt  of  deficient  endothelial  cell  development  and  lack  of  vessels  (Carmeliet et al., 1996; Ferrara et al., 1996) .    The  generation  of  an  extracellular  gradient  of  VEGF - A  is  essential  for  directed  migration  of  endothel ial  cells  during  vessel  patterning.  This  property  is    Fi gure  3 . An angiogenic sprout consists of endothelial tip and stalk cells.   (A) A confocal image of vascular sprouts from a postnatal day 5 mouse retina.  Endothelial tip cells (T) have many filopodia protrusions (arrowheads) compared  to  endothelial stalk cells (S). The retina has been stained with Isolectin - B4, which  recognizes endothelial cells as well as microglial cells (m). (B) A simplified cartoon  of a tip cell (green) with many filopodia and trailing stalk cells (blue) lining th e  vessel lumen. Tip and stalk cells are also molecularly different: tip cells express  Pdgfb, Dll4, Kdr and Unc5b more strongly than do stalk cells.    20     Figure  4 . VEGF - A isoforms and their binding properties.   ( A ) The human  VEGF - A  gene consists of eight exons. Alternative splicing of  VEGF - A  generates two mRNA isoform families, t he pro - angiogenic  VEGF - A xxx  (left) and  the  anti - angiogenic  family  VEGF - A xxx b   (right).  Alternate  5’  and  3’  splice  site  selection in exons 6, 7 and 8 generate multiple isoforms. The  VEGF - A xxx  isoforms  are generated by proximal splice site (PSS) selection in  exon 8 and the  VEGF - A xxx b   from  exon  8  distal  splice  site  (DSS)  choice.  Thus,  VEGF - A 165   formed  by  PSS  selection in exon 8 has  VEGF - A 165 b  has its DSS sister isoform; both isoforms encode  proteins of the same length.  xxx  is the number of amino acids. ( B ) Prot ein structure of  VEGF - A containing the dimerization sites and binding sites for heparin, VEGFR - 1  (encoded by exon 3) and VEGFR2 (encoded by exon 4), which are present in all  isoforms. Exon 6 encodes a heparin - binding domain, while exons 7 and 8 encode a  ne uropilin/heparin - binding  domain.  The  six  amino  acids  at  the  extreme  carboxyl  terminus of the protein can be either pro - angiogenic (encoded by exon 8a) or anti - angiogenic (encoded by exon 8b).  (Harper and Bates, 2008)       conferred by the heparin/heparan sulphate binding ability of VEGF - A. There are at  least seven different human  pro - angiogenic   VEGF - A  isoforms: VEGF - A 121 , VEGF -  A   145 , VEGF - A   148 , VEGF - A   165 , VEGF - A   183 , VEGF - A   189  and VEGF - A   206   (see  Figure  4 ;  Harper and Bates, 2008) . I n mouse, the VEGF - A isoforms are one amino  acid  shorter  i.e.  VEGF - A 120   etc.  The  isoforms  differ  in  their  ability  to  bind  heparin/heparan  sulphate  and  neuropilin - 1  and  - 2  with  the  longer  isoforms  (e.g.  VEGF - A 183 ,  VEGF - A 189   and  VEGF - A 206 )  exhibiting  greatest   affinity  to  these  molecules.  In  mouse  postnatal  retina  and  embryonic  hindbrain,  VEGF - A 164   and  VEGF - A 188  are required for the establishment of a steep extracellular VEGF gradient     21     Figure  5 . VEGF receptor - binding properties and si gnalling complexes.   ( A ) Mammalian VEGFs bind to three VEGF receptor (VEGFR) tyrosine kinases,  VEGFR1/Flt1, VEGFR2/Kdr/Flk - 1 and VEGFR3/Flt4, leading to the formation of  VEGFR  homodimers  and  heterodimers.  The  VEGFRs  contain  a  750 - amino - acid - residue extracel lular domain, which is organized into seven immunoglobulin (Ig) - like folds. In VEGFR3, the fifth Ig domain is replaced by a disulphide bridge. The  extracellular domain is followed by a single transmembrane region, a juxtamembrane   domain, a split tyrosine - kinase domain that is interrupted by a 70 - amino - acid kinase  insert,  and  a  C - terminal  tail  (Olsson  et  al.,  2006) .  VEGF - A  binds  VEGFR1  and  VEGFR2; VEGF - C and VEGF - D bi nd VEGFR2 and VEGFR3; PLGF and VEGF - B  bind  only  to  VEGFR1;  and  VEGF - E  (not  shown)  binds  only  to  VEGFR2.  The  unprocessed  full - length  forms  of  VEGF - C  and  VEGF - D  preferentially  bind  VEGFR3 and have low affinity for VEGFR2; however, fully processed forms have  increased  affinity  for  VEGFR2  (Joukov  et  al.,  1997;  Stacker  et  al.,  1999) .  ( B )  VEGFR  signalling  is  modulated  by  different  co - receptors.  VEGFs  as  well  as  VEGFRs bind to co - receptors such as heparan sulphate proteogly cans (HSPGs) and  neuropilins (Nrp1 and/or Nrp2). Neuropilins are transmembrane glycoproteins and  are also co - receptors for the semaphorin class of proteins  (Pellet - Many et al., 2008) .  Binding of  VEGFs to Nrp1 is mediated by the basic heparin - binding domain and the  
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Nrp1/heparin-binding  domain  (Soker  et  al.,  1998).  The  formation  of  a  ternary 
complex  of  VEGF-A165,  VEGFR2  and  Nrp1  potentiates  VEGF-A165  binding  to 
VEGFR2 (Soker et al., 2002). PLGF, placental growth factor. Illustrations are from 
(Olsson et al., 2006). 
 
 
(Gerhardt et al., 2003; Ruhrberg et al., 2002). In the developing retina, astrocytes in 
hypoxic  regions  of  the retina  are  the  source  of VEGF-A  production;  the  highest 
VEGF-A concentration is therefore found in the avascular periphery of the retina, 
and  the  lowest  is  found  in  the  vascularized  centre,  in  particular  close  to  arteries 
carrying oxygenated blood. Perturbation of this VEGF-A gradient results in defective 
tip  cell  filopodia  formation  –  filopodia  are  shorter  and  aberrantly  orientated 
(Gerhardt  et  al.,  2003).  A  disturbed  VEGF-A  gradient  also  inhibits  directed 
endothelial tip cell migration. The same phenotypes are also observed from ectopic 
activation of Kdr or VEGFR2, a receptor for VEGF-A, within the vasculature. These 
findings  indicate  that  retinal  endothelial  tip  cell  migration  depends  on  an  intact 
gradient of Kdr agonistic activity that is highest at tip cells, where Kdr is expressed 
on  the  filopodia  (Gerhardt  et  al.,  2003).  In  addition,  Neuropilin-1  (Nrp1),  a 
transmembrane glycoprotein that binds to VEGF-A164 and associates with Kdr as a 
co-receptor (Soker et al., 2002; Soker et al., 1998), regulates endothelial tip cell 
guidance.  In  the  hindbrain  of  mice  deficient  for  Nrp1,  the  subventricular  zone 
vascular plexus is mispatterned due to failure of tip cells to change direction at a 
specific location in the developing brain (Gerhardt et al., 2004).  
  Curiously, endothelial stalk cells do not respond to a VEGF-A gradient but to 
the local concentration of VEGF-A. Ectopic increase in Kdr activity increased stalk 
cell proliferation so that the number of endothelial cells per vessel length and the 
diameter of vessels are increased, whilst branching frequency is unaffected (Gerhardt 
et al., 2003). Vessel patterning therefore depends on the balance of guided tip cell 
migration and stalk cell proliferation. 
1.2.1.3  Vessel patterning is regulated by repulsive cues 
Besides attractive cues, there are also repulsive signals that restrict vessel sprouting 
within  specific  regions  and  also  keep  specialized  blood  vessels  separate.  Several 
pathways  have  been  proposed  to  serve  such  a  function.  These  include  the 
semaphorin/plexin and ephrinB2/EphB4 pathways, which I will describe below, as 
well as the netrin/Unc5B signalling pathway.  
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  Semaphorins (SEMAs) are a large family of secreted and membrane-bound 
repulsive cues that are divided into seven classes (Pellet-Many et al., 2008). They 
were originally identified for their ability to modulate axon steering, fasciculation 
and branching in developing nervous tissue (Kruger et al., 2005). Of the family of 
SEMAs, members from class 3 (SEMA3) are important in vascular morphogenesis. 
The SEMA3 subfamily comprises seven members (SEMA3A to SEMA3G), each a 
disulphide-linked  homodimer  that  binds  to  a  receptor  complex  composed  of 
Neuropilin (Nrp-1 or Nrp-2) and Plexin (PlexinA1-4 or PlexinD1). Nrp is the ligand-
binding  subunit  of  SEMA3  receptor  complexes  whereas  Plexin  constitutes  the 
signalling component of the receptor (Takahashi et al., 1999). 
  Data indicating that Class III semaphorins regulates endothelial cell guidance 
were derived from endothelial cell culture treatment with SEMA3A.  Binding to 
Nrp1 by SEMA3A inhibits directed endothelial cell motility, elicits the dismantling 
of their lamellipodia and actin stress fibers, and hampers capillary sprouting from 
aortic rings (Miao et al., 1999). A similar role of SEMA3/Nrp/Plexin also exists in 
vivo. In zebrafish embryos, semaphorins sema3aa and sema3ab are expressed in the 
developing somites, but are excluded from intersomitic boundaries. The co-receptor 
plexinD1 is complementarily expressed in endothelial cells of intersegmental vessels 
(ISVs) that sprout from the dorsal aorta adjacent to intersomitic boundaries. The 
knockdown of sema3ab or plexinD1 expression in zebrafish embryos results in the 
misguidance of ISVs during patterning (Torres-Vazquez et al., 2004). Instead of a 
regular, segmented pattern of ISVs, a chaotic, misrouted vessel network is formed. 
Conversely, overexpression of sema3ab in somitic muscle resulted in the inhibition 
of ISV growth (Torres-Vazquez et al., 2004). In the mouse, Sema3E is the ligand 
involved in PlexinD1 signalling. Similar to the zebrafish, Sema3E is expressed in the 
caudal region of the somites, immediately adjacent to the intersomitic blood vessels 
expressing  PlexinD1.  Genetic  ablation  of  Sema3E  and  PlexinD1  in  mice  also 
produced a disorganized intersomitic vessel pattern (Gu et al., 2005). Interestingly, 
Nrp is not required for Sema3E-PlexinD1 signalling as Sema3E binds directly to 
PlexinD1  and  Nrp-1
Sema3-/-;Nrp-2
-/-  double-mutant  mice,  in  which  interactions 
between Sema3s and neuropilins are abolished, show normal segmental blood vessel 
patterns (Gu et al., 2005). Current experimental data therefore indicate a role for 
SEMA3E-PlexinD1 signalling in restricting blood vessel growth, for example, within 
the somite boundaries.   
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The large families of Eph receptor tyrosine kinases and their ephrin ligands 
transduce signals in a cell-cell contact-dependent fashion. Eph/ephrin interaction at 
the cell surface triggers bidirectional signals both in receptor- and ligand-expressing 
cells,  respectively.  In  many  settings  and  cell  types,  forward  signalling  leads  to 
repulsion of the Eph receptor-expressing cell (Kuijper et al., 2007). For example, 
activation  of  Eph  receptors  on  migrating  axonal  growth  cones  triggers  retraction 
away from tissues expressing the corresponding ephrin ligand (Klein, 2004). As a 
result,  the  Eph-positive  cells  may  stall,  turn  and  change  direction.  Within  the 
vascular system, arterial endothelial cells predominantly express ephrinB2 whereas 
venous endothelial cells specifically express EphB4. Arteries and veins are separated 
by a capillary bed; the failure to do so results in arteriovenous malformations, which 
permit arterial blood to enter the venous system directly. It has been proposed that 
during  angiogenesis,  EphB4/ephrinB2  signalling  may  provide  repulsive  cues  to 
restrict cell movement across an arterial-venous boundary and inhibit the formation 
of arteriovenous malformations (Adams, 2003; Adams et al., 1999; Eichmann et al., 
2005). However, such a defect is not observed upon targeted deletion of Efnb2 and 
Ephb4  in  mice,  although  they  are  essential  for  angiogenic  remodelling  and 
embryonic  survival  (Wang  et  al.,  1998). In  fact,  ephrinB2  may  not  be  a  critical 
determinant of arterial-venous segregation since its transcript is still expressed in 
mouse  deficient  for  endoglin,  whose  protein  is  a  TGFβ  co-receptor  that  is 
predominantly  expressed  in  endothelial  cells  at  embryonic  and  adult  stages,  and 
endoglin-deficient  mice  display  a  lack  of  distinct  arterial  and  venous  boundaries 
(Sorensen et al., 2003). 
1.2.1.4  Vessel patterning is also influenced by non-endothelial cells 
The  formation  of  a  new  vascular  sprout  requires  the  degradation  of  basement 
membrane that envelops an existing vessel. This activity needs to be regulated to 
prevent  excessive  sprouting.  The  expression  of  a  membrane-anchored  matrix 
metalloproteinase, MT1-MMP, is confined largely to the sprouting tips of capillaries 
(Yana et al., 2007) where it degrades multiple basement membrane components such 
as type IV collagen, laminin and fibronectin (Hotary et al., 2006) thereby allowing 
endothelial  cells  to  migrate  and  invade  the  surrounding  tissue.  This  localized 
expression of MT1-MMP is regulated by vSMCs. vSMCs produce Angiopoietin 1 
(Ang-1),  which  is  a  major ligand  for  Tek (also  known  as  Tie-2),  a  cell  surface,  
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endothelial-specific  receptor  tyrosine  kinase  that  plays  a  central  role  in  vessel 
maturation.  Tek  negatively  regulates  the  transcription  of  MT1-MMP  in  the  stalk 
region  and  acts  to  confine  MT1-MMP  expression  to  the  leading  edge  of  the 
neovasculature  (Yana  et  al.,  2007).  vSMCs  therefore  restrict  excessive  vessel 
sprouting. 
Non-vascular  cells  also  influence  vessel  guidance  and  patterning.  For 
example, the inner retinal vascular plexus develops in close association with a pre-
existing  layer  of  astrocytes  (Fruttiger,  2007). In  fact,  all  endothelial  tip  cells  are 
closely attached to astrocytes and stretch most of their filopodia along the astrocyte 
cell bodies and processes during plexus growth (Gerhardt et al., 2003). Alteration in 
the density of astrocytic network has a direct impact on vessel patterning. Astrocyte 
hyperplasia leads to the formation of a super-imposed multilayered vascular network 
whereas hypoplasia results in a sparser vascular network (Gerhardt et al., 2003). In 
both  situations,  tip  cell  filopodia  remain  closely  associated  with  the  astrocytes, 
suggesting that astrocytes provide the principal cues for guidance of endothelial tip 
cells and their filopodia in retinal vascularization. 
 
 
 
 
Figure 6. Angiogenic sprouting. 
Sprouting is controlled by the balance between pro-angiogenic signals (+) such as 
VEGF-A and factors that promote endothelial quiescence (-) such as tight pericyte 
contact and certain extracellular matrix (ECM) molecules. In the presence of VEGF-
A, some endothelial cells are selected to become tip cells. These tip cells migrate 
along an extracellular VEGF-A gradient that is inversely correlated to the oxygen 
tension of the tissue. In the retina, astrocytes ahead of the growing vascular plexus 
experience hypoxia (blue). As a result, they express high concentrations of VEGF-A; 
and,  as  the  tissue  becomes  vascularized  and  oxygen  tension  increases,  astrocytes 
express less VEGF-A. Tip cell filopodia are closely associated with the astrocytes 
during migration. Some components of ECM e.g. collagen I promote endothelial cell 
migration. Tip cells express certain matrix metalloproteinases (MMPs) that degrade 
vascular basement membrane (BM), thereby promoting migratory activity. Tip cells 
also  express  platelet-derived  growth  factor  B    (PDGFB),  which  promotes  the 
recruitment  of  pericytes  to  new  sprouts.  During  sprouting,  EC-EC  junctions  are 
dynamic or plastic to allow endothelial cell migration. However, once a lumen is 
formed, endothelial cell junctions are reinforced to maintain vessel   integrity and to 
prevent  leakage.  Tight  interactions  between  endothelial  cells  and  pericytes  and 
endothelial  cells  and  vascular  basement  membrane  prevent  sprout  formation  and 
maintain vessel integrity.    26       
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1.2.2    VESSEL MORPHOGENESIS 
Endothelial cells have the ability to undergo marked shape changes during the course 
of angiogenesis. Ex vivo, they can retract and exhibit a spindle-shaped morphology 
when  exposed  to  matrix  components  such  as  collagen  I.  They  can  migrate  and 
realign themselves to form solid cords organized in a polygonal pattern and within 
days,  these  cords  mature  to  form  tubes  with  hollow  lumens  (Davis  and  Senger, 
2005).  Similarly,  time-lapse  imaging  of  developing  blood  vessels  in  zebrafish 
embryos  revealed  dynamic  endothelial  shape  changes  during  the  process  of 
sprouting, migration and tube morphogenesis. Once a functional vascular network is 
established,  the  same  endothelial  cells  become  quiescent.  These  different 
morphogenic events occur while endothelial cells remain connected with each other, 
indicating that at the same time when endothelial cells exhibit explorative behaviour, 
they  also  maintain  tight  contacts  with  adjacent  cells  so  that  collectively,  they 
preserve the tubular structure of blood vessels during sprouting. Endothelial cells are 
therefore  very  versatile  in  their  morphology  and,  depending  on  the  extrinsic  and 
intrinsic cues they receive, they can adopt many cellular shapes that influence the 
morphology of blood vessels. 
1.2.2.1  Regulation of endothelial cell morphogenesis by the ECM 
The  different  matrix  components  surrounding  endothelial  cells  influence  cell 
morphology. For example, the binding of collagen I to α1β1 and α2β1 integrins in 
endothelial cells ex vivo suppresses cAMP and consequently protein kinase A (PKA) 
activity,  which  is  cAMP-dependent.  Suppression  of  PKA  activity  leads  to  an 
induction  of  actin  polymerization  that  contributes  to  the  formation  of  prominent 
stress  fibres  and  endothelial  cell  contractility  (Whelan  and  Senger,  2003).  These 
intracellular changes are also observed during cord formation ex vivo (Whelan and 
Senger, 2003). Collagen I also induces activation of Src and Rho, both of which 
induce actin stress fibres that mediate cell retraction and vessel morphogenesis (Liu 
and Senger, 2004). RhoA has also been demonstrated to regulate endothelial cell 
assembly into new blood vessels in vivo (Hoang et al., 2004). However, exposure of 
endothelial cells to laminin-I does not regulate the level of cAMP nor induce actin 
polymerization, and this is correlated to the inability of laminin-1 to induce changes 
in cell shape (Whelan and Senger, 2003).    28   1.2.2.2   Lumen formation and tubulogenesis    The morphogenesis of seamless, properly patterned endothelial tubes is essential for  the developme nt of a functional circulatory system. Work on 3D endothelial cell  cultures demonstrate that the assembly of endothelial tubes depends on the formation  and coalescence of integrin - dependent pinocytic intracellular vacuoles to create an  ECM - free  luminal  spa ce  (Bayless  et  al.,  2000;  Davis  and  Bayless,  2003) .  These  intracellular  lumens  subsequently  undergo  exocytic  fusion  with  the  plasma  membrane  and  form  endothelial  junctional  contacts  and  continuous  luminal  structures  with adjacent endothelial cells  (Davis and Bayless, 2003) . The study of  vascular lumens has also extended to an  in vivo  model of angiogenesis, the zebrafish.  By using high - resolution time - lapse imaging of transgenic zebrafish, the sequence of  intracellul ar vesicle formation, intracellular vesicle fusion and intercellular merging  of vacuolar compartments to form continuous lumens were observed in endothelial  cells during the formation of the ISVs  (Kamei et al., 2006) .   The formation of an endothelial tube is  regulated by intrinsic and extrinsic  factors. Within the endothelial compartment, the activities of Rho GTPases Cdc42  and Rac1 are required for the formation of vacuoles and lumens  (Davis and Bayless,  2003) . Both  ex vivo  and  in vivo , membranes of vacuole s and the developing lumen    Figure  7 .  A  model  of  vascular  lumen  formation  by  intracellular  and  intercellular fusion of endothelial vacuoles.   The  diagram  illustrates  the  mechanistic  sequence  of  steps  proposed  to  lead  to  intercellular  lumen  formation:  intracell ular  vesicle  formation,  intracellular  vesicle  fusion,  and  finally  intercellular  merging  of  vacuolar  compartments  and  lumen  formation.  (Kamei et al., 2006)    
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are strongly labelled with Cdc42 and Rac1 (Davis and Bayless, 2003) (Kamei et al., 
2006)  and  dominant  negative  Cdc42  and  Rac1  proteins  markedly  inhibit  the 
formation of vacuoles and lumens in collagen matrices (Davis and Bayless, 2003). 
Lumen formation also requires rearrangement of the actin and microtubule networks 
within endothelial cells. The addition of actin- or microtubule-disrupting agents such 
as cytochalasin B or nocodazole  completely inhibits endothelial cell vacuole and 
subsequent  lumen  formation  (Davis  and  Camarillo,  1996).  Furthermore,  genes 
associated with cytoskeletal regulations e.g. coronins 2A and 2B, myosin IC and 
myosin  VI  are  up-regulated  during  endothelial  cell  morphogenesis  (Davis  and 
Bayless, 2003).  
Tubulogenesis also requires junctional rearrangements between endothelial 
cells. For example, during the formation of the primitive dorsal aorta and cardinal 
vein,  there  are  intimate  tight  junctions  between  angioblasts  that  becomes  less 
extensive  as  arterial  and  venous  angioblasts  separate  to  form  distinct  tubular 
structures (the dorsal aorta and cardinal vein). The retention of such extensive tight 
junctions prevents the separation of arterial and venous angioblasts, lumen formation 
and also prevents differentiated endothelial cells from acquiring the squamous shape 
that lines the aorta and vein (Parker et al., 2004). This defect is observed in zebrafish 
deficient in EGF-like domain 7 (Egfl7), an endothelial-specific secreted factor (De 
Maziere et al., 2008; Parker et al., 2004). 
Non-vascular cells also influence endothelial tube formation. For example, 
the presence of fibroblasts promotes intercellular lumen formation by the secretion 
and organization of an ECM that is conducive for tube formation (Berthod et al., 
2006). The ECM also regulates the size or diameter of the vessel lumen. In laminin 
α4 and α5 knockout mice, there is an increase in vessel diameter (Miner et al., 1998; 
Thyboll et al., 2002). In an assay where embryonic stem cells with targeted deletions 
of lamc1 (the gene coding LM-γ1) were induced to differentiate into endothelial cells 
and  form  vascular  sprouts,  the  loss  of  laminin  in  vascular  basement  membrane 
resulted  in  an  increase  in  vessel  diameter  due  to  an  increase  in  endothelial  cell 
proliferation (Jakobsson et al., 2008). Therefore, in this model of angiogenesis where 
there  is  an  absence  of  flow  and  vascular  tone, laminin  may  function  through  an 
integrin-dependent signalling pathway to fine-tune tube morphogenesis by regulating 
endothelial  cell  proliferation.  The  development  of  the  lumen  diameter  is  also 
influenced by endothelial cell shape and motility. For example, in zebrafish mutants  
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that do not express ccm1, which is a protein that associates with the cytoskeleton and 
components  of  signal  transduction  pathways  and  cell  junctions,  a  progressive 
vascular dilation is observed in the cardinal vein and subintestinal vein (Hogan et al., 
2008). This is a result of increased broadening and spreading of endothelial cells and 
thinning of vessel walls, without changes in endothelial cell number and cell-cell 
contact (Hogan et al., 2008). 
 
1.2.3    VESSEL STABILITY 
Once  a  functional  vessel  network  is  established,  active  angiogenesis  such  as 
sprouting and endothelial cell proliferation is switched off or dampened. Instead, 
factors that help to promote endothelial quiescence and vessel homeostasis are turned 
on  to  stabilize  the  vessel  network.  Vessel  stability  is  achieved  through  tight 
interactions between endothelial cells and also between endothelial cells and non-
endothelial components such as mural cells and the vascular basement membrane.  
1.2.3.1  Endothelial cell junctions 
Endothelial cell junctions are composed of a complex network of adhesion proteins 
that are linked to the intracellular cytoskeletal network and signalling molecules. 
These proteins are organized into distinct structures called adherens junctions and 
tight junctions. In addition, several adhesion proteins such as platelet endothelial cell 
adhesion molecule (PECAM or CD31), intercellular adhesion molecule 2 (ICAM2) 
and  others  cluster  at  cell-cell  contacts  that  are  different  from  adherens  and  tight 
junctions.  Adherens  junctions  have  a  pivotal  role  in  vessel  integrity  while  tight 
junctions  are  important  in  maintaining  the  barrier  functions  of  endothelial  cells, 
controlling vascular permeability and leukocyte extravasation (Wallez and Huber, 
2008). 
There is considerable variability in tight junctions among different segments 
of the vascular network. For example, tight junctions are less complex in capillaries 
than in arterioles, and even less in venules, which is the primary site of leukocyte 
extravasation.  The  blood-brain-barrier  (BBB)  and  blood-retinal-barrier  (BRB)  are 
rich in complex tight junctions (Wallez and Huber, 2008). Three types of structural 
transmembrane components form tight junctions: the IgG-like family of junctional 
adhesion  molecules  (JAMs)  and  members  of  the  claudin  and  occludin  families. 
Although  tight  junctions  without  occludin  are  rare,  tight  junctional  strands  and   31   barrier function are still present in cells and epithelial tissues deficient for occludin  (Niessen, 2007) , indicating that occludin is not essential for tight junction forma tion.  Instead, members of the claudin family can induce cell - cell adhesion and are crucial  in  the  formation  of  tight  junction  strands.  Claudins  exhibit  homophilic  and  heterophilic  (with  other  claudin  subtypes)  adhesive  activities  through  their  extracellula r domain to form tight junction strands. Occludins, claudins and JAMs  are  unable  to  directly  interact  with  each  other  at  the  tight  junction.  Instead,  scaffolding proteins such as the zonula occludens proteins (ZO - 1, ZO - 2 and ZO - 3),  MUPP1  and  MAGI  proteins  cluster  the  transmembrane  proteins  together  at  tight  junctions  (Niessen, 2007) . For example, ZO proteins bind directly with occludin and  claudins via their PDZ domains and associate with actin through their C - terminus,  thereby  providing   a  direct  link  with  the  cytoskeleton  (Schneeberger  and  Lynch,  2004) .   Adherens  j unctions  are  formed  by  members  of  the  cadherin  family  of  adhesion proteins. Endothelial cells express relatively high levels of two cadherins:  vascular endothelial – cadherin (VE - cadherin), which is endothelial specific, and      Figure  8 . Schematic representation of the basic structural components of tight  junctions.   ZOs, cingulin, MUPP1 and MAGI can provide a link for claudins, occludins and  JAMs to the actin cytoskeleton to form tight junctional strands. ZO, zona occludens;  MUPP1,  mul tiple  PDZ  domain  protein;  MAGI,  membrane - associated  guanylate  kinase.  (Niessen, 2007)   (Furuse and Tsukita, 2006) . In endothelial cells, Claudin 5 is  the principal member from the claudin family that forms tight juncti ons  (Morita et  al., 2003) .      32     Figure  9 . Schematic representation of  adherens junctions and complexus  adherens in endothelial cells.   (A)  In  complexus  adherens,  VE - cadherin  associates  with  vimentin  filaments  via  plakoglobin/desmoplakin or p0071. (B) In adherens junctions, VE - cadherin directly  interacts with  β - catenin and pla koglobin at the membrane - distal site, and with p120  and p0071 at the juxtamembrane site. The exact molecular link between the VE - cadherin - catenin complex and the actin filaments is still obscure.  (Wallez and Huber,  2 008)     neuronal cadherin (N - cadherin), which is also expressed in other cell types such as  neural cells and smooth muscle cells  (Bazzoni and Dejana, 2004) . VE - cadherin is a  type II cadherin  that harbours high adhesive activity. In endothelial cells, it is the  major  component  of  adherens  junctions  and  is  a  crucial  determinant  of  vascular  integrity.  It  is  proposed  that  VE - cadherin  dimers  interact  in  trans   through  their  extracellular domain 1 an d VE - cadherin trimers interact  in cis  via their extracellular  domain 4 to form a hexameric structure  (Hewat et al., 2007; Legrand et al., 2001) .  The intracellular domain of VE -  cadherin contains a proximal binding s ite for p120  and  p0071,  and  a  distal  binding  site  for  β - catenin  and  plakoglobin  (Wallez  and  Huber,  2008) .  β - catenin  and  plakoglobin  bind  to  α - catenin,  which  interacts  with  several  actin - binding  proteins  including  α - actinin,  ajuba  and  zonula  occludens - 1  (ZO - 1). It is believed that the interaction of  α - actinin to  β - catenin is dynamic in that  α - catenin shuttles between the junction and the cytoskeleton, where it induces actin  bundling after detaching from the cadherins  (Dejana et al., 2008) . The VE - c adherin  complex  may  also  associate  with  the  vimentin  cytoskeleton  in  some  vascular  
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locations. This association is mediated by the interaction of either plakoglobin or 
p0071 to desmoplakin, which in turn associates with vimentin (Kowalczyk et al., 
1998; Schmelz et al., 1994). The indirect association between VE-cadherin and the 
cytoskeletal network is required for control of junction stabilization. Deletion of the 
domain that is responsible for binding to β-catenin and plakoglobin jeopardizes the 
strength of the cell junction (Navarro et al., 1995). In the mouse, truncation of this 
domain  impairs  vascular  remodelling  and  results  in  embryonic  lethality  that  is 
similar to the phenotype caused by complete absence of VE-cadherin (Carmeliet et 
al.,  1999).  Importantly,  VE-cadherin  is  important  in  the  maintenance  of  nascent 
vessels since endothelial cells that lack VE-cadherin or are subjected to VE-cadherin 
blocking antibodies disassemble from the vessels (Crosby et al., 2005) 
 
1.2.3.2  Endothelial-Pericyte interactions 
Pericytes are vascular mural cells that are embedded within the vascular basement 
membrane of blood microvessels. They differ from vSMCs by their localization to 
blood  vessels,  their  morphology  and  also  their  marker  expression.  Pericytes  are 
found around blood capillaries, pre-capillary arterioles, post-capillary venules and 
collecting venules where they extend long cytoplasmic processes that wrap around 
the abluminal endothelium wall. vSMCs, however, are separated from the vascular 
basement membrane by a layer of mesenchymal cells and the intima, and compose a 
separate ECM layer called the media. They are usually localized to bigger vessels 
such as arteries and vein where they mediate vascular tone and contraction (Armulik 
et al., 2005).  
  In the CNS, there is a high percentage of pericyte coverage of microvessels 
(e.g. in the retina, the ratio of pericytes to EC is 1:1 (Shepro and Morel, 1993)) 
probably  because  pericytes  contribute  to  the  formation  of  the  blood-brain-barrier 
(Armulik et al., 2005). Although their contractile forces can serve as a supporting 
scaffold for vessels, pericytes also synthesize and promote assembly of basement 
membrane  components  (Davis  and  Senger,  2005),  therefore  enriching  the 
perivascular scaffold. The interaction between pericytes and endothelial cells induces 
transforming growth factor-β (TGFβ) activation (Sato et al., 1990), which results in 
increased  ECM  synthesis  and  deposition  and  decreased  ECM  turnover  through  
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secretion of proteinase inhibitors such as TIMP3 (Davis and Senger, 2005) (Saunders 
et al., 2006). 
Pericytes also communicate with endothelial cells by direct physical contact 
and paracrine signalling pathways. Gap junctions between the cytoplasm of pericytes 
and endothelial cells allow exchange of ions and small molecules; adhesion plaques 
anchor pericytes to endothelial cells; and peg-and-socket contacts enable the cells to 
penetrate through interruptions in the vessel basement membrane and touch each 
other (Rucker et al., 2000).  
  The  functional  importance  of  pericyte  recruitment  and  attachment  to 
endothelial  cells  became  apparent  from  genetic  studies  in  mice  where  signalling 
pathways such as that of Angiopoietin 1 (Ang1)/Tie2, platelet-derived growth factor 
B (PDGFB)/PDGF receptor β (PDGFRβ) and sphingosine-1-phosphate (S1P)/S1P 
receptors (S1P1) have been perturbed. Ang1, which is expressed mainly by mural 
cells, is an agonistic ligand of Tie2, which is specifically expressed by endothelial 
cells  (Suri  et  al.,  1996).  Mice  null  for  Ang1  or  Tie2  die  at  midgestation  from 
cardiovascular  failure,  and  their  vessels  exhibit  a  poorly  organized  basement 
membrane, reduced pericyte coverage and detachment of pericytes from endothelial 
cells (Dumont et al., 1994; Suri et al., 1996). Overexpression of Ang1, on the other 
hand, leads to an expanded and stabilized, leakage-resistant vasculature (Suri et al., 
1998)  (Thurston  et  al.,  1999;  Uemura  et  al.,  2002).  These  studies  indicate  that 
pericytes mediate the maturation and quiescence of the microvascular endothelium 
by producing Ang1.  
The PDGFB/PDGFRβ pathway is critically important for the expansion of 
the  pericytic  population  and  also  for  pericyte  migration  along  growing  vessels. 
During angiogenesis, endothelial cells, in particular endothelial tip cells, express and 
secrete  PDGF-B,  which  signals  through  PDGFR-β  expressed  by  mural  cells  to 
induce mural cell proliferation and migration during vessel maturation (Armulik et 
al., 2005). Mice homozygous for targeted disruption of genes encoding PDGF-B or 
PDGFR-β lack pericytes, resulting in endothelial hyperplasia, abnormal junctions 
and excessive luminal membrane folds (Hellstrom et al., 2001) and these mice die 
perinatally from vascular dysfunction (Leveen et al., 1994) (Lindahl et al., 1997) 
(Soriano,  1994).  In  addition,  the  level  of  PDGF-B  expression  and  the  ability  of 
PDGF-B to binding to heparan sulphate proteoglycans (HSPGs) to create a gradient 
of PDGF-B in the vicinity of endothelial cells  also contribute to proper pericyte  
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coverage of vessels. Mice heterozygous for the gene encoding PDGF-B have reduced 
pericyte numbers compared to wild-type mice (Hammes et al., 2002) and pericytes of 
mice that express retention motif-deficient PDGF-B are partially detached (Lindblom 
et al., 2003).  
Sphingosine-1-phosphate (S1P) is a secreted sphingolipid that binds to G-
protein coupled receptors, denoted as S1P1 to 5. During embryonic development, S1P1 
is expressed in the endothelium (Liu et al., 2000) and endothelial-specific deletion of 
S1p1  results  in  defects  in  mural  coverage  of  vessels  (Allende  et  al.,  2003).  The 
proposed role of S1P1 in mural cell attachment is its  signalling through Rac1 in 
endothelial cells to induce microtubule polymerization and trafficking of N-cadherin 
to polarized plasma membrane domains to endothelial-mural cell contacts, thereby 
strengthening pericyte attachment to endothelial cells (Paik et al., 2004).  
1.2.3.3  The extracellular matrix (ECM) 
The vascular basement membrane is composed of laminins (predominantly laminin-
8/laminin  α4β1γ1  and  laminin-10/laminin  α5β1γ1),  type  IV  collagens,  perlecan, 
nidogens, collagen XVIII and von Willebrand factor (Hynes, 2007). Laminins are the 
primary determinants of basement membrane assembly while the others listed above 
are  accessory  components  (Davis  and  Senger,  2005).  The  structural  integrity  of 
vascular basement membrane is particularly important during mechanical stress since 
mice homozygous for loss of collagen IV, perlecan and laminin α5 chain display 
dilated blood vessels (Costell et al., 1999; Miner et al., 1998; Poschl et al., 2004). In 
mice lacking collagen IV, perlecan or laminin α4, the vascular basement membrane 
matrix forms but becomes unstable and breaks-down over time (Costell et al., 1999; 
Poschl et al., 2004; Thyboll et al., 2002).  
In  addition  to  the  mechanical  function  of  the  ECM,  the  adhesion  of 
endothelial  cells  to  specific  components  of  the  basement  membrane  promotes 
endothelial cell quiescence. For example, it is thought that laminins play a role in 
stabilizing endothelial tubes by interacting with laminin-binding integrins (e.g. α6β1, 
α3β1)  expressed  by  endothelial  cells.  Activation  of  these  receptors  may  promote 
vessel  stabilization  by  suppressing  endothelial  cell  proliferation  and  signalling 
pathways that regulate endothelial cell activation such as the Ras-MAPK and NFκB 
pathways  (Klein  et  al.,  2002;  Mettouchi  et  al.,  2001).  Laminin-1  also  induces 
persistent  activation  of  GTPase  Rac  and  PKA  and  suppresses  Rho  activity  to  
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maintain endothelial cells in a quiescent state (Davis and Senger, 2005). Therefore, 
the laminin-rich basement membrane that envelops established vessels sustains Rac 
activity in endothelial cells and also bars endothelial cells from interstitial collagen I 
(which induces EC morphogenesis), thereby keeping vessels stabilized (Davis and 
Senger, 2005). 
The ECM also serves as a source of substrates for the production of inhibitors 
of  angiogenesis.  For  example,  endostatin  is  a  C-terminal  proteolytic  fragment  of 
collagen XVIII and is recognized as a negative regulator of angiogenesis especially 
in  a  tumour  setting  (Folkman,  2006).  However,  the  mechanism  of  action  of 
endostatin remains obscure (Hynes, 2007) although there are reports that binding to 
integrin α5β1 on endothelial cells down-regulates RhoA activity and consequently 
disrupts focal adhesions and actin stress fibres (Wickstrom et al., 2003). Tumstatin is 
also a product of an ECM molecule, collagen α3 (type IV), and binds to αvβ3 on 
endothelial cells ex vivo and in vivo, and appears to be an endogenous inhibitor of 
angiogenesis (Hamano et al., 2003). Endorepellin, a proteolytic fragment of perlecan, 
also  has  anti-angiogenic  activity  by  blocking  endothelial  cell  migration  and  tube 
formation in vitro, and inhibits growth factor-induced angiogenesis in Matrigel plugs 
and the CAM assay (Bix et al., 2004).  
  It therefore appears that the anti-angiogenic activity of ECM is dependent on 
the  activities  of  proteases  such  MMPs  and  serine  proteinases.  For  example,  the 
generation of tumstatin from collagen α3 is mediated by MMP-9 (Hamano et al., 
2003).  Other  MMPs  are  also  known  to  degrade  basement  membrane  matrix 
components,  and  these  include  membrane-type MMPs  (MT-MMPs),  MMP-3  and 
MMP-10 (Davis and Senger, 2005). However, the activities of these enzymes need to 
be tightly regulated since degradation of the matrix also leads to destabilization of 
the  vessel  structure.  The  tissue  inhibitor  of  metalloproteinase  (TIMP)  class  of 
enzymes provides native protection to endothelial cells by inhibiting the function of 
MMPs. In the vascular milieu, endothelial-derived TIMP-2 and pericytic TIMP-3 
block the activities of MMP-1, MMP-10, ADAM15 and MT1-MMP (Baker et al., 
2002; Saunders et al., 2006), thereby stabilizing the vascular  structure. It is also 
interesting that the pericytic expression of TIMP-3 is increased when co-cultured 
with  endothelial  cells  (Saunders  et  al.,  2006),  highlighting  the  importance  of 
intercellular interactions in regulating vessel homeostasis.   
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1.2.4  VESSEL REGRESSION. 
Although angiogenesis is largely viewed as the formation of new blood vessels, this 
term also encompasses the process of vessel regression, which occurs during vessel 
network remodelling and maturation. The molecular mechanisms that govern vessel 
regression  are  still  relatively  unknown.  However,  it  is  assumed  that  for  vessel 
regression or pruning to occur, vessels have to lose integrity or stability as a result of 
degradation of the vascular basement membrane, detachment of mural cells from the 
vessels  and/or  unstable  endothelial  cell  junctions.  Although  unidentified,  the 
mechanism behind vessel regression requires temporal and spatial regulation as loss 
of a tight regulation can lead to vessel rupture and excessive vessel regression.  
Vessel  regression  is  observed  when  pro-angiogenic  factors  are  removed 
(Benjamin et al., 1999). In the eye, the hyaloid vessels that surround the lens during 
embryogenesis regress within the first two weeks of birth (Ito and Yoshioka, 1999). 
The regression of hyaloid vessels requires endothelial cell apoptosis, an event that is 
induced by Wnt signalling (Lobov et al., 2005). However, it is also possible that 
apoptosis may not be a cause but rather a consequence of vessel regression. The 
latter case is supported by various studies. Activation of Rho-kinase signalling and 
cell contractility in endothelial cells result in retraction of sprouting vessels in an in 
vitro 3D culture system that is also accompanied by cell death (Mavria et al., 2006). 
The observed apoptosis is the result of changes in cell shape and detachment from 
the extracellular matrix since apoptosis followed cell rounding (Im and Kazlauskas, 
2007a;  Mavria  et  al.,  2006).  In  addition,  inhibition  of  apoptosis  by  the  caspase 
inhibitor ZVAD failed to prevent cell rounding and retraction induced by Rho-kinase 
(Mavria et al., 2006).  
  Vessel regression may also be a consequence of loss or decrease in signals 
that promote endothelial cell survival and vessel stability. For example, PI3K/Akt 
pathway  is  important  in  the  formation  and  stabilization  of  vessel  tubes  (Im  and 
Kazlauskas, 2007a). Reduction of PI3K/Akt signalling by limiting the amount of 
PI3K substrate, PtdIns-4,5-P2, results in tube regression without an effect on tube 
formation  (Im  and  Kazlauskas,  2007a).  This  is  mediated  through  the  competing 
activity of PLCγ for PtdIns-4,5-P2, therefore antagonizing PI3K/Akt signalling (Im 
and  Kazlauskas,  2007a).  Another  pathway  that  prevents  vessel  regression  is  the 
ERK1/2-MAPK pathway. ERK1/2 inhibits Rho-kinase activation, whose activity has 
been  demonstrated  to  induce  vessel  regression  in  vitro  and  in  vivo  (Im  and  
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Kazlauskas, 2007b; Mavria et al., 2006). In addition, the Src family kinases (SFKs) 
have been demonstrated to prevent tube regression by activating the ERK pathway 
and thereby antagonising Rho/ROCK pathway (Im and Kazlauskas, 2007b). 
  As  mentioned  above,  vessel  stability  is  promoted  by  vascular  basement 
membrane and by vascular mural cells. It is therefore possible that the loss of vessel 
stability from disintegration of the basement membrane or detachment of mural cells 
can lead to vessel regression. In a 3D collagen matrix, the soluble proteases MMP-1 
and  MMP-10  increase  tube  regression  by  degrading  collagen  type  I  without 
compromising tube morphogenesis (Davis and Senger, 2005; Saunders et al., 2005). 
As MMP-10 also cleaves collagen IV, laminin and perlecan, which are responsible 
for  the  establishment  of  basement  membrane  and  maintenance  of  vascular  tube 
networks,  it  is  also  plausible  that  MMP-10  activity  can  contribute  to  vessel 
regression  in  vivo.  Angiopoietin  2  (Ang2)  antagonizes  Ang1-mediated  Tie2 
signalling  and  causes  vessel  destabilization  involving  detachment  or  loss  of 
pericytes. This conclusion is drawn from experiments where upregulation of Ang2 
expression in the eye induced pericyte detachment from retinal vessels (Hammes et 
al., 2004). Furthermore, systemic overexpression of Ang2 resulted in impairment in 
the association of tumour pericytes and endothelial cells, leading to tumour vessel 
regression within 24 hours without a concomitant decrease in VEGF signalling (Cao 
et al., 2007).  
  The integrity of endothelial cell junctions is also essential for maintaining 
vascular integrity and VE-cadherin serves such a function. However, tight adhesion 
between cells is diminished when VE-cadherin is cleaved by proteases such as the 
disintegrin and metalloprotease ADAM10 to release a carboxyl-terminal membrane 
stub, which is a substrate for γ-secretase cleavage (Schulz et al., 2008). Although, 
ADAM10  activity  increases  vascular  permeability  and  facilitates  leukocyte 
transmigration (Schulz et al., 2008), it is not known whether it also regulates vessel 
regression by its ability to weaken adhesion junctions.  
 
1.2.5    SUMMARY  
As  outlined  above,  angiogenesis  is  a  very  dynamic  and  complex  process  that 
involves multicellular components at different phases of vascular development. The 
formation of an organized, hierarchical vessel network requires tight coordination of  
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cell proliferation, differentiation, migration, matrix adhesion and cell-cell signalling 
during vessel morphogenesis.  
 
1.3  NOTCH SIGNALLING 
The Notch pathway is an evolutionarily conserved signalling system that is required 
for normal embryonic development and also functions to regulate tissue homeostasis 
and maintenance of stems cells in adults (Artavanis-Tsakonas et al., 1999; Gridley, 
1997). The pathway was originally identified in Drosophila, where the first mutant 
allele gave rise to a notched wing. Since then, proteins of the Notch pathway have 
been discovered in virtually all metazoans and studied extensively in flies, worms 
and mammals. These studies have unravelled the multiple roles of Notch signalling 
in  cell  fate  specification,  patterning  and  morphogenesis  through  effects  on 
differentiation, proliferation, survival and apoptosis (Bray, 2006; Fiuza and Arias, 
2007). Furthermore, Notch signalling integrates with other core signalling networks 
such as Hedgehog, transforming growth factor β (TGFβ) and Wnt to form a larger, 
more  complex  signalling  system  to  achieve  the  morphological  complexity  of 
metazoans. 
  The  importance  of  Notch  signalling  during  development  and  in  adults  is 
underscored by the finding that several diseases are associated with irregular Notch 
signalling. Aberrant Notch signalling has been identified in several cancers such as 
head  and  neck  squamous  cell  carcinoma  (Zeng  et  al.,  2005)  and  T-cell  acute 
lymphoblastic leukaemia (Weng et al., 2004), and also in congenital diseases such as 
the  Alagille  syndrome  and  the  cerebral  autosomal  dominant  arteriopathy  with 
subcortical infarcts and leukoencephalopathy (CADASIL), both of which affect the 
blood vasculature. Although the link between Notch pathway and disease is very 
interesting,  I  will,  however,  only  discuss  Notch  signalling  in  the  context  of 
developmental biology in this thesis. 
 
1.3.1  THE CORE PATHWAY 
In mammals, there are five canonical Notch ligands, Delta-like 1 (Dll1), Delta-like 3 
(Dll3), Delta-like 4 (Dll4), Jagged1 (Jag1) and Jagged 2 (Jag2), which are classified 
as DSL (Delta, Serrate, LAG-2) ligands. The ligands are type 1 cell-surface proteins    40     Figure  10 . Protein structure of the vertebrate DSL family of ligands.   The  canonical  DSL  ligands  are  type  1  cell – surf ace  proteins  that  have  multiple  tandem epidermal growth factor (EGF) repeats in their extracellular domains. The  DSL  domain,  the  flanking  N - terminal  (NT)  and  the  first  two  EGF  repeats  are  required for DSL ligands to bind Notch  (Parks et al., 2006; Shimizu et al., 1999) . As  well as having almost twice the number of EGF repeats as Delta - like ligands, Jag1  and Jag2 have an additional cysteine - rich region (CR). The intracellular regions of  DSL ligands lack obvious sequen ce homology except that most, but not all, contain  multiple  lysine  residues  and  a  C - terminal  PDZ  (PSD - 95/Dlg/ZO1)  ligand  motif,  which  are  required  for  ligand  signalling  activity  and  interactions  with  the  cytoskeleton, respectively. Striped boxes, DSL domai n; white boxes, EGF repeat;  grey  boxes,  calcium - binding  EGF  repeat.  NT,  N - terminal  domain;  DSL,  Delta/Serrate/LAG - 2 domain; EGF, epidermal growth factor - like; CR, cysteine - rich  region;  TM,  transmembrane  domain;  PDSL,  PDZ  ligand  motif.  (D'Souza  et  al.,  2008)       with multiple tandem epidermal growth factor (EGF) repeats in their e xtracellular  domains (ECDs) ( Figure  10 ). DSL ligands bind to Notch receptors, which are large  (300kDa) single - pass type I transmembrane receptors ( Figure  11 ). In mammals, there  are  f our  Notch  receptors,  Notch1  to  Notch  4.  Binding  of  a  DSL  ligand  to  the  extracellular  domain  of  Notch  receptor  (NECD)  triggers  a  series  of  proteolytic  cleavages  of  Notch,  first  by  a  member  of  the  disintegrin  and  metalloproteases  (ADAM) within the juxtamembr ane regions (known as S2), followed by  γ - secretase  within the transmembrane domain (known as S3; See  Figure  12 ). The final cleavage  releases  the  Notch  intracellular  domain  (NICD)  from  the  cell  membrane,  which  transl ocates to the nucleus where it directly interacts with the CSL ( C BF1,  S u(H),  L AG1) transcription factor. In the absence of NICD, CSL represses transcription  through interactions with a co - repressor complex that contains a histone deacetylase  (Kao et al., 1998) . However, binding of NICD to CSL displaces the co - repressor  complex  and  replaces  it  with  a  transcriptional  activation  complex  that  includes   41   NICD, Mastermind - like 1 and histone acetyltransferases  such as p300 to  turn on  expression of Notch target genes such as the basic helix - loop - helix (bHLH) proteins  Hairy/Enhancer of Split  ( Hes ),  Hes - related proteins  ( Hey/HRT/HERP ) and  Notch - regulated ankyrin repeat protein  ( Nrarp ). However, the subset of Notch primary  target  genes transcribed is cell type - dependent. The  Hes  and  Hey  genes are, in turn,  transcriptional repressors of their own expression and also of further downstream  genes.           Figure  11 . Domain organization of Notch receptors.   Proteol ytic  cleavage  by  furin  produces  two  subunits,  Notch  extracellular  domain  (NECD)  and  Notch  intracellular  domain  (NICD),  which  remain  noncovalently  associated  at  the  cell  surface.  EGF - like  modules  11  and  12  participate  in  ligand  binding (shaded, EGF repeats  in yellow). C - terminal to the EGF repeats are three  LNR  repeats,  which  play  a  role  in  maintaining  the  receptor  in  its  resting  conformation  when  not  bound  to  ligand.  Two  consecutive  proteolytic  cleavages  induced  upon  ligand  activation  release  the  intracellu lar  domain  of  NICD.  NICD  consists of the RAM domain, which binds to CSL, NLS, ankyrin repeats, TAD , EP  domain,  which  binds  to  the  histone  acetylase  p300,  and  the  PEST/OPA  motif.  NECD,  Notch  extracellular  domain;  NICD,  Notch  intracellular  domain;  EGF,  epid ermal growth factor; LNR, lin - Notch repeats; RAM, RBPjk - associated molecule;  NLS,  nuclear  localization  signal;  TAD,  transactivation  domain,  PEST,  proline,  glutamate,  serine,  theronine - rich;  OPA,  glutamine - rich  sequence.  (Lubman  et  al. ,  2004)            42     Figure  12 . Current overview of Notch signal transduction.     The canonical Notch pathway mediates the regulation of a diverse array of cell fate  decisions through juxtacrine signalling. In the ER and Golgi, the NECD  is modified  by  a  series  of  glycosylation  events  mediated  by  Fringe  and  other  glycosyltransferases. In the  trans - Golgi, Notch undergoes proteolysis by a furin - like  convertase (S1 site), generating a glycosylated, presumably divalent - cation - stabilized  Notch  heterodimer. Upon ligand binding, NECD is removed through cleavage by an  ADAM  metalloprotease,  TNF - α   converting  enzyme  (TACE,  site  S2).  NECD  remains bound to the ligand, and both proteins may be endocytosed by the ligand - presenting cell. The physical forc e generated by this ligand/NECD internalization  may be required for receptor cleavage by TACE. After cleavage by TACE, cleavage  by the  γ - secretase complex (S3 site) releases NICD from the cell membrane. NICD  translocates to the nucleus and associates with  the CSL transcriptional regulator. In  the absence of NICD, CSL is part of a repressor complex. Upon NICD binding, co - repressors are exchanged for co - activators including Mastermind and p300, leading  to the activation of target genes such as members of the  Hes  and  Hey  families and  Nrarp . Both the ligand and receptor can undergo ubiquitin - regulated internalization  and degradation. Note that the cellular compartments where modifications of Notch  receptors are depicted are only hypothetical. It is possible that  S2 and S3 cleavages  occur in an endosomal compartment.  (Hurlbut et al., 2007)   
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1.3.2  REGULATION OF NOTCH RECEPTOR ACTIVITY. 
The activation of Notch signalling is highly regulated. Prior to localization at the cell 
membrane, the Notch receptor is cleaved at the S1 site in the extracellular domain by 
a furin-like protease to produce a mature heterodimeric Notch (hNotch) receptor in 
the  trans-Golgi  network  ((Logeat  et  al.,  1998);Figure  12).  The  extracellular  and 
membrane-bound intracellular furin-cleavage fragments of hNotch are held together 
through non-covalent interactions that prevent receptor activation in the absence of 
ligand.  
The EGF repeats of Notch receptor are further modified by glycans such as 
O-fucose  glycans,  O-glucose  glycans  and  complex  N-glycans  (Stanley,  2007). 
Inactivation of protein O-fucosyl transferase 1 (POFUT1) or other activities required 
for  O-fucose  glycans  synthesis  results  in  inactive  Notch  receptors  and  Notch 
signalling defects in Drosophila (Haines and Irvine, 2003), zebrafish (Appel et al., 
2003) and mammals (Lu and Stanley, 2006). O-fucosylation of Notch is therefore 
absolutely  required  for  Notch  signalling.  It  is  postulated  that  O-fucosylation  is 
necessary for the stable cell surface expression of Notch receptors by regulating the 
trafficking of the receptor between the endoplasmic reticulum and the cell membrane 
(Okajima et al., 2005) (Sasamura et al., 2007). 
The transfer of N-acetylglucosamine (GlcNAc) to fucose on Notch is also 
required for Notch activity. In Drosophila, the glycosyltransferase responsible for 
this event is Fringe (Fng), while in mammals, there are three Fringe genes, Lunatic 
Fringe (Lfng), Manic Fringe (Mfng) and Radical Fringe (Rfng). Modification of O-
fucose by Fringe affects the strength of Notch-ligand binding so that different Notch 
signalling output arises (Yang et al., 2005). For example, in the Drosophila wing 
disc Fringe enhances Notch signalling induced by Delta but inhibits Notch signalling 
induced by Serrate to restrict Notch signalling to a stripe of cells at the dorsal/ventral 
boundary (Haines and Irvine, 2003). In mammals, Lfng and Mfng generally inhibit 
Jag1-induced Notch1 signalling and increase Dll1-induced Notch signalling (Stanley, 
2007). 
Modification of Notch by Fringe is followed by addition of Gal residues to 
GlcNAcβ(1,3)Fuc-O  dissacharide  by  a  Gal-transferase  (Moloney  et  al.,  2000). 
Again,  this  modification  of  Notch  receptor  regulates  Notch  activity  since  mice  
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lacking  β4GalT-1  have  poor  expression  of  several  Notch  targets  genes  at  mid-
gestation and these embryos have an extra lumbar vertebra (Chen et al., 2006). 
 
1.3.3  REGULATION OF DSL LIGANDS. 
The  expression  of  DSL  ligands  is  itself  regulated  by  Notch  signalling.  Notch-
mediated lateral inhibition and inductive signalling negatively and positively regulate 
DSL ligand expression, respectively, in neighbouring cells (D'Souza et al., 2008). 
There is therefore a feedback loop, whereby the signal-receiving cell is induced to 
express less or more ligand after Notch receptor activation. In addition, the Notch 
pathway  interacts  with  a  number  of  different  signalling  pathways,  which  also 
influence DSL ligand expression. For example, activation of Kdr up-regulates the 
expression of Dll4 (Liu et al., 2003; Patel et al., 2005). 
Apart  from  cell  type-specific  expression  of  DSL  ligands,  the  ligands  are 
regulated  post-translationally  by  ubiquitination,  endocytosis  and  proteolysis, 
processes  that  also  modulate  Notch  signalling  in  the  signal-receiving  cell. 
Ubiquitination of DSL ligands regulates ligand signalling activity and cell surface 
expression (Le Borgne and Schweisguth, 2003). The intracellular domains of Dll1, 
Dll4,  Jag1  and  Jag2  contain  multiple  lysine  residues  that  can  serve  as  potential 
ubiquitination sites. There are two structurally distinct RING-containing E3 ligases 
that influence Notch signalling, Neuralized (Neur) and Mind bomb (Mib), which 
function to enhance ligand endocytosis. In mammals, there are two Neur proteins, 
Neur1  and  Neur2,  and  two  Mib  proteins,  Mib1  and  Mib2.  Mib  ubiquitination  is 
responsible  for  DSL  ligand  endocytosis  that  activates  Notch  signalling  and  Neur 
functions downstream of Mib to direct lysosomal degradation of internalized ligands 
and thereby regulate the level of ligand available for Notch activation (Song et al., 
2006). In vertebrates, Neur and Mib do not appear to be functionally equivalent in 
modulating Notch signalling. Of the E3 ligases, only the disruption of Mib1 in mice 
produces the known Notch phenotypes and Notch embryonic lethality (Koo et al., 
2005; Koo et al., 2007). For example, Neur1 and Neur2 are dispensable for normal 
neurogenesis in mice, but Mib1 mutant embryos have strong neurogenic phenotypes 
in the brain and neural tube (Koo et al., 2005; Koo et al., 2007). Although Mib1 and 
Mib2 are functionally redundant (Zhang et al., 2007), Mib2 is not strongly expressed   45   during  embryonic  development.  There  is  therefore  the  requirement  for  Mib1  in  Notch - dependent embryonic processes  (Koo et al., 2007) .   The  endocytosis  of  DSL  ligand  is  required  for  Notch  activation  and  this  occurs in a ubiquiti nation -  and clathrin - dependent manner  (Le Borgne et al., 2005;  Nichols et al., 2007b) . In the absence of endocytosis, the ligands accumulate at the  cell surface where they are unable to activate Notch  (Nichols et al., 2007a; Parks et  al.,  2000) .  There  are  several  proposals  for  the  requirement  of  DSL  ligand    Figure  13 . Notch - induced DSL endocytosis.   DSL ligands are ubiquitinated (orange circles) by the E3 ligases Neuralized (Neur)  and/or  Mind  bomb  (Mib).  Binding  of  ubiquitinated  ligand  to  Notch  receptor  on  adjacent cell stimulates clustering of ligands and generate multiple interaction sites  within  DSL  clusters  for  the  ubiquitin - interacting  motif - containing  adaptor  epsin.  Multiple  epsin - DSL  interactions  may  stabil ize  ligand  within  the  clathrin - coated  vesicle  during  its  internalization  of  bound  Notch.  A  ‘pull’  generated  by  DSL  internalization  is  proposed  to  dissociate  the  bound  Notch  heterodimer,  allowing  NECD to be internalized along with DSL. Internalized NECD - DSL  complexes may  be dissociated and sorted during endosomal trafficking to allow DSL to be recycled  back to the plasma membrane, while NECD is degraded. DSL recycling may involve  deubiquitination by an unknown deubiquitinating enzyme.  (Nichols et al., 2007b)     
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endocytosis. As soluble DSL ligands require clustering for activity, it is possible that 
endocytosis clusters ligands, which are then recycled back to the cell surface for 
receptor interaction. Another suggestion is that sorting of ligands to an intracellular 
compartment  may  convert  the  ligand  to  an  active  form.  Alternatively,  recycling 
could  direct  ligand  to  a  specific  plasma  membrane  microdomain  or  maintain 
effective levels of ligand at the cell surface. Also, DSL recycling may be required to 
return the ligand to the cell surface following its internalization with NECDs during 
receptor  activation  (Nichols  et  al.,  2007a),  a  process  known  as  transendocytosis 
whereby the NECD is taken up into the signal-sending cell (Nichols et al., 2007a; 
Parks et al., 2000). Such a process would inflict a mechanical strain in Notch to 
expose the ADAM cleavage site and allow proteolytic activation for downstream 
signalling (D'Souza et al., 2008).  
Like the Notch receptor, the activity of DSL ligand can be regulated by the 
proteolytic activities of ADAMs and γ-secretase. Following cleavage by ADAMs in 
the juxtamembrane region, the extracellular domains of DSL ligands are released 
extracellularly as soluble proteins. However, not all soluble forms of DSL ligands 
activate Notch (Zolkiewska, 2008). For example, the soluble form of Drosophila 
Delta  is  inactive  in  vivo  and,  in  cultured  mammalian  cells,  soluble  extracellular 
domains of Dll1, Dll4 or Jag1 block Notch activity (Zolkiewska, 2008). In addition, 
increase in cleavage of DSL ligand leads to downregulation of Notch activity in 
trans (Muraguchi et al., 2007). DSL ligands can also bind to Notch receptors present 
in the same cell through their extracellular domains at the cell surface. Unlike trans 
interaction,  cis  interaction  between  ligand  and  receptor  is  antagonistic,  an  effect 
known as cis inhibition(Dyczynska et al., 2007; Zolkiewska, 2008). 
  Following ADAM-mediated processing, DSL ligands become substrates of γ-
secretase (Ikeuchi and Sisodia, 2003; Six et al., 2003) and the intracellular fragment 
of the ligand is released. All DSL ligands contain positively charged residues that 
can serve as nuclear localization signals (NLS), thereby targeting the ligand to the 
nucleus (LaVoie and Selkoe, 2003; Zolkiewska, 2008). It may therefore be possible 
that  DSL  ligands  themselves  regulate  gene  transcription.  Indeed,  the  soluble 
intracellular domain of Dll1 can bind to Smad2, Smad3 and Smad4 and enhance 
Smad3  transcriptional  activity  in  response  to  stimulation  of  cells  with  TGFβ 
(Hiratochi  et  al.,  2007).  These  findings  point  towards  a  bi-directional  signalling 
between Notch-expressing and ligand-expressing cells.  
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1.3.4  NON-CANONICAL NOTCH LIGANDS. 
Unlike canonical Notch ligands that share many features, non-canonical ligands are 
structurally  diverse  and  include  integral  membrane,  glycosylphosphatidylinositol 
(GPI)-linked and also secreted proteins (D'Souza et al., 2008).  
Delta-like 1 (Dlk-1) is an example of a membrane-tethered non-canonical 
ligand that binds to Notch. Only cis-interactions between Dlk-1 and Notch occur to 
induce cis-inhibition and not trans-activation of Notch signalling (Baladron et al., 
2005).  Non-canonical  ligands  can  also  activate  Notch  signalling,  as  shown  for 
F3/contactin1,  which  encodes  a  GPI-linked  neural  cell  adhesion  molecule. 
Contactin1 can interact with Notch in trans to activate Notch signalling to induce 
oligodendrocyte  differentiation  (Hu  et  al.,  2003).  Although  contactin  binding  to 
Notch produces NICD, in a γ-secretase manner, that can translocate to the nucleus 
for  signalling,  it  is  unable  to  activate  canonical  CSL-induced  Notch  signalling. 
Instead, contactin induces Notch signalling that involves Deltex (Cui et al., 2004; Hu 
et al., 2003).  
In vertebrates, two types of secreted, non-DSL proteins have been identified 
as  putative  Notch  ligands:  CCN3,  a  member  of  the  connective  tissue  growth 
factor/cysteine-rich  61/nephroblastoma  overexpressed  gene  (CCN)  family  of 
proteins, and MAGP-1 and -2, members of the microfibril-associated glycoprotein 
family (Gibson et al., 1996; Gibson et al., 1991). CCN3 is able to interact with the 
EGF repeats of Notch1 through its C-terminal cysteine knot domain (Sakamoto et al., 
2002).  The  findings  that  co-expression  of  CCN3  in  cell  cultures  can  potentiate 
endogenous CSL-dependent Notch signalling and that gains and losses in CCN3 lead 
to corresponding changes in Hes1 expression suggest that CCN3 may activate Notch 
in  an  autocrine  fashion  (Sakamoto  et  al.,  2002;  Minamizato  et  al.,  2007).  The 
interaction  between  MAGP-1  and  -2  with  Notch  induces  γ-secretase-dependent 
NICD generation and CSL-dependent activation (Miyamoto et al., 2006). Like DSL 
ligands,  MAGP-2  can  induce  ADAM-independent  dissociation  of  the  Notch 
heterodimer that is required for proteolytic activation and downstream signalling. 
Interestingly, MAGP-2 has an angiogenic function. It is able to promote endothelial 
cell sprouting by antagonizing Notch signalling induced by Jag1 (Albig et al., 2008; 
Albig et al., 2007). 
  It is still unclear whether endocytosis of non-canonical ligands is required for 
inducing  Notch  activity.  As  non-enzymatic  dissociation  of  Notch  is  required  for  
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signal activation, it has been postulated that tethering of the non-canonical ligands to 
the ECM may generate sufficient pulling force on the Notch receptor (D'Souza et al., 
2008). 
1.3.5  CSL-INDEPENDENT SIGNALLING 
Although much of Notch activation is effected through the CSL-dependent pathway, 
there  is  growing  evidence  that  the  activation  of  Notch  receptor  triggers  cellular 
responses through CSL-independent pathways. One such pathway is the activation of 
β1  integrins  by  Notch1  (Hodkinson  et  al.,  2007).  This  event  also  relies  on  the 
production of NICD1 from S3 cleavage of the Notch receptor. NICD1 specifically 
activates R-Ras, which antagonizes H-Ras-mediated integrin suppression to increase 
integrin affinity (Hodkinson et al., 2007). The increase in integrin activity enhances 
cell  adhesion  to  extracellular  matrix  proteins.  For  example,  human  myeloid  cells 
(K562)  that  have  been  transfected  with  NICD1  or  that  have  been  activated  with 
recombinant Dll4 exhibit increased adhesion to fibronectin (Hodkinson et al., 2007). 
Also, overexpression of intracellular domain of Notch4 (NICD4) in endothelial cells 
results in β1 integrin-mediated increase in adhesion to collagen and these cells have 
reduced capacity to sprout in response to VEGF both in vitro and in vivo (Leong et 
al., 2002). The activation of R-Ras does not require CSL-mediated transcription and 
may therefore transmit rapid changes in cellular signalling in response to interaction 
with Notch ligands expressed on adjacent cells (Hodkinson et al., 2007). 
  Another  CSL-independent  pathway  that  is  activated  after  Notch  receptor 
binding  is  Abl  tyrosine  kinase  and  its  accessory  proteins  Disabled  and  Trio. 
Interesting  studies  performed  in  Drosophila  showed  that  Notch  binds  directly  to 
Disabled and Trio to regulate Abl signalling (Crowner et al., 2003; Le Gall et al., 
2008). Specific deletion of the Disabled binding domain in Notch results in defects in 
embryonic axon patterning with little or no effect on neurogenesis (Le Gall et al., 
2008). In addition, the authors showed that the canonical Notch signalling pathway is 
dispensable  for  axonal  function.  Therefore,  although  axon  patterning  and 
neurogenesis  are dependent on Notch signalling, the mechanisms that drive their 
processes  differ.  In  the  former  case,  a  CSL-independent  pathway  that  involves 
Disabled and Abl is required while in the latter case, the canonical CSL-dependent 
pathway is important.  
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1.3.6  NOTCH SIGNALLING IN VASCULAR DEVELOPMENT 
Notch receptors and DSL ligands are expressed in vascular cells, suggesting that 
Notch signalling may have important roles in growth and differentiation of blood 
vessels.  For  example,  the  transcripts  of  Notch1  and  Notch4  are  expressed  in 
endothelial cells and Notch3 is expressed in vascular smooth muscle cells (vSMCs) 
of arteries. The ligands Dll1, Jag1 and Dll4 are also expressed in endothelial cells 
(Claxton and Fruttiger, 2004; Villa et al., 2001). The requirement of Notch signalling 
in  blood  vessel  formation  is  reflected  in  the  failure  of  proper  blood  vessel 
development after genetic deletion of different Notch components in mouse as well 
as in zebrafish (see Table 1). 
1.3.6.1  Notch regulates arterial-venous differentiation 
It is now apparent that genetic factors underlie blood vessel identity and that the 
Notch pathway acts at a specific step in arterial-venous differentiation to repress a 
venous cell fate program (Lawson et al., 2001). There are differences in the spatial 
expression of certain Notch receptors and ligands among blood vessels. For example, 
during zebrafish embryonic vascular development, notch5 and grl are expressed in 
the dorsal aorta (DA) but not in the posterior cardinal vein (PCV) (Zhong et al., 
2000). In the mouse, Notch4 is expressed more strongly in arterial endothelium than 
in venous endothelium (Claxton and Fruttiger, 2004). Also, the ligand Dll4 is mostly 
restricted to arterial endothelium in the mouse and zebrafish (Claxton and Fruttiger, 
2004; Leslie et al., 2007; Mailhos et al., 2001; Siekmann and Lawson, 2007).  
Analyses of several mouse mutants where a Notch receptor, a DSL ligand or 
a Notch effector has been genetically knocked out revealed deformities in arterial-
vein formation (Table 1). Dll4 heterozygous mouse embryos exhibit malformations 
of arteries that include stenosis and atresia of the aorta, defective arterial branching 
and loss of arterial markers such as Ephrin-B2 (Gale et al., 2004; Krebs et al., 2004). 
The loss of arterial markers is also observed in the zebrafish mindbomb (Lawson et 
al., 2001) and gridlock mutants and in mice where Rbpj (Krebs et al., 2004) and both 
Hey1 and Hey2 (Fischer et al., 2004) are deleted. The reduction or loss of Notch 
signalling is accompanied by an expansion of veins and ectopic expression of venous 
markers such as flt4 and ephB4 in the dorsal aorta of the zebrafish (Lawson et al., 
2001;  Zhong  et  al.,  2001). The  converse  experiments,  where  Notch  signalling  is 
ectopically activated, results in decreased flt4 expression in venous vessels (Lawson  
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et al., 2001). These findings suggest that Notch signalling acts to repress the venous 
fate  within  the  developing  arterial  primordium.  This  hypothesis  is  further 
strengthened by the finding that COUP-TFII, a venous marker, suppresses Notch 
signalling  in  venous  endothelium.  COUP-TFII  (chicken  ovalbumin  upstream 
promoter-transcription  factor  II)  is  an  orphan  nuclear  receptor  that  has  a  cell-
autonomous role in the formation of the venous endothelium and is also important in 
the maintenance of venous cell fate (You et al., 2005). Endothelial-specific deletion 
of  COUP-TFII  results  in  ectopic  expression  of  the  arterial  endothelial  marker, 
Ephrin-B2, and Notch pathway genes such as Notch1, Jag1 and Hey2 in the veins of 
mutant mice (You et al., 2005). Conversely, overexpression of COUP-TFII in all 
endothelial cells completely converts cells of arterial lineage to the venous lineage.  
Together,  the  genetic  studies  in  mouse  and  zebrafish  have  revealed  the 
requirement of Notch signalling in arterial-venous differentiation.  
 
1.3.6.2  Notch regulates vascular smooth muscle cell (vSMC) differentiation 
Notch  signalling  plays  an  important  role  in  the  differentiation,  physiology  and 
function of vSMCs. Inactivation of Notch signalling specifically in mouse neural 
crest cells revealed that Notch signalling is required for the differentiation of cardiac 
neural crest cells into smooth muscle cells (High et al., 2007). In addition, Jag1-
mediated Notch signalling promotes SMC differentiation from human aortic smooth 
muscle  cells  and  murine  embryonic  fibroblast  cell  line  (Doi  et  al.,  2006). 
Furthermore, the smooth muscle cell markers smooth muscle myosin heavy chain 
and smooth muscle α-actin have been demonstrated to be direct Notch target genes 
(Doi et al., 2006) (Noseda et al., 2006).  
  Genetic deletion of mouse Notch3, which is expressed in vSMCs of arteries 
but not of veins, results in a thinner vSMC coat around arteries than that found 
around wildtype arteries (Domenga et al., 2004). Arterial vSMCs are distinct from 
venous vSMCs in its gene expression. For example, arterial, but not venous, vSMCs 
express smoothelin (van der Loop et al., 1997) and have active SM22α promoter 
activity (Moessler et al., 1996). In Notch3
-/- mice, vSMCs that surround arteries lose 
their arterial identity and acquire a venous one, as observed by loss of smoothelin 
and  SM22α  promoter-driven  β-galactosidase  protein  (Domenga  et  al.,  2004). 
Although  the  arteries  in  Notch3
-/-  mice  consequently  fail  to  mature  and  exhibit  
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marked defects, they still express endothelial cell arterial markers such as ephrin B2 
and  connexin  40  (Domenga  et  al.,  2004),  indicating  that  the  arterial  identity  of 
endothelial cells and of vSMCs that surround them is specified independently. 
Together, these studies demonstrate that Notch signalling not only regulates 
differentiation of vSMCs but also regulates the arterial specification of vSMCs.   
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Table 1. Vascular phenotypes of mice deficient in Notch signalling components. 
     
Gene disrupted  Lethality?  Vascular Phenotype? 
DSL Ligand     
   Dll1  E12  Severe haemorrhage at E10. (Hrabe de Angelis et al., 1997) 
   Dll3  P0-P10  None. 
   Dll4  Viable  Dll4
+/-: 
E10.5  
The Dll4 gene is haploinsufficient so that even heterozygosity causes malformation of arteries 
(stenosis and atresia of the aorta), defective arterial branching. There is also absence of vessel 
remodelling in yolk sacs. (Gale et al., 2004; Krebs et al., 2004) 
   Jag1  E11.5  Embryos have severe haemorrhages and lack vascular remodelling. 
Yolk sacs lack large vessels. (Xue et al., 1999) 
   Jag2  Perinatal viable  None.(Jiang et al., 1998) 
     
Receptor     
   Notch1  E11.5  Yolk  sacs  display  disorganized,  confluent  vascular  plexus  and  lack  large  vitelline  blood 
vessels. 
In  the  embryo  proper,  there  is  defective  cardinal  vein,  lack  of  intersomitic  vessels  and 
collapsed dorsal aorta. (Krebs et al., 2000) 
   Notch2  E10.5  Cardiovascular dysfunction and pericardial oedema. (McCright et al., 2006) 
   Notch3  No  Arterial defects: enlarged artery, defective arterial myogenic responses. 
vSMC defects: thinner vSMC coat around arteries, altered cell morphology (thin, elongated 
cytoplasmic processes). 
Thin, disorganized tunica media composed of discontinuous layers of non-cohesive vSMCs. 
   Notch4  Viable  None.(Krebs et al., 2000) 
   Notch1 + Notch4  E9.5  More severe phenotype than Notch1 null mutant. (Krebs et al., 2000) 
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Notch effectors and 
target genes 
   
   Rbpj    Lack of vascular remodelling in yolk sac and primitive vasculature in embryo. 
Loss of arterial markers. (Krebs et al., 2004) 
   Hey1    None. 
   Hey2 or gridlock  P10  In mouse, deletion of Hey2 leads to ventricle septum defects and other cardiac abnormalities 
without vascular defects. (Gessler et al., 2002) (Donovan et al., 2002) 
Mutations of grl in zebrafish results in defective arterial-venous differentiation. Decrease of 
grl function ablates regions of the artery while expands contiguous regions of the vein. (Zhong 
et al., 2001) 
   Hey1 + Hey2  E11.5  Hey1 and Hey2 double knockout mice have severe haemorrhage and enlarged pericardial sac.  
Yolk sacs lack vessel remodelling and vitelline vessels, which may have degenerated. 
Reduction or loss of aorta and cardinal vein.(Fischer et al., 2004) 
     
Notch modulators     
   Mindbomb   
 
 
EC-specific: 
E11.5 
 
Mib
ta52b zebrafish mutants show: defects in arterial-venous differentiation with dysregulation 
of arterial and venous endothelial markers, cranial haemorrhage, lack of circulation, arterial-
venous shunts and aberrant ISV projections (Lawson et al., 2001). 
Endothelial specific deletion of Mib1 in mouse using Tie2-Cre results in embryonic lethality 
at E11.5. There are defects in vascular remodelling: avascular yolk sac, pericardial effusion, 
and also abnormal formation of dorsal aorta with loss of arterial markers.(Koo et al., 2007) 
   Pofut1  E10.5  Defects in the formation of head vessel and ISVs. Disorganized vessels.  (Shi and Stanley, 
2003)   54   1.4   A NIMAL MODELS OF ANGI OGENESIS   Two animal models were used intensively to study the mechanisms of angio genesis  during my PhD: the postnatal mouse retina and the embryonic zebrafish, where I  have focused on the development of intersegmental vessels.   1.4.1   T HE EARLY POST NATAL  MOUSE RETINA   Unlike primate retinas, rodent retinas become vascularized soon after birth through  sprouting angiogenesis. Endothelial cells migrate into the retina through the optic  nerve head and form a primary vascular network that spreads radia lly, reaching the  periphery  of  the  retina  within  7  to  8  days  after  birth.  Retinal  vascularization  is  closely associated with the astrocytic network that forms prior to the emergence of  endothelial  cells  (see  1.2.1.4 ).    The  astrocytic  network  serves  as  a  scaffold  for  nascent blood vessels and is also a source of VEGF - A production. Astrocytes at the  periphery of the retina, which is hypoxic, express abundant amounts of VEGF - A  whereas those nearer the optic nerve and  are in close proximity to blood vessels  express  less.  A  gradient  of  VEGF - A  is  therefore  established,  and  this  gradient  induces guided migration of endothelial cells toward hypoxic regions of the retina.  As the vessels expand radially to vascularize the su rface of the retina, they undergo    Figure  14 . Retinal vessel development in the mou se.   Retinas from post - natal day 3 (P3,  A ), 5 (P5,  B ) and 7 (P7,  C  and  D ) mice were  stained with Isolectin - B4, which binds to endothelial and microglial cells, and flat - mounted for imaging. Endothelial cells migrate into the retina through the optic  nerve h ead (O) and expand radially so that by P7, the entire surface of the retina is  vascularized and a hierarchy of arteries (A), veins (V) and capillaries is formed.  Furthermore, there is a new wave of endothelial sprouting commencing at P6 - P7  from  the  vein  an d  venous  vessels  (arrows  in  C  and  D ).  These  sprouts  migrate  perpendicular to the primary plexus to form two more vessel plexuses. Image  D  shows  Claudin  5  (red)  staining  outlining  endothelial  tight  junctions  as  well  as  filopodia of new endothelial sprouts ( arrows). Bars, 100µm.    55   differentiation  and  extensive  remodelling  so  that  a  hierarchical  network  of  blood  vessels comprising of arteries, veins and capillaries is formed.   Two further vascular plexuses, the inner and outer deeper plexuses, develop  in  the  retina  independently  of  retinal  astrocytes.  At  about  1  week  after  birth,  endothelial cells sprout from veins, venules and capillaries near veins of the primary  vascular plexus and migrate into the retina perpendicular to the primary plexus. This  process commences from the centre of the retina and expands tow ards the periphery.  It is likely that this process is stimulated by the transient expression of VEGF in the  somatas located in the inner nuclear layer (INL)  (Stone et al., 1995) . These nascent  sprouts grow along Mül ler cells, which are glial cells found in vertebrate retinas, and  branch  laterally  when  they  reach  the  inner  and  outer  boundaries  of  the  INL  to  establish two further networks parallel to the primary plexus.      The  post - natal  retina  has  gained  popularity  as  a  model  system  to  study  angiogenesis in recent years. As vessels develop in a central to peripheral manner,    vessels at the migrating front of the developing plexus are less mature compared to  more central vessels. There is therefore a spatial separation o f different aspects of  angiogenesis such as vessel sprouting and anastomosis at the growing edge of the  plexus, and tubulogenesis, arterial - venous differentiation and vessel regression at the    Figure  15  Vascular networks in the retina.   A sc hematic of a retinal cross - section ( A ,  (Fruttiger, 2007) ) and a cross section of a  whole - mount P14 retina stained with Isolectin - B4 ( B ) showing the primary, inner  deeper and outer deeper plexuses. RGC, retinal ganglion cells; IPL, inner plexiform  lay er;  INL,  inner  nuclear  layer;  OPL,  outer  plexiform  layer;  ONL,  outer  nuclear   layer; RPE, retinal pigment epithelium.    
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more  proximal  plexus.  Thus,  it  is  possible  to  study  and  compare  various 
morphogenic events in a temporal manner in the retinas of normal, as well as, mutant 
animals. Another advantage of the retina as a useful model is the flat nature of the 
primary plexus, which allows high-resolution imaging. 
 
1.4.2  ZEBRAFISH (DANIO RARIO) 
The developing zebrafish is another useful model system in which to examine the 
mechanisms of blood vessel formation and patterning during development because of 
its  genetic  and  experimental  accessibility  and  the  optical  clarity  of  the  embryos 
(Vogel  and  Weinstein,  2000).  In  addition,  the  development  of  several  tools  has 
facilitated the study of developing blood vessels in living embryos in high resolution. 
The  first  of  these  is  confocal  microangiography,  where  small  fluorescent 
microspheres are injected into the circulation of living embryos or larvae (Weinstein 
et al., 1995). Optical sections of the fluorescent blood vessels are then  collected 
using  a  confocal  microscope  and  with  3D  rendering,  the  spatial  structure  of  the 
functioning,  patent  vasculature  is  determined.  The  second  significant  tool  is  the 
generation of transgenic fish that express fluorescent proteins specifically in blood 
vessels. To date, the most widely used such model is the Tg(fli1:EGFP)
y1 transgenic 
fish, which expresses stable green fluorescent protein (GFP) under the endothelial 
fli1  promoter.  The  use  of  this  fish  has  permitted  the  visualization  of  not  only 
functional blood vessels but also non-patent vessels and even migrating progenitor 
cells (Isogai et al., 2001; Isogai et al., 2003) (Lawson and Weinstein, 2002). The 
third reason for its popularity is the possibility to knockdown gene expression in the 
embryos using morpholino antisense oligonucleotides. Morpholino oligonucleotides 
are specifically designed either to block translation or modify pre-mRNA splicing of 
the  gene  of  interest,  thereby  permitting  functional  analysis  of  the  gene  during 
embryonic development. 
  The blood vessels of the developing trunk are ideal for studying the cues and 
mechanisms guiding vascular patterning during development (Isogai et al., 2003). At 
approximately  16.5  hours  post-fertilization  (hpf),  the  dorsal  aorta  and  posterior 
cardinal vein (PCV) begin to form by vasculogenesis at the trunk midline and by 
approximately 23hpf, they develop a patent lumen and circulation initiates shortly 
thereafter.  In  contrast  to  the  axial  vessels,  the  intersegmental  vessels  (ISVs)  and  
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parachordal vessels (PAV) form by angiogenesis that is independent of circulatory 
flow. At 19-20 hours post-fertilization (hpf), pairs of endothelial sprouts (termed 
primary sprouts) emerge bilaterally from the dorsal aorta adjacent to the vertical 
myotomal  boundaries  between  somites.  These  primary  sprouts  grow  dorsally 
between the somites and notochord and then between the somites and the neural 
tube, tracking along vertical myotomal boundaries. The endothelial tip cells of each 
sprout extend numerous dynamic filopodia during the process of sprout elongation. 
Once the ISVs reach the dorsolateral roof of the neural tube (at ~28hpf), they divide 
caudally and rostrally, elongate and then fuse with neighbouring tip cells to form the 
bilateral  dorsal  longitudinal  anastomotic  vessels  (DLAVs).  By  1.5  dpf,  two 
completed lattices of endothelial vessels are present on each side of the trunk. As the 
formation  of  the  primary,  aorta-derived  vessel  network  is  completed,  a  new 
secondary  set  of  vascular  sprouts  begins  to  emerge  at  ~1.5dpf.  These  secondary 
sprouts  emerge  exclusively  from  the  posterior  cardinal  vein  at  every  myotomal 
segment  and  grow  dorsally,  often  towards  and/or  alongside  the  nearest  primary 
vessel. Approximately half of the secondary sprouts eventually make a connection to 
the  adjacent  primary  vessel  segment,  linking  the  PCV  to  the  primary  vascular 
network. Once this connection to the vein is made and the secondary vessel segment 
begins to carry robust venous blood flow, the adjacent ventral-most regions of the 
primary vessel will regress and disappear. This vessel then assumes its final identity 
as  an  intersegmental  vein.  The  remaining  secondary  sprouts  do  not  connect  to 
adjacent  primary  vessel  segments.  Some  simply  regress  and  disappear,  however, 
most contribute to the formation of and serve as ventral venous roots for a separate 
set  of  vessels,  the  parachordal  vessels  (PAVs).  PAVs  form  along  the  horizontal 
myosepta  to  either  side  of  the  notochord.  They  are  composed  of  the  secondary 
sprouts from PCV and from additional sprouts that emerge form ISVs at the level of 
the horizontal myoseptum. When a secondary sprout forms a root for the parachordal 
system,  the  adjacent  primary  segment  almost  always  becomes  an  intersegmental 
artery.  Parachordal  sprouts  only  rarely  emerge  from  intersegmental  arteries,  and 
intersegmental arteries do no initially connect to the parachordal system (Isogai et 
al., 2003).   58       1.5   A IMS OF  P H D   Notch signalling has been described to regulate arterial - venous differentiation and  also vascular smooth muscle differentiation. However, its role in the patterning of  blood vessels during dev elopmental angiogenesis had not yet been explored. Thus,  one  of  the  projects  undertaken  was  to  investigate  whether  the  Notch  signalling  pathway  regulates  vessel  patterning  in  the  postnatal  mouse  retina.  In  a  second  project,  I  embarked  on  the  study  of  the  N otch  target  gene,  Nrarp,  to  determine  whether it has a role in angiogenesis.       Figure  16  Anatomy of a 3dpf zebrafi sh trunk and its blood vessels.   A ,  overview  of  a  2dpf  Tg(fli1:EGFP) y1  transgenic  fish  that  expresses  GFP  in  its  blood vessels.  B , a cross - section cartoon of the zebrafish trunk (white line in A). At  3dpf, intersegmental vessels have differentiated into eit her intersegmental arteries  (ISA) or veins (ISVs) and are linked together dorsally via paired dorsal longitudinal  anastomotic vessels (DLAV). There is active blood flow through the dorsal aorta  (DA), posterior cardinal vein (PCV) and most intersegmental ar teries (ISAs) and  veins (ISVs). At this stage, parachordal vessels (PAVs) are developing longitudinally  to either side of the notochord, along the horizontal myoseptum . The PAVs are  linked to the PCV and ISVs (arrows). G, gut; M, myotomes; N, notochord; N T,  neural tube; P, left pronephric duct; and Y, yolk mass. From  (Isogai et al., 2003) .   A   B   B   
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2  Methods and Material 
2.1  MOUSE EXPERIMENTS 
2.1.1    ANIMALS 
Mice  were  maintained  by  the  Biological  Resources  Services  provided  by  Cancer 
Research  UK.  All  animal  breeding  and  experiments  conformed  to  legal  and  UK 
ethical standards. Unless otherwise stated, the different strains of transgenic mice 
(see Table 2) have been bred on a C57Bl6/J background.  
 
Mouse line  Reference 
BAT-gal  (Maretto et al., 2003) 
BATlacZ  (Nakaya et al., 2005) 
Ctnnb1
lox  (Brault et al., 2001) 
Ctnnb1
lox(Ex3)  (Harada et al., 1999) 
Dll4 (ICR background)  (Hellstrom et al., 2007) 
Lef1  (van Genderen et al., 1994) 
Pdgfb-iCreER  (Claxton et al., 2008) 
Rosa26R-EYFP   (Srinivas et al., 2001) 
TNR   (Duncan et al., 2005) 
Table 2. List of mice used. 
 
Nrarp null mice were generated by Regeneron (New York, USA), where the 
entire coding sequence of the single-exon Nrarp gene was replaced by a LacZ gene 
fused to the endogenous ATG by the Volocigene technology (Figure 17; Valenzuela 
et al., 2003). Briefly, a bacterial artificial chromosome (BAC) containing the Nrarp 
gene was modified to replace the coding region by a LacZ gene. This vector was then 
linearized and used to target the Nrarp gene in F1H4 (C57Bl/6:129 hybrid) mouse 
embryonic stem (ES) cells. Correctly targeted ES cells were identified by using the 
loss of native allele (LONA) assay as described in (Valenzuela et al., 2003) and were 
used to generate chimaeric male mice that were complete transmitters of ES-derived 
sperm. Chimaeras were then bred to C57Bl6/J females to generate F1 mice, which 
were genotyped by LONA assay and β-galactosidase histochemical assays. In order 
to establish our own Nrarp mouse colony, frozen sperm from Nrarp
+/- males were 
sent  to  the  UK  from  the  USA  and  were  used  for  in  vitro  fertilization  (IVF)  in   60   C57Bl6/J mice.  Nrarp +/ -  mice generated by  in vitro  fertilization were used for further  breeding; offspring of appropriate Mendelian ratio were obtained.   To activate Cre recombination in an inducible manner, 4OH - tamoxifen was  injected intra peritoneally into early postnatal pups at 80 µ g/g.        Figure  17 . Generation of  Nrarp  knockout mice.     2.1.2   A NIMAL EXPERIMENTS   Experimental  procedures  on  mice  were  conducted  by  myself,  staff  from  the  Biological  Resources  Service  (Sue  Wat ling,  Craig  Thrussell  and  Claire  Darnborough) and my supervisor, Holger Gerhardt, who performed the intraocular  injections. Unless otherwise stated, mice were culled by decapitation at the end of  experiments before collecting eyes for analyses.   2.1.2.1   Suppression  of Notch signalling by  γ - secretase inhibition.   γ - secretase  activity  was  inhibited  pharmacologically  using  DAPT  (N - [N - (3,5 - Difluorophenacetyl - L - alanyl)] - S - phenylglycine  t - Butyl  EsterMerck,  Cat.  No.  565770). A working solution of 10mg/ml DAPT dissolved in 1 0% ethanol and 90%  corn oil was prepared by addition of 50µl ethanol to 5mg DAPT, heating to 40 ° C for  a few minutes until dissolved and addition of 450µl corn oil. The dissolved DAPT  was used on the same day or stored at  - 20ºC for use the next day (warmed  before  use). Early postnatal mice were treated with DAPT at 100mg/kg (10µl/g of 10mg/ml  working solution)   
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2.1.2.2  Genotyping 
Mouse  Wildtype  Mutant/transgenic allele 
Nrarp  Fwd:GCTGCAGTCGCTGCTGCAGAAC 
Rev:CTCATCACCAAGGCCAAGTACG 242bp 
Fwd:ATACTGTCGTCGTCCCCTCAAACTG 
Rev:ACCACGCTCATCGATAATTTCA 600bp 
TNR    Fwd:ATGGTGAGCAAGGGCGAGGA 
Rev:TTACTTGTACAGCTCGTCCA 800bp 
BATlacZ    Fwd:ATACTGTCGTCGTCCCCTCAAACTG 
Rev:ACCACGCTCATCGATAATTTCAC 600bp 
Ctnnb1
lox  Fwd:AAGGTAGAGTGATGAAAGTTGTT 
Rev:CACCATGTCCTCTGTCTATTC 221bp 
Fwd:AAGGTAGAGTGATGAAAGTTGTT 
Rev:CACCATGTCCTCTGTCTATTC 324bp 
Ctnnb1
lox(Ex3)  Fwd:GCTGCGTGGACAATGGCTAC 
Rev:GCTTTTCTGTCCGGCTCCAT 359bp 
Fwd:gctgcgtggacaatggctac 
Rev:GCTTTTCTGTCCGGCTCCAT 550bp 
Pdgfb-
iCreER 
  Fwd:GCCGCCGGGATCACTCTCG 
Rev:CCAGCCGCCGTCGCAACTC 450bp 
Rosa26R-
EYFP  
Fwd:AAAGTCGCTCTGAGTTGTTAT 
Rev:GGAGCGGGAGAAATGGATATG 650bp 
Fwd:AAAGTCGCTCTGAGTTGTTAT 
Rev:GCGAAGAGTTTGTCCTCAACC 350bp 
Table 3. Primers used for genotyping. 
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subcutaneously for 3, 6 or 48 hours. For 48 hour treatments, mice were injected once 
a day for 2 days.  
2.1.2.3  Ectopic activation of Notch signalling by Jagged1 peptide treatment. 
Jagged1 (CDDYYYGFGCNKFCRPR) or scrambled (RCGPDCFDNYGRYKYCF) 
peptide  was  dissolved  in  50%  DMSO  and  50%  dH2O  and  injected  at  500mg/kg 
subcutaneously for 6 or 48 hours. For 48 hour treatments, mice were injected twice a 
day at alternate sites for 2 days.  
2.1.2.4  BrdU administration for proliferation assay. 
A working stock of 10mg/ml bromodeoxyuridine (BrdU, Sigma) dissolved in PBS 
was prepared and stored at -20
oC. Mice were injected once at 50 mg/kg (5µl/g of 
10mg/ml working solution) intraperitoneally and eyes were collected 3 hours later.  
2.1.2.5  Dll4-Fc administration 
Dll4-Fc  and  hFc  were  a  gift  from  Regeneron  (Lobov  et  al.,  2007).  A  working 
solution of 10µg/µl peptide in sterile PBS was prepared fresh for each experiment 
and stored at 4°C. 4µg (in 0.4µl) of Dll4-Fc or hFc were injected once intraocularly 
and eyes were collected 24 hours later. To carry out this procedure, mice were deeply 
anaesthetized by isoflurane inhalation. Injections were performed using 10µl gastight 
Hamilton syringes equipped with 33 gauge needles attached to a micromanipulator.  
 
2.1.3  ENDOTHELIAL CELL ISOLATION AND CULTURE 
2.1.3.1  Tissue digestion 
Lungs were removed from mice and kept in DMEM (Dulbecco’s modified Eagle’s 
medium) containing 10% foetal calf serum, penicillin/streptomycin and amphotericin 
B on ice. Lungs were chopped into small pieces (e.g.1mm
3 or as small as possible) 
using scissors in a Petri dish placed on ice. Tissue pieces were washed in 20ml 
Hank’s  Buffered  Salt  Solution  (HBSS,  Ca
2+/Mg
2+-free)  containing 
penicillin/streptomycin and amphotericin B in a 50ml Falcon tube. Lung pieces were 
poured through a 40µm cell strainer, placed on a 50ml Falcon tube, to remove blood 
constituents.  Tissue  pieces  were  digested  in  5ml  2.4U/ml  dispase  II (GIBCO)  in 
HBSS containing penicillin/streptomycin and amphotericin B for 1 hour at 37°C,  
63 
with rotation and occasional vortexing. At the end of incubation, the cell suspension 
was  filtered  through  a  40µm  cell  and  cells  were  pelleted  by  centrifugation  at 
1200rpm for 3 min at 4°C.  
2.1.3.2  Endothelial cell isolation 
Cell pellets were resuspended in PBS containing 0.5% bovine serum albumin (BSA) 
and EDTA (PBS/BSA/EDTA). To prevent isolation of non-endothelial cells, cells 
were  incubated  with  an  irrelevant  mouse  antibody,  anti-OKT8  (4µg/ml  in 
PBS/BSA/EDTA), to block Fc receptors on macrophages for 20 minutes on ice with 
occasional agitation. This was followed by incubation of cells with rat anti-mouse 
CD31 (also known as PECAM-1; BD Pharmingen) at ~10µg/ml in PBS/BSA/EDTA 
for 30 minutes at 4°C with gentle shaking, and then goat anti-rat IgG microbeads for 
15  minutes  at  4°C  with  gentle  shaking.  Microbead-coated  endothelial  cells  were 
separated from non-endothelial cells using magnetic cell sorting using the MACS 
MS column (Miltenyi Biotec). 
2.1.3.3  Culture of mouse lung endothelial cells 
Isolated endothelial cells from 1 pair of lungs were seeded on 1 well of a 24-well 
culture plate that was coated with fibronectin and mouse recombinant Dll4 protein 
(R&D Systems). Cells were cultured in Endothelial Cell MV medium (PromoCell) 
supplemented  with  10%  FCS,  0.4%  ECGs/H  (this  contains  bovine  hypothalamus 
extract  supplemented  with  heparin),  0.1ng/ml  epidermal  growth  factor,  1µg/ml 
hydrocortisone,  1ng/ml  basic  fibroblast  growth  factor,  penicillin/  streptomycin, 
50ng/ml amphotericin B and glutamine at 37°C and 5% CO2. 
2.1.3.4  Culture of bEND5 cells 
The cell line bEND5 has been established from brain endothelial cells of BALB/c 
mice.  Immortalisation  has  been  carried  out  by  infection  of  primary  cells  with 
retrovirus  coding  for  the  Polyoma  virus  middle  T-antigen.  bEND5  cells  were 
cultured in DMEM supplemented with 10% FCS and penicillin/streptomycin at 37°C 
and 5% CO2. 
2.1.4  IMMUNOFLUORESCENCE STAINING 
For  most  immunofluorescent  procedures,  eyes  were  fixed  for  2  hours  at  room 
temperature  or  overnight  at  4°C  in  4%  paraformaldehyde  (PFA)  in  phosphate  
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buffered saline (PBS). Eyes were then washed in PBS followed by dissection of 
retinas and removal of hyaloid vessels. An exception was when retinas were to be 
stained with antibodies against VE-cadherin and zona occludens-1 (ZO1). In this 
case,  mice  were  anaesthetized  by  injection  of  a  combination  of  Hypnovel 
(Midazolam) and Ketaset intraperitoneally before transcardiac perfusion with PBS 
until blood has drained from body. Eyes were subsequently removed, fixed briefly in 
4% PFA for 5-10 minutes at room temperature, and dissected in PBS to remove 
hyaloid vessels. Retinas were then flattened by making 4 to 5 incisions. Excess PBS 
was removed and retinas were fixed in cold methanol while flattened. Retinas were 
stored at -20°C in methanol until use. Before staining with antibodies, the retinas 
were rehydrated in increasing proportion of PBS/methanol and finally in PBS. 
Retinas were blocked in PBS containing 1% bovine serum albumin (BSA, 
Sigma) and 0.5% Tween-20 for 2 hours at room temperature. All antibodies were 
incubated for 2 hours at room temperature or overnight at 4°C in PBS containing 
0.5%  BSA  and  0.25%  Tween-20  except  for  Isolectin-B4  and  antibodies  against 
Endomucin and NG2, which were incubated in PBS (pH6.8), 1% Tween-20, 1mM 
CaCl2, 1mM MgCl2 and 0.1mM MnCl2 (PBlec). Secondary antibodies conjugated 
with  Alexa  Fluor  488,  568  and  633  from  Molecular  Probes  were  used  to  detect 
primary antibodies. Retinas were washed in PBS containing 0.1% Tween-20 (PBT; 3 
times, 15 minutes each) in between antibody incubations. After antibody staining, 
retinas  were  post-fixed  in  4%  PFA  for  15  minutes  before  flat-mounting  in 
MOWIOL. For flat-mounting of retina, 4 to 5 short incisions were made and excess 
PBS removed.   
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Antibody  Conjugated?  Raised in…  Reactivity  Company  Cat. No.  Dilution 
β-catenin (Ctnnb1)     mouse clone 14  mouse  BD Transduction        
BrdU      mouse     Molecular Probes  A21300  1:50 
Claudin 5     mouse clone 4C3C2  mouse  Zymed Lab.  35-2500  1:100 
Collagen IV     rabbit  mouse  AbD Serotec  2150-1470  1:100-1:200 
Delta-like 4    goat  mouse  R&D Systems  AF1389  1:100 
Endomucin     rat  mouse  Dietmar Vestweber     1:20 
GFAP     rabbit  mouse  DakoCytomation  Z0334  1:75 
GFAP  Cy3  mouse  mouse  Sigma   C9205    
GFP     rabbit     Molecular Probes  A11122  1:100 
GFP  Alexa Fluor 488  rabbit     Molecular Probes  A21311  1:100 
Isolectin B4  Biotin        Sigma   L2140  1:10 
Isolectin B4   Alexa Fluor 488        Molecular Probes  I21411  1:100 
Isolectin B4   Alexa Fluor 568        Molecular Probes  I21412  1:100 
NG2  (Chondroitin 
sulfate proteoglycan 4)     rabbit  mouse  Chemicon  AB5320  1:100 
Notch  1  intracellular 
domain (NICD1)    Rabbit 
Human, 
mouse  Abcam  Ab8925   
VE-cadherin (CD144)     rat clone 11D4.1  mouse  BD Biosciences  555289  10µg/ml 
Table 4. Antibodies used for immunofluorescent staining in mouse retinas. 
 
  
66 
2.1.4.1  Additional treatment before BrdU staining. 
Retinas were incubated with 10µg/ml Proteinase K in PBT for 20 minutes. Digestion 
was stopped by treatment of retinas with 2mg/ml glycine dissolved in PBT for 10 
minutes, washed in PBT (2 x 5 min), post-fixed in 4% PFA for 20 minutes and then 
washed in PBT. Retinas were treated with 0.1unit/µl DNase I diluted in 50mM Tris-
HCl, 10mM MgCl2, pH 7.5 for 2 hours at 37
oC. DNase I was heat-inactivated by 
incubating samples for 10 minutes at 70
oC with preheated 50 mM Tris-HCl, pH 7.5 
and then cooled on ice for 3 min. All steps were carried out at room temperature 
unless stated otherwise. Retinas were subsequently used for anti-BrdU staining. 
 
2.1.5  IN SITU HYBRIDIZATION (ISH) 
2.1.5.1  Isolation of RNA for cDNA generation 
Retinas were dissected from postnatal day 5 C57Bl6/J mice quickly and snap-frozen 
and stored at -80°C. Tissue was lysed in Buffer RLT (RNeasy Mini Kit, Qiagen) and 
homogenized  using  QiaShredder  (Qiagen).  Total  RNA  was  isolated  using  the 
RNeasy Mini Kit, according to the manufacturer’s protocol. RNA was stored at -
80°C. 
2.1.5.2  Generation of vector encoding template of interest 
cDNA was generated by reverse transcription of RNA isolated from retina using 
SuperScript  III  (Invitrogen)  and  oligodT(20),  according  to  the  manufacturer’s 
guidelines. Primers designed to generate in situ probes were then used to amplify 
genes of interest (Table 5) using Taq DNA Polymerase HotMasterMix (Eppendorf). 
5µl  of  PCR  reaction  was  run  on  an  agarose  gel  to  check  that  a  product  of  the 
anticipated  size  was  obtained.  The  PCR  product  in  2µl  of  the  reaction  mix  was 
subsequently  cloned  into  the  pGEM-  Easy  (Promega)  using  the  T4  DNA  ligase 
according to the manufacturer’s instructions. Competent XL-Blue subcloning–grade 
competent cells (Stratagene) were transformed with ligated plasmid and cultured on 
LB agar containing ampicillin overnight at 37°C. Clones were picked, cultured in LB 
broth containing ampicillin and plasmid DNA was isolated. The correct sequence 
and  orientation  of  insert  was  determined  by  DNA  sequencing  using  the  Applied 
Biosystems 3730 DNA Analyser and the ABI BigDye  chemistry.  
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Gene  Forward primer (5’-3’)  Reverse primer (5’-3’)  Ta (°C)  Size 
(bp) 
Nrarp  ctagctctgcggcaacatga  agcccggtaatggttgtttg  64  830 
Vegfa  agccagaaaatcactgtgagc  aagaaaatggcgaatccagtc  60  418 
Table 5. Primers used for generating in situ riboprobe. 
 
2.1.5.3  In vitro transcription 
Plasmids containing template for riboprobe generation were linearized ( 
 Table 6). In vitro transcription was performed by adding 1µg linearized DNA, 1X 
transcription  buffer,  1X  DIG-labelled  RNA  Labelling  Mix  (2µl;  Roche),  25U/µl 
RNase inhibitor (Promega) and 2U/µl T7 RNA polymerase (Stratagene) in nuclease-
free water to a total volume of 20µl. Incubated reaction in 37°C for 2 hours. To test 
probe quality, 0.5µl of reaction mix was run on a 1% agarose gel. At the end of the 
transcription,  2µl  RNAse-free  DNase  I  (Ambion)  was  added  to  the  reaction  and 
incubated for 30 minutes at 37°C. To precipitate the riboprobe, 2.5µl 4M lithium 
chloride and 75µl cold ethanol were added to the reaction, mixed well and incubated 
at  -80°C  for  30  minutes  or  -20°C  overnight.  Precipitated  RNA  was  pelleted  by 
centrifugation  at  13,200  rpm  at  4°C.  RNA  concentration  was  measured  using  a 
NanoDrop ND-1000 spectrophotometer. An equal volume of hybridization mix was 
added to the resuspended riboprobe and stored at -20°C. 
 Table 6. Enzymes used to generate antisense riboprobes. 
2.1.5.4  Tissue preparation 
Eyes were fixed for 1 to 2 hours in 4% PFA and washed briefly in PBS. Eyes were 
dissected  in  PBS  to  remove  hyaloid  vessels  and  then  returned  to  4%  PFA  for 
Gene  Restriction enzyme  RNA polymerase  Vector 
Dll4  EcoR1  T7  pBluscript SK+ 
Nrarp  Sal1  T7  pGEM-T Easy 
Pdgfb  XbaI  T7  pBluscript SK+ 
Vegfa  Sal1  T7  pGEM-T Easy 
Gene  Restriction enzyme  RNA polymerase  Vector 
Dll4  EcoR1  T7  pBluscript SK+ 
Nrarp  Sal1  T7  pGEM-T Easy 
Pdgfb  XbaI  T7  pBluscript SK+ 
Vegfa  Sal1  T7  pGEM-T Easy  
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continued fixation overnight at 4°C. The next day, eyes were washed in PBS and 
retinas were flattened by making 4 to 5 incisions. Excess PBS was removed and 
retinas were fixed in cold methanol while flattened. Retinas were stored at -80°C in 
methanol until use. 
2.1.5.5  Buffers and reagents required for ISH 
2.1.5.5.1  Hybridization mix 
50%  deionized  formamide  (Sigma),  1.3X  SSC,  5mM  EDTA  (2-[2-
(Bis(carboxymethyl)  amino)ethyl-(carboxymethyl)amino]acetic  acid),  50Mg/ml 
yeast  RNA  (Sigma),  0.2%  Tween-20,  0.5%  CHAPS  (3-[(3-Cholamidopropyl) 
dimethylammonio]-1-propane  sulfonate;  Sigma)  and  50mg/ml  heparin  (Sigma) 
prepared in nuclease-free water.  
2.1.5.5.2  TBST 
137mM  NaCl,  2.7mM  KCl,  25mM  Tris-HCl,  pH7.5,  0.1%  Tween-20  and  2mM 
levamisole hydrochloride (Sigma) in Milli-Q water (ultrapure laboratory grade water 
that has been filtered and purified through reverse osmosis). 
2.1.5.5.3  MABT 
0.1M  Maleic  acid,  pH  7.5,  0.15M  NaCl  and  1%  Tween-20  in  Millipore  water. 
MABT was made fresh on the day of use. 
2.1.5.5.4  NTMT 
100mM NaCl, 100mM Tris-Cl, pH9.5, 50mM MgCl2, 0.1% Tween 20 and 2mM 
levamisole in Milli-Q water.  
2.1.5.6  Wholemount retina ISH 
Reagents were prepared or diluted in PBT unless stated otherwise. Incubations were 
carried out at room temperature except where indicated. Solutions used on Day 1 
were prepared in an RNAase-free manner. 
2.1.5.6.1  Day 1 – Pre-treatments and hybridization 
Retinas were rehydrated in 75%, 50% and 25% methanol, and finally in PBT for 5 
min at each step. This was followed by bleaching in 6% hydrogen peroxide for 1 
hour and washes in PBT. Retinas were digested in 10µg/ml Proteinase K for 25  
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minutes followed by incubation in 2mg/ml glycine and washes in PBT. Retinas were 
fixed in 4% PFA/0.1% glutaraldehyde for 20 minutes, washed in PBT, rinsed in 1:1 
PBT/hybridisation mix and then in hybridisation mix for 1 hour at 65°C. Retinas 
were then incubated with approximately 0.2µg/ml DIG-labelled RNA probe diluted 
in hybridization mix overnight at 65°C with gentle and intermittent shaking. 
2.1.5.6.2  Day 2 – Post-hybridization washes 
Hybridization mix containing RNA probe was removed from retinas and stored for 
future use at -20°C. While keeping samples on the heating block, retinas were rinsed 
twice with pre-warmed hybridization mix. This was followed by further washes: 2 x 
30  minutes  in  pre-warmed  hybridization  mix  at  65°C,  20  minutes  in  1:1 
hybridization mix/TBST at 65°C and 2 x 30 minutes in TBST at room temperature. 
Finally, retinas were incubated in MABT for more than 1 hour before incubation 
overnight  at  4°C  with  anti-digoxigenin-alkaline phosphatase  (AP),  Fab  fragments 
(Roche) diluted 1:1000 in MABT containing 10% sheep serum. 
2.1.5.6.3  Day 3 – Post-antibody washes 
Retinas were washed throughout the day at room temperature and overnight at 4°C in 
MABT. 
2.1.5.6.4  Day 4 –Colorimetric detection 
Retinas were washed in NTMT before incubation in NBT (Nitro-Blue Tetrazolium 
Chloride;  Roche)/BCIP  (5-Bromo-4-Chloro-3'-Indolyphosphate  p-Toluidine  Salt; 
Roche)  diluted  in  NTMT  at  room  temperature.  Some  probes  required  a  longer 
incubation period such that retinas were left overnight at 4°C in NBT /BCIP. 
2.1.5.7  Counterstaining with antibodies 
After colorimetric detection of RNA, the retinas were washed in PBS and post-fixed 
in 4% PFA. This was followed by incubation with Isolectin-B4 or GFAP (see 2.1.4 
for procedure). 
 
2.1.6  REAL-TIME PCR 
2.1.6.1  RNA isolation  
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Eyes were immediately placed in RNALater (Qiagen) after removal from animals 
and kept at 4°C. Retinas were dissected in RNALater, snap-frozen on dry-ice and 
stored at -80°C until use. To isolate RNA, 1 or 2 retinas were lysed in Buffer RLT 
(RNeasy  Mini  Kit,  Qiagen)  and  homogenized  using  QiaShredder  (Qiagen). Total 
RNA  was  isolated  using  the  RNeasy  Mini  Kit,  according  to  the  manufacturer’s 
protocol.  An  on-column  DNAse  I  (Qiagen)  reaction  was  carried  out  to  remove 
genomic  DNA.  RNA  concentration  was  measured  using  a  NanoDrop  ND-1000 
spectrophotometer and stored at -80°C. 
2.1.6.2  cDNA synthesis 
cDNA was generated by reverse transcription of RNA isolated from retinas using 
SuperScript  III  (Invitrogen)  and  oligodT(20),  according  to  the  manufacturer’s 
guidelines. A final incubation with RNase H was carried out at 37°C for 20 minutes. 
The reverse transcription reaction was used immediately for PCR or stored at -20°C 
for a few days before use. An exception was when isolated endothelial cells from 
mouse lungs were used for qPCR analysis. In these experiments, the TaqMan Gene 
Expression  Cell-to-Ct  Kit  (Applied  Biosystems)  was  used  to  lyse  and  synthesize 
cDNA from the cells. 
2.1.6.3  Relative quantitative PCR 
TaqMan Gene Expression Assays developed by Applied Biosystems were used for 
relative  quantitative  PCR  (qPCR)  experiments  to  compare  differences  in  gene 
expression  between  different  treatment  groups  or  between  animals  of  different 
genotypes.  The  TaqMan  Gene  Expression  Assay  is  a  pre-formulated  assay  that 
contains 2 unlabelled PCR primers (900nM each final concentration) and 1 FAM 
dye-labelled TaqMan MGB probe (250nM final concentration) specific for the gene 
of interest. Duplex PCR reactions were carried out; primers and VIC-labelled MGB 
probe  for  endogenous  β-actin  were  added  into  each  reaction  containing  specific 
primers and probes for the gene of interest (see Table 7). Reactions were performed 
in duplicates. PCR was carried out in TaqMan Universal PCR Master Mix (Applied 
Biosystems) using Applied Biosystems 7900HT sequence detection system. Gene 
expression was normalized to the endogenous control, β-actin, and an average ΔCt 
value was calculated for each animal. 
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Gene  Product number 
CyclinD1  Mm00432360_m1 
Dll4  Mm00444619_m1 
Flt1 (VEGFR1)  Mm00438980_m1 
Hey1  Mm00468865_m1 
Hey2  Mm00469280_m1 
Kdr (VEGFR2)  Mm00440099_m1 
Lnfg  Mm00456128_m1 
Nrarp  Mm00482529_s1 
Nrp1  Mm00435372_m1 
Pdgfb  Mm00440678_m1     
Slc2a  Mm00441473_m1 
Vegfa  Mm00437304_m1 
            Table 7. TaqMan probes used. 
 
2.1.7  SDS-PAGE AND WESTERN BLOTTING 
Retinas were lysed in RIPA buffer (50mM Tris-HCl, pH 7.5, 150mM NaCl, 1mM 
EDTA, 1% Nonidet P-40, 0.25% Na-deoxycholate and protease inhibitor mixture). 
Protein  was  quantified  by  bicinchoninic  acid  assay  (Pierce).  30µg  protein  were 
separated  by  NuPAGE  Novex  Bis-Tris  Gel  (Invitrogen)  and  transferred  onto 
polyvinylidene difluoride membranes (Amersham). Membranes were incubated with 
mouse anti-LEF1 (Chemicon) and rabbit anti-actin (Sigma). Binding of antibodies to 
the blots was detected using chemiluminescence ECL Western Blotting detection 
reagent (Amersham). 
2.1.8  CONFOCAL IMAGING 
Confocal laser scanning microscopy was performed using a Zeiss LSM 510 Meta 
microscope.  Objectives  frequently  used  were:  63x  water  immersion  NA1.2  C-
APOCHROMAT (especially for endothelial tip cells), 40x water immersion NA1.2 
C-APOCHROMAT,  25x  water  immersion  NA0.8  Plan-NEOFLUAR  and  2.5x 
NA0.075 Plan-NEOFLUAR (for overviews of retinas).  
   72   2.1.9   M ETHODS USED FOR QUAN TIFYING VESSEL FEATU RES .   2.1.9.1   Radial expansion of retinal vasculature    For  vessel  migration,  the  distance  of  vessel  growth  from  the  o ptic  nerve  to  the  periphery  was  measured.  4  to  5  measurements  were  made  from  each  retina  per  animal.  The  average  distance  of  vessel  migration  per  animal  was  used  in  comparisons between animals of different genotypes.   2.1.9.2   Quantification of vessel branchpoints   T o assess vessel density, the number of vessel branchpoints in 100 µ m 2  fields was  counted. At least 6 images of the capillary plexuses or vascular fronts were taken  from  each  animal  and  at  least  3  animals  per  genotype  were  analyzed.  A  40X  objection was used  to take the images.    2.1.9.3   Filopodia quantification   Images  of  endothelial  tip  cells  were  taken  with  a  40X  objective  in  settings  that  revealed the filopodia clearly. The number of filopodia at the circumference of the  vascular front was counted. The number of fil opodia/100µm distance was plotted.    2.1.9.4   Quantification of vessel regression    For vessel regression, the skeletal length of Isolectin - B4 - positive and collagen IV - positive vessels was measured and the ratio calculated ( Figure  18 ).            Figure  18 . Quantification of vessel regression.   
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2.1.9.5  Proliferation 
The  number  of  BrdU-positive  endothelial  cells  in  10,000µm
3  volume  of  vessels 
(measured by Volocity software, Improvision, UK) in the sprouting vascular front 
was counted. 
2.1.10   STATISTICAL ANALYSES 
Statistical  analysis  was  performed  with  Prism  5  software  (GraphPad)  using  two-
tailed, unpaired t test. 
 
2.2  ZEBRAFISH EXPERIMENTS 
2.2.1  GENERAL CARE 
Zebrafish were maintained at 28°C in dechlorinated London tap water on a 14/10 
hour light/dark cycle. Embryos were collected from spontaneous spawning. Staging 
was according to Kimmer et al (Kimmel et al., 1995). 
 
2.2.2  TRANSGENIC FISH 
Tg(fli1:EGFP)
y1 (Lawson and Weinstein, 2002) embryos were obtained by crossing 
GFP-positive (either heterozygous or homozygous) adults. 
 
2.2.3  MORPHOLINO INJECTION 
Antisense morpholino oligonucleotides (Gene Tools) were diluted in Danieau buffer 
(58mM  NaCl,  0.4mM  MgSO4,  0.6mM  Ca(NO3),  5mM  HEPES,  pH  7.1-7.3) 
containing 0.2% phenol red. 2nL oligonucleotide was injected into the yolk of 2- to 
4-cell-stage embryos. The morpholinos used (Table 8) were published by (Ishitani et 
al., 2005), where the authors showed significant knockdown in the protein expression 
of Nrarp-a, Nrarp-b and Lef1. The control oligonucleotide is the standard control 
offered by Gene Tools that should have no target or no significant biological activity 
in zebrafish. 
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Morpholino  Dose/embryo  Sequence 
nrarp-a  5 or 10ng  5′-GATGCTTCACACTGGGAGAAACTCG-3′ 
nrarp-b  10ng  5′-ATGATTTCAGCAGG TTGACCAAAACG-3′ 
lef1  2ng  5’-CTCCTCCACCTGACAACTGCGGCAT-3’ 
control  2, 5 or 10ng  5'-CCT CTT ACC TCA GTT ACA ATT TAT A-3' 
Table 8. Morpholino sequences. 
 
2.2.4  WHOLEMOUNT IN SITU HYBRIDIZATION 
Wholemount  zebrafish  ISH  was  performed  according  to  Ariza-McNaughton  and 
Krumlauf (Ariza-McNaughton and Krumlauf, 2002) and is similar to that described 
in 2.1.5.6 for wholemount retina ISH. A difference was in the washing step on Day 
3, when embryos were washed in PBS containing 0.1% Tween-20 for 2-4 hours at 
room temperature. 
2.2.5  WHOLEMOUNT IMMUNOFLUORESCENCE 
Embryos  were  dechorionated  before  fixation  in  4%  PFA  for  2  hours  at  room 
temperature  or  overnight  at  4°C.  This  was  followed  by  washes  and  storage  of 
embryos in PBS containing 0.1% Tween-20 (PBT). For GFP staining, embryos were 
incubated in rabbit anti-GFP-Alexa Fluor 488 antibody (Molecular Probe) in PBS 
containing 0.5% BSA and 0.25% Tween-20. Embryos were post-fixed in 4% PFA 
after staining with antibodies. 
2.2.5.1  Zona occludens 1 (ZO-1) staining 
This staining protocol was kindly provided by Yannick Blum and Markus Affolter 
from  Biozentrum,  Basel,  Switzerland.  Embryos  were  blocked  in  PBS  containing 
0.1% Tween-20 and 0.1% Triton-X (PBTX) containing 10% BSA and 1% normal 
goat serum for 2 hours and incubated in mouse anti-human ZO-1 (1:200 dilution; 
Zymed)  in  PBTX  containing  1%  BSA  and  0.1%  goat  serum  overnight  at  4°C. 
Embryos were then washed in PBTX containing 1% BSA and 0.1% goat serum for 6 
hours (with changes) and incubated with goat anti-mouse Alexa Flour 568 antibody 
in PBTX containing 1% BSA and 0.1% goat serum overnight at 4°C and washed in 
PBT.  
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2.2.5.2  Collagen XII staining 
The anti-Collagen XII antibody and staining protocol were generously provided by 
Florence Ruggiero and Hanah Bader, Lyon. Embryos were permeabilized in acetone 
for  1  hour  at  -20°C  and  then  washed  in  water  and  PBT.  This  was  followed  by 
blocking in PBS containing 2% normal goat serum, 1% BSA, 1% DMSO and 0.1% 
Tween-20 (PSBDT) for 30 minutes at room temperature. Guinea pig anti-Collagen 
XII antibody (1:250 dilution) was incubated in PSBDT overnight at 4°C. The next 
day, the embryos were washed in PBS containing 1% DMSO and 0.1% Tween-20 
(PDT)  for  2  hours  with  several  changes  of  wash  buffer.  Goat  anti-guinea  pig 
conjugated to Rhodamine (Abcam) was incubated in PSBDT overnight at 4°C and 
embryos were washed in PDT. 
 
2.2.6  PROLIFERATION ASSAY 
A stock of 5% BrdU dissolved in water was diluted to 0.5% in E3 Buffer (5mM 
NaCl, 0.17mM KCl, 0.33mM CalCl2, 0.33mM MgSO4). At 19hpf, Tg(fli1:EGFP)
y1 
embryos  were  transferred  to  E3  buffer  containing  0.5%  BrdU  until  48hpf,  when 
embryos were fixed in 4% PFA for 2 hours at room temperature or overnight at 4ºC. 
Embryos  were  then  washed  in  PBT,  rinsed  once  in  methanol  and  incubated  in 
methanol at -20ºC for 1 hour. Embryos were then permeabilized in 20% DMSO/80% 
MeOH at room temperature for at least 2 hours with gentle rocking and rehydrated in 
50% and 25%PBT/MeOH and finally PBT (10 minutes each). Embryos were washed 
in water for 10 minutes, and incubated for 1 hour in 2N HCl at room temperature 
with gentle rocking. This was followed by washes in PBT and incubation in PBS 
containing 1% BSA and 0. 5% Tween-20 for 1-2 hours. To detect BrdU, the embryos 
were incubated with mouse anti-BrdU antibody (1:50 dilution; Molecular Probes) in 
PBS containing 0.5% BSA and 0.25% Tween 20 overnight at 4ºC, washed in PBT 
for 1 hour and incubated in goat anti-mouse IgG1 Alexa Fluor-568 antibody in PBS 
containing 0.5% BSA and 0.25% Tween-20 overnight at 4ºC. 
 
2.2.7  TUNEL ASSAY 
Embryos were fixed in 4% PFA for 2 hours at room temperature or overnight at 4ºC. 
Embryos  were  then  washed  in  PBT,  rinsed  once  in  methanol  and  incubated  in  
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methanol at -20ºC for at least 1 hour. Embryos were then permeabilized in 20% 
DMSO/80% MeOH at room temperature for at least 2 hours with gentle rocking and 
rehydrated in 50% and 25%PBT/MeOH and finally PBT (10 minutes each). They 
were blocked in PBS containing 0.25mg/ml BSA for 10 minutes. Apoptosis was 
detected by using the In Situ Cell Death Detection Kit containing TMR red labelling 
nucleotides (Roche) according to the protocol provided by the manufacturer. 
 
2.2.8  CONFOCAL MICROSCOPY 
Confocal  laser  scanning  microscopy  was  performed  using  a  Zeiss  LSM  510 
microscope.  For  live  imaging  of  Tg(fli1:EGFP)
y1  zebrafish,  the  embryos  were 
anaesthetized in aquarium water containing 320µg/ml Tricaine (Sigma) and mounted 
on a glass-bottom dish (MatTek) in 0.2% agarose. Images were captured with a Zeiss 
LSM 510 Meta inverted confocal microscope using a 40X NA1.2 water immersion 
lens. Embryos were maintained at 28ºC in an environmental chamber during the 
course of the experiment. 
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3  Notch signalling regulates endothelial tip and stalk cell 
formation 
3.1  INTRODUCTION 
The formation of endothelial tip cells is required for directed vessel migration and 
patterning. Thus far, the regulation of tip cell selection has been attributed to VEGF 
signalling  through  Kdr  (VEGFR2)  (Gerhardt  et  al.,  2003).  The  aim  of  the  work 
described in this chapter is to investigate whether Notch signalling also modulates tip 
cell  selection  using  the  early  post-natal  mouse  retina  as  a  model  system.  This 
hypothesis is extrapolated from the observation that tip cells express the endothelial 
specific Notch ligand, Dll4 (Claxton and Fruttiger, 2004).  
  This project was highly collaborative involving close interactions between 
the  laboratories  of  Holger  Gerhardt  and  Christer  Betsholz  in  Sweden.  In  the 
following pages, I shall describe the experiments that I performed in this project. 
Most of my experiments are pharmacological manipulations of the Notch pathway 
whereas  the  Betsholz  Lab  performed  the  genetic  experiments  and  analyses.  The 
conclusions that I will later state are based on the combined results of these studies 
and in some regions of the text, I will cite our published article ‘Hellstrom et al., 
2007’ to refer to data that was generated by our collaborators and not by myself.  
 
3.2  RESULTS 
3.2.1  NOTCH ACTIVITY DURING SPROUTING ANGIOGENESIS. 
During  sprouting  angiogenesis  in  the  retina,  Dll4  mRNA  is  highly  expressed  in 
endothelial cells at the leading front of the migrating vasculature in a salt-and-pepper 
manner  ((Claxton  and  Fruttiger,  2004),  Figure  25B).  However,  localization  of 
endothelial  Notch  activity  has  not  been  demonstrated.  We  therefore  investigated 
endothelial Notch activity by using a transgenic Notch reporter mouse (TNR) that 
has a transgene composed of a CBF-1 response element with four CBF-1 binding 
sites and a minimal SV40 promoter followed by an enhance green fluorescent protein 
(EGFP) sequence (Duncan et al., 2005). We observed Notch signalling, as shown by 
GFP expression, in endothelial cells of the developing retinal vasculature in a non-   78   F igure  19 . Dll4 expression and Notch signalling in migrating blood vessels of  early postnatal mouse retina.   P5  retinas  from  TNR  mice  were  stained  with  anti - GFP  (green),  anti - Dll4  (red),  Isolectin - B4 (blue or grey) and DAPI (nuclear  blue).  A , Notch signalling (green) is  detected  in  a  subset  of  endothelial  cells  at  the  migrating  vascular  front.  Some  microglial cells also display Notch activity. Note that some extravasated erythrocytes  (bottom left of image) autofluoresce (green).  B , Dl l4 protein is often found localized  to cell membrane (arrowheads); however, it is also localized intracellularly (arrow),  indicating  that  the  ligand  had  recently  undergone  ligand - receptor  activation  and  subsequent endocytosis. This intracellular localizati on of Dll4 is commonly detected  in tip cells. In B’ and B”, Notch signalling is activated in stalk cells adjacent to tip  cells  with  intracellular  Dll4  protein,  suggesting  lateral  signalling  occurs  between  endothelial tip and stalk cells. T, tip cell; S, st alk cell.      79     Figure  20 . Dll4 expression and Notch signalling in artery and arterioles of early  postnatal mouse retina.   P5  retinas  from  TNR  mice  were  stained  with  anti - GFP  (green),  anti - Dll4  (red),  Isolectin - B4 (blue). Notch signa lling is intermittent in endothelial cells of arteries  and arterioles. There is also active Dll4 - Notch signalling as indicated by intracellular  localization of Dll4 in some endothelial cells lining the artery (C, arrows). Microglial  cells also express Dll4  (m in C).       
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uniform manner (Figure 19). At the sprouting front, we detected endothelial cells 
with active Notch signalling amid endothelial cells without Notch signalling (Figure 
19A,B). There is also a similar pattern of Notch-active and –inactive endothelial cells 
in arteries (Figure 20). Notch activity was also detected in other cell types such as 
microglial cells (Figure 20C).  
Staining with an anti-Dll4 antibody revealed widespread membrane-localized 
Dll4 expression (Figure 19B, Figure 20). However, in some endothelial cells, Dll4 
was  internalized  to  a  perinuclear  localization  (Figure  19,  Figure  20C),  indicating 
previous  engagement  with  Notch  receptor  and  consequent  activation  of  Notch 
signalling in the adjacent cell. This is exemplified in Figure 19B’ and B’’ where 
endothelial  tip  cells  of  vascular  sprouts  display  internalized  Dll4  but  not  Notch 
signalling whereas the adjacent stalk cells have Notch activity. In addition, there are 
regions  where  endothelial  cells  display  both  internalized  Dll4  as  well  as  Notch 
signalling (Figure 19B and Figure 20). This observation can be explained by the long 
half-life of eGFP protein, which does not give a true depiction of the transient nature 
of  Notch  signalling.  Alternatively,  due  to  the multicellular  organization  of  blood 
vessels, it is also possible that an adjacent cell expressing a Notch ligand could at the 
same  time  stimulate  the  cell  with  internalized  Dll4,  therefore  triggering  Notch 
activity.  
81 
3.2.2  SUPPRESSION  OF  NOTCH  SIGNALLING  IN  VIVO  BY  DAPT  RESULTS  IN 
EXCESSIVE  FILOPODIA  FORMATION  AND  INCREASE  IN  VESSEL  SPROUTING 
AND DENSITY. 
To  investigate  the  function  of  endothelial  Notch  signalling  during  sprouting 
angiogenesis,  early  postnatal  mice  (P4  or  P5)  were  treated  subcutaneously  with 
DAPT,  a  γ-secretase  inhibitor,  at  100mg/kg.  γ-secretase  is  required  for  Notch 
activation by catalyzing the proteolytic cleavage of the Notch intracellular domain 
(NICD) from the plasma membrane.  Treatment with DAPT for 3 hours resulted in 
an  increase  in  endothelial  filopodia  protrusion  at  the  migrating  front  of  the 
vasculature (Figure 21B, E) when compared with vehicle-treated animals (Figure 
21A). 6-hour treatment led to an increase in filopodia protrusion (Figure 21D, E) as 
well as an increase in vessel density (Figure 22B). Prolonged treatment (48 hours) 
produced a vascular plexus that is even denser. Quantification of vessel branchpoints 
revealed a significant increase in vessel density after 48 hours of DAPT treatment 
when compared to vehicle-treated animals (Figure 22C-E). The ectopic increase in 
sprouting  after  DAPT  treatment  occurred  in  the  retinal  region  that  underwent 
vascularization  during  the  period  of  treatment,  indicating  that  the  effect  of  γ-
secretase  inhibition  was  strongest  in  actively  migrating  endothelial  cells  of 
developing vessels compared to endothelial cells of formed vessels. 
  Filopodia protrusion is a morphological feature of endothelial tip cells. To 
examine whether the observed increase in filopodia formation after DAPT treatment 
was a consequence of increased tip cell formation, the expression of Pdgfb, which is 
a tip cell indicator, was investigated using wholemount in situ hybridization (ISH) 
and quantitative PCR (qPCR) using RNA isolated from retinas of P5 animals treated 
with vehicle or DAPT for 6 hours (Figure 23). Both techniques revealed a significant 
increase in endothelial cells expressing Pdgfb after inhibition of γ-secretase activity. 
Combined with the observed increase in filopodia, these data indicate an increase in 
endothelial tip cell formation after DAPT treatment. 
   82         Figure  21 .   DAPT treatment leads to increased filopodia protrusion.   Early postnatal mice  (P4 - P5) were treated with DAPT at 100mg/kg subcutaneously.  Retinas were stained with Isolectin - B4 and analyzed at 3 ( A ,  B ) or 6 ( C ,  D ) hours  post - treatment.  E , Graph illustrates the number of filopodia protrusion per vessel  length at the migrating vascular  front of P5 mice that have been treated with either  vehicle or DAPT for 3 or 6 hours. n  ≥  20. ***, p < 0.0001. Values represent mean  ±   S.E.M.      83             Figure  22 . DAPT treatment increases vessel density.   Early postnatal mice (P4 - P5 ) were treated with DAPT at 100mg/kg subcutaneously.  Retinas were stained with Isolectin - B4 and analyzed 6 ( A, B ) or 48 ( C, D ) hours  post - treatment.  E , Graph illustrates the number of branchpoints per image field of P7  mice that have been treated with eith er vehicle or DAPT for 48h (P5 to P7). n  ≥  10.  ***, p < 0.0001. Values represent mean  ±  S.E.M.                  84         Figure  23 . Increase in endothelial  Pdgfb  expression after DAPT treatment.   Pdgfb   ISH  (blue)  of  P5  retinas  after  6h  of  vehicl e  ( A )  or  DAPT  ( B )  treatment.  Retinas were counterstained with Isolectin - B4 (green). Graph in  C  illustrates the  percentage  of  vessels  expressing  Pdgfb   mRNA  in  6h  vehicle -   and  DAPT - treated  retinas. ***, p > 0.0001; n = 10.  D  shows relative expression of  Pdgf b  in retinas of  P5 animals after 6h vehicle or DAPT treatment. *, p = 0.026; n  ≥  7. Values represent  mean  ±  S.E.M.             
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3.2.3  DAPT TREATMENT INHIBITS ENDOTHELIAL NOTCH SIGNALLING. 
In  addition  to  Notch  receptors,  γ-secretase  also  cleaves  other  molecules  such  as 
CD44, E-cadherin and ErbB-4, which are modulators of angiogenesis (Boulton et al., 
2008). It was therefore important to determine whether Notch activity was altered 
after DAPT treatment and that the morphological changes in endothelial cells were a 
result  of  altered  Notch  signalling.  Two  approaches  were  used  to  examine  Notch 
activity  after  short-term  treatment  of  mice  with  DAPT:  i)  assessment  of  Notch 
receptor cleavage by using an antibody against Notch1 intracellular domain (NICD1) 
and  ii),  transcriptional  regulation  of  downstream  endothelial  Notch  target  genes 
Hey1, Hey2 and Nrarp in the retina by qPCR and ISH.  
  In retinas of control mice that have been treated with vehicle for 3 hours, the 
NICD1  antibody  labelled  the  nuclei  of  endothelial  cells  at  the  leading  front  of 
angiogenic vessels as well as those of microglia and astrocytes (Figure 24A). At the 
sprouting front, nuclear NICD1 staining was observed in many but not all endothelial 
cells.  However,  after  3  hours  DAPT  treatment,  there  was  a  marked  decrease  in 
endothelial nuclear NICD1 staining (Figure 24B), indicating a decrease in Notch1 
proteolysis by γ-secretase. 
  Inhibition of γ-secretase activity for 6 hours resulted in a decrease of ~25% in 
Hey1 and Hey2 expression and a significant decrease of ~70% in Nrarp expression 
(p < 0.0001) when compared to control retinas (Figure 24E). To determine whether 
there  was  down-regulation  of  Notch-induced  transcription  in  endothelial  cells, 
whole-mount retinal ISH was performed for Nrarp mRNA expression. In control 
retinas, Nrarp expression is prominent in endothelial stalk cells at the vascular front; 
however,  this  endothelial  expression  decreased  after  6h  DAPT  treatment  (Figure 
24D).  Together  with  the  NICD1  immunofluorescence  data,  the  Nrarp  ISH 
experiments show that short-term DAPT treatment inhibited Notch activity in retinal 
endothelial cells. 
  As Notch signalling also regulates the expression of Notch ligands such as 
Dll1 (de la Pompa et al., 1997), the expression of the endothelial specific Notch 
ligand, Dll4, in the retina was also examined after 6 hours of DAPT treatment by 
ISH  and  qPCR.  The  qPCR  result  showed  a  significant  decrease  of  20%  in  Dll4 
expression compared to control retinas (p = 0.0286; Figure 25A), suggesting that   86     Figure  24 .  Short - term  DAPT  treatment  in  vivo   leads  to  down - regulation  of  endothelial Notch signalling in the retina.   A  and  B , Immunofluorescence of Notch1 intracellular domain (NICD1, green) in the  vascular  front  of  P5  retinas.  Red,  Isolectin - B4;  Blue,  DAPI.  Arrows  point  to  endothelial  nuclear  localization  of  NICD1,  indicating  active  Notch  signalling.  Arrowheads indicate  endothelial cells that lack Notch signalling. There is a decrease  in NICD1 staining after 3 hours DAPT treatment (B).  C  and  D ,  Nrarp  ISH in P5  retinas. There is a marked decrease in endothelial  Nrarp  mRNA expression after 6h  DAPT  treatment.  E ,  qPCR  of  Not ch  target  genes.  There  is  a  decrease  in  retinal  expression of  Hey1 ,  Hey2  and  Nrarp  after 6h DAPT treatment. ***, p < 0.0001.  Control, n = 9; DAPT, n = 11. Values represent mean  ±  S.E.M.    87     Figure  25 . Short - term DAPT treatment alt ers Dll4 expression  in vivo .   After  DAPT treatment  for  6  hours  in  P5  mice,  retina  Dll4   qPCR  and  ISH  were  performed.  A ,  qPCR  data  shows  a  significant  decrease  in  retinal  Dll4  mRNA  expression after DAPT treatment. *, p = 0.0286. Control, n = 9; DAPT, n = 11.  Values  represent  mean  ±   S.E.M.  Dll4   ISH,  however,  shows  a  more  widespread  expression  of  Dll4   (blue),  indicated  by  the  red  line  with  arrows,  after  DAPT  treatment ( C ) compared to vehicle - treated mice ( B ).      
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Notch signalling induces Dll4 expression. However, the ISH experiment showed a 
more diffused expression of Dll4 in the endothelial cells at the migrating front of the 
vessels when compared to the control retinas, where Dll4 expression in endothelial 
cells  is  more  distinct  and  salt-and-pepper-like  (Figure  25B,C).  A  possible 
explanation for this diffused expression pattern is the loss of Notch-induced lateral 
inhibition. Lateral inhibition creates a feedback loop that renders the level of ligand 
expression in neighbouring cells interdependent i.e. an increase in the expression of a 
ligand in one cell will drive the decrease in its neighbours. In the case of DAPT-
treated animals, there is a decrease in endothelial Notch activity and therefore Notch-
induced lateral inhibition, which may result in unregulated and more diffused Dll4 
expression even though the level of expression was decreased.   89   3.2.4   G ENETIC  DELETION  OF  D LL 4   IN  MICE  LEAD S  TO  INCREASED  TIP  C ELL  FORMATION .   Mice with  Dll4  haploinsufficiency are embryonically lethal  (Duarte et al., 2004 ;   Gale  et al., 2004 ;   Krebs et al., 2004) . However, some  Dll4 +/ -  mice survive when  Dll4 +/ -   embryonic  stem  cells  are  injected  into  ICD  host  embryos  and  bred  on  an  ICD  background  (Duarte et al., 2004) . It was therefore possible to study the function of  Dll4  during sprouting angiog enesis in early post - natal mouse retina. Loss of one  Dll4   allele in mice resulted in a vascular phenotype that is very similar to mice that have  been treated with DAPT or other  γ - secretase inhibitors: blood vessels displayed an  increase in filopodia protru sion and vessel density ( Figure  26 ,  Hellstrom et al., 2007 ;   Lobov et al., 2007 ;   Suchting et a l., 2007) ).  In addition, by performing retina ISH and  qPCR, there was an increase in the tip cell indicator  Pdgfb  in  Dll4 +/ -  mice ( Figure  26 ), indicating that there was an increase in endothelial tip cell formatio n.    Together, data from the DAPT experiments and genetic inactivation of one  Dll4  allele in mice demonstrate that endothelial Notch signalling negatively regulates  endothelial  tip  cell  formation.  The  loss  of  Notch  signalling  increased  endothelial  sprouting  as a consequence of increased tip cell formation.        Figure  26 . Increase in tip cell indicator  Pdgfb  in  Dll4 +/ -  retinas.   ISH of  Pdgfb  expression (blue) in P5  Dll4 +/+  ( A ) and  Dll4 +/ -  ( B ) retinas. Retinas have  been counterstained  with Isolectin - B4 (green).    
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3.2.5  ALTERATION  OF  VEGF-A  AND  VEGF  RECEPTOR  EXPRESSION  AFTER 
INHIBITION OF NOTCH SIGNALLING. 
Endothelial tip cell filopodia formation and polarity are dependent on a gradient of 
astrocyte-derived  VEGF-A  (Gerhardt  et  al.,  2003).  We  therefore  investigated 
whether  Notch  inhibition  by  DAPT  affected  astrocytes  or  VEGF-A  expression. 
GFAP staining showed normal astrocytic patterning in the retinas treated with DAPT 
for 6 hours when compared to control retinas (Figure 27A,B). However, there was a 
significant increase of 13% in the level of Vegfa mRNA produced after 6 hours 
DAPT treatment (p = 0.0066; Figure 27C). In control retinas, a gradient of Vegfa 
expression  with  strongest  expression  ahead  of  the  vessels  was  observed  (Figure 
27A). The amount of Vegfa produced by astrocytes decreased upon contact with the 
vascular network so that a boundary of high and low expression is formed at the 
vascular front (highlighted by the dotted line in Figure 27A). However, treatment of 
DAPT  for  6  and  48  hours  led  to  an  expansion  of  the  area  of  Vegfa  expression 
towards  the  region  of  increased  vessel  density  (Figure  27B,  F).  Astrocytes  are 
induced to express Vegfa during hypoxia. We therefore assessed whether the increase 
in Vegfa expression from DAPT treatment was a result of increased hypoxia in the 
retina. Analysis of the hypoxia marker solute carrier family 2 member 1 (Scl2a1) by 
qPCR did not show an increase in hypoxia in the retina after 6h DAPT treatment 
(Figure  27D).  Like  DAPT-treated  retinas,  there  was  an  expansion  of  Vegfa 
expression  within  the  vascular  plexus  in  P5  Dll4
+/-  retinas  when  compared  to 
littermate Dll4
+/+ retinas, as observed by ISH (Figure 28).In a separate study using 
Dll4-Fc, a protein that inhibits endogenous Dll4 activity, there was also an increase 
of ~10% in retinal Vegfa mRNA expression(Lobov et al., 2007). These data suggest 
that the vascular abnormalities from DAPT treatment could be an effect of increased 
Vegfa expression. However, there was no significant increase in the total amount of 
VEGF-A protein and isoforms 120, 144, 164 and 188 in P5 retinas after 48 hour 
DAPT  treatment  when  compared  to  vehicle-treated  littermates  (Hellstrom  et  al., 
2007). Therefore, even though there was an increase in Vegfa transcription, total 
VEGF-A  protein  level  remained  unchanged  after  long-term  DAPT  treatment 
suggesting that the increase in endothelial sprouting may not be caused by alteration 
in the level VEGF-A expression. However, the technique used to assess VEGF-A 
protein  level  does  not  provide  spatial  information  on  VEGF-A  expression  in  the  91     Figure  27 . DAPT treatment increases  Vegfa  expression in the retina.     A ,  B ,  E ,  F ,  Vegfa  ISH (black) of retinas from mice that have been treated with DAPT  for  6h  (A,B)  or  48h  (E,F).  A - B,  P5  mice;  E  and  F,  P6  mice.  Retinas  were  counterstained with Isolectin - B4 (green). Dotted red line indicates the boundary at  the vascular plexus  where  Vegfa  expression decreases in normal retina. Dotted red  line with arrows indicates expansion of  Vegfa  expression in the vascular plexus in  DAPT - treated retinas. qPCR of  Vegfa  ( C ) and  Slc2a , a hypoxia - regulated gene ( D ),  in retinas of P5 mice treated  with vehicle or DAPT for 6 hours. * *, p < 0.01. control,  n = 8; DAPT, n = 9. Values are mean  ±  S.E.M.   
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the retina after DAPT treatment. 
The increase in Vegfa mRNA expression may therefore be a secondary effect 
of Notch inhibition. The excessive vessels that form at the migrating vascular front 
upon Notch inhibition may not all be functional i.e. some vessels may be poorly 
perfused.  This  was  demonstrated  in  tumours  overexpressing  Dll4-Fc,  a  soluble 
dimerized version of Dll4 that inhibits endogenous Dll4 activity and consequently, 
Notch activity. Despite an increase in blood vessel density, tumours overexpressing 
Dll4-Fc have increased hypoxia as  a result of poor vascular perfusion (Noguera-
Troise et al., 2006). In the retina, DAPT treatment may lead to a greater area of 
hypoxia  compared  to  control  retinas,  leading  to  increased  Vegfa  expression  by 
astrocytes  at  the  vascular  front  (Figure  27B).  Although  we  did  not  observe  an 
increase in Slc2a expression after DAPT treatment, we cannot exclude the possibility 
that there may be regional hypoxia that was not detected by the qPCR experiment, 
which only assessed the total level of gene expression in the retina. 
  VEGF-A binds, with varying affinities, to Flt1 (also known as VEGFR1) and 
Kdr (VEGFR2). Additionally, the splice isoform VEGF-A165 binds to the co-receptor 
Neuropilin 1 (Nrp1). Activation of VEGF receptors results in many biological effects 
on  endothelial  cells  such  as  migration,  proliferation,  survival,  endothelial 
differentiation and induction of endothelial gene expression (Siekmann et al., 2008). 
We next examined whether there were any changes in VEGF receptor expression in 
the retina that may mediate the phenotypic changes we had observed after DAPT 
treatment  by  qPCR.  The  level  of  Kdr  was  not  significantly  altered  (there  was  a 
decrease of 14%; Figure 29). However, there was a significant decrease of 47% in 
Flt1 expression (p = 0.047) and a significant increase of 41% in Nrp1 expression (p 
= 0.0022) when compared to control retinas (Figure 29).    93   Figure  28 . Loss of one allele of  Dll4  increases  Vegfa  e xpression in the retina.   A  and  B ,  Vegfa  ISH (black) of retinas from P5  Dll4 +/+   and  Dll4 +/ -   mice. Isolectin - B4  staining is in green. Dotted red line indicates the boundary at the vascular plexus  where  Vegfa   expression  decreases  in  normal  retina.  Dotted  red  line  with  arrows  indicates  expansion  of  Vegfa   expression  in  the  vascular  plexus  in  DAPT - treated  retinas.     Figure  29 .  DAPT treatment alters the expression of VEGF receptors.   The relative expression of  Flt1  ( VEGFR1) ,  Kdr  ( VEGFR2)  a nd  Nrp1  were assessed  by qPCR. P5 mice were treated with vehicle or DAPT for 6 hours before obtaining  retinas for RNA isolation. * *, p < 0.01. Control, n = 9; DAPT, n = 11. Values are  mean  ±  S.E.M.   
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3.2.6  ECTOPIC  ACTIVATION  OF  NOTCH  SIGNALLING  RESULTS  IN  DECREASED 
FILOPODIA ACTIVITY AND VESSEL BRANCHING. 
The  loss-of-function  experiments  described  above  indicate  that  endothelial  Notch 
signalling  suppresses  endothelial  tip  cell  phenotype.  To  further  corroborate  this 
hypothesis, a gain-of-function experiment was performed whereby Notch signalling 
was  ectopically  activated  using  a  synthetic  peptide  corresponding  to  the 
δ/serrate/Lag-2 (DSL) domain of the human Jag1 protein that has been reported to be 
a Notch receptor agonist (Weijzen et al., 2002). To determine whether this peptide 
also activates Notch signalling in vivo in the blood vessels of the retina, the Jag1 
peptide was injected subcutaneously into P5 TNR mice for 6 hours. There was a 
marked increase in GFP signal in the vasculature compared to littermate controls 
where  a  scrambled  Jag1  (scJag1)  peptide  was  administered  (Figure  30A,B). 
Furthermore, there was a significant increase of 22% in Hey2 expression in the retina 
after 6 hours of Jag1 peptide treatment (p = 0.0354, Figure 30C). However, Hey1 
expression  remained  unchanged  and  there  was  a  unexpected  decrease  of  60%  in 
Nrarp expression (p < 0.0001) after treatment (Figure 30C). These results suggest 
that the expression of Notch target genes is differentially regulated by Jag1-induced 
Notch activation. 
  Short-term treatment with Jag1 peptide for 6 hours produced a phenotype that 
is opposite to that of DAPT treatment. There was a significant decrease of 35% in the 
number of filopodia formed at the leading edge of the migrating vessels (Figure 31A-
C). A longer duration of Jag1 peptide treatment (48 hours) resulted in a vascular 
network  that  was  much  sparser  compared  to  scJag1  peptide-treated  mice  (Figure 
31D-F). This was particularly prominent in arterial regions of the vascular plexus 
(Figure 31F). There was a decrease of 45% in the number of branchpoints formed in 
vessels where Notch signalling was ectopically activated when compared to control 
mice (Figure 31D). 
   95           Figure  30 . Jagged1 peptide t reatment upregulates endothelial Notch signalling  in vivo .   A  and  B , Treatment with Jagged1 (Jag1) peptide but not scrambled Jag1 (scJag1)  peptide results in increased Notch activity in TNR mouse. Notch activity is detected  in green/yellow and Isolectin - B4  in red.  C , qPCR of Notch target genes in retinas of  P5 C57Bl6/J mice treated with either scJag1 or Jag1 peptide for 6 hours. *, p =  0.0354; **, p < 0.0001. scJag1, n = 11; Jag1, n = 12. Values represent mean  ±  S.E.M.    96     Figure  31 .  Jag1  peptide  treatment  decreases  filopodia  formation  and  vessel  density  in vivo .     There  is  a  significant  decrease  in  filopodia  protrusion  from  endothelial  cells  of  migrating vessels in the retina after 6 hours Jag1 peptide treatment ( B ) that is not  obs erved in scJag1 - treated retinas ( A ). Boxed regions in A and B are magnified in A’  and  B’,  respectively.  Isolectin - B4  staining  is  in  white.  C ,  number  of  filopodia  protrusion per 100µm vessel length at the migrating vessel front of P5 C57Bl6/J  mice treated w ith scJag1 or Jag1 peptide for 6 hours. ***, p < 0.0001. scJag1, n = 20;  Jag1, n = 20. Values represent mean  ±  S.E.M.  D , number of vessel branchpoints in  200µm 2  area of P5 C57Bl6/J mice treated with scJag or Jag1 peptide for 48 hours.  ***, p < 0.0001. scJa g1, n = 22; Jag1, n = 33. Values represent mean  ±  S.E.M.  E  and  F , Retinas of C57Bl6/J mice were stained with Isolectin - B4 (red) after 48 hours (P4 - P6) of scJag1 or Jag1 treatment. A, artery.   
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3.3  DISCUSSION 
3.3.1  NOTCH  REGULATES  THE  FORMATION  OF  ENDOTHELIAL  TIP  AND  STALK 
CELLS DURING SPROUTING ANGIOGENESIS. 
During angiogenesis, new vessels emerge from existing vessels to form new sprouts. 
This requires the selection of a tip cell from a population of quiescent endothelial 
cells. The newly formed endothelial tip cell then becomes the leader of a new sprout 
and guides the trailing stalk cells in the patterning of a new vascular plexus. Data 
from the DAPT experiments and genetic deletion of one Dll4 allele show that the 
formation of new endothelial tip cells has to be tightly regulated since excessive tip 
cell formation resulted in a poorly-patterned, hyperdense vessel network that may not 
be functional. The data also show that the Notch signalling pathway is important in 
the regulation of tip cell formation and that it functions to maintain the stalk cell 
phenotype  i.e.  it  promotes  a  non-sprouting  endothelial  phenotype.  Furthermore, 
studies from two other independent groups also support this conclusion (Lobov et al., 
2007;  Suchting  et  al.,  2007).  The  cell  autonomous  role  of  Notch  signalling  in 
suppressing  tip  cell  formation  was  confirmed  by  specific  deletion  of  Notch1  in 
endothelial  cells  using  the  tamoxifen-inducible  VE-cadherin-CreER
T2  conditional 
mouse that has been crossed to the Cre reporter mouse called R26R (Hellstrom et al., 
2007). Because Cre recombination was infrequent (10 – 30%), it was possible to 
analyze Notch1-deficient endothelial cells, which are LacZ-positive, in an otherwise 
normal retina. By counting the number of endothelial cells that are LacZ-positive and 
–negative at the leading front of the vessels, the authors discovered that 73% of 
LacZ-positive  endothelial  cells  exhibit  tip  cell  characteristics  whereas  within  the 
LacZ-negative cell population, there was a 50:50 distribution of tip and stalk cells 
(Hellstrom  et  al.,  2007).  This  mosaic  analysis  indicates  that  endothelial  Notch1 
activity  suppresses  tip  cell  formation.  Indeed,  the  retinas  of  VEcad-
CreER
T2/R26R/Notch1
lox/lox  mice  exhibit  regions  of  increased  vessel  density  and 
filopodia protrusion (Hellstrom et al., 2007). 
The regulatory role of Notch signalling in endothelial tip/stalk formation is 
not limited to the mouse. In the zebrafish, DAPT treatment, Dll4 protein knockdown 
by morpholino oligonucleotide and genetic deletion of Dll4 resulted in excessive 
sprouting and branching during the development of ISVs and dorsal longitudinal 
anastomotic  vessels  (DLAV)  (Leslie  et  al.,  2007;  Siekmann  and  Lawson,  2007).  
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Excessive branching is also obtained when notch1b (Leslie et al., 2007) and rbpsuh 
(also  known  as  CSL,  Siekmann  and  Lawson,  2007)  were  knocked-down. 
Importantly, the cell-autonomous function of Notch signalling in limiting tip cell 
formation  was  demonstrated  in  a  mosaic  experiment  where  rbpsuh-deficient 
Tg(fli1:EGFP)
y1 cells were transplanted into wild-type zebrafish embryos (Siekmann 
and Lawson, 2007). Data from this experiment showed that rbpsuh-deficient, and 
therefore Notch-deficient, endothelial cells have increased propensity to occupy the 
DLAV but have reduced base cell localization when compared to wild-type to wild-
type transplantation experiments (Siekmann and Lawson, 2007). Furthermore, there 
is increased endothelial cell motility and proliferation so that a significantly higher 
number of endothelial cells migrate from the dorsal aorta to newly formed ISVs 
(Siekmann and Lawson, 2007).  
Over-activation of Notch signalling, on the other hand, reduces the migratory 
behaviour of endothelial cells. This was demonstrated by the reduction of filopodia 
formation by Jag1 peptide administration (Figure 30B) and overexpression of Dll4 in 
the mouse decreased endothelial cell migration and sprouting from the dorsal aorta to 
form intersomitic vessels (Trindade et al., 2008). In the zebrafish, overexpression of 
the Notch intracellular domain using a GAL4-UAS technique inhibited the migration 
and filopodia activity of endothelial cells to form ISVs (Leslie et al., 2007; Siekmann 
and Lawson, 2007).  Furthermore, when Tg(fli1:EGFP)
y1 cells with activated Notch 
were  transplanted  into  wild-type  zebrafish  embryos,  these  cells  show  increased 
incorporation  at  the  base  of  the ISV  but  did  not  occupy  positions  in  the  DLAV 
(Siekmann and Lawson, 2007). These experiments demonstrate that Notch signalling 
regulates angiogenic behaviour of endothelial cells by limiting the number of cells 
that become tip cells. 
The  formation  of  a  new  vessel  does  not  only  require  the  selection  of  an 
endothelial tip cell but also requires endothelial cell proliferation in order for the 
sprout to elongate. In endothelial cell cultures, Notch1 and Notch4 activity inhibit 
proliferation by transcriptional downregulation of p21
CIP1 and consequent reduction 
in nuclear translocation of cyclin D and cdk4 and downregulation of cyclin D-cdk4-
mediated Rb phosphorylation (Noseda et al., 2004). Indeed, suppression of Notch 
signalling  resulted  in  increased  endothelial  cell  proliferation  in  both  mouse  and 
zebrafish. In the mouse, there is a small increase in endothelial cell proliferation that 
may contribute to increased vessel diameter and branching after DAPT treatment  
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(Hellstrom et al., 2007), neutralization of Dll4 activity by Dll4-Fc (Lobov et al., 
2007) and in Dll4
+/- mutants (Suchting et al., 2007). In the zebrafish, the increase in 
proliferation  and  aberrant  migratory  behaviour  of  endothelial  cells  result  in  an 
increased  number  of  endothelial  cells  that  compose  ISVs  in  rbpsuh-deficient 
zebrafish  (Siekmann  and  Lawson,  2007).  Conversely,  overexpression  of  Dll4  in 
mouse decreased endothelial cell proliferation (Trindade et al., 2008).  
In  summary,  Notch  signalling  promotes  endothelial  cell  quiescence  by 
suppressing tip cell formation and endothelial cell proliferation. Furthermore, these 
experiments revealed that the phenotypes of endothelial cells are not permanent but 
can be altered and that Notch signalling modulates the phenotypic switch between tip 
cells and stalk cells. 
 
3.3.2  NOTCH  SIGNALLING  MODULATES  VEGF  RECEPTOR  EXPRESSION  AND 
SIGNALLING. 
In the experiments described above, DAPT treatment resulted in significant decrease 
in Flt1 and increase in Nrp1 expression levels, but no apparent change in Kdr level, 
in the mouse retina (Figure 29). Other published in vivo data where Notch signalling 
has been suppressed by different means partially support this result. In Dll4
+/- retinas, 
a decrease in Flt1 expression has also been shown (Suchting et al., 2007). However, 
data on Kdr expression after suppression of Notch signalling is conflicting. In Dll4
+/- 
retinas, there is an increase in Kdr expression (Suchting et al., 2007); conversely, in 
retinas where Dll4 activity has been neutralized by Dll4-Fc for 24 hours, there is a 
decrease in Kdr expression (Lobov et al., 2007). The disparity between my data and 
those published may be a result of different approaches used to isolate RNA for PCR 
analysis. In my experiments, I have used whole retina lysates. However, Suchting et 
al  isolated  RNA  from  retinal  endothelial  cells  for  their  PCR  experiments.  As 
neuronal cells in the retina also express Kdr, it may be possible that any change in 
endothelial  Kdr  expression  after  DAPT  treatment  is  masked  by  neuronal  Kdr 
expression.  
Further insight into VEGF receptor regulation by Notch signalling can be 
sought from Notch overexpression studies. In Dll4-overexpressing mice, there is an 
increase  in  Flt1  and  a  decrease  in  Kdr  expression  (Trindade  et  al.,  2008),  and 
overexpression of Dll4 in HUVECs results in significant decreases in Kdr and Nrp1  
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levels (Harrington et al., 2008; Williams et al., 2006) and increase in Flt1 protein as 
well as the inhibitory soluble alternative splice variant of Flt1 (sFlt1) (Harrington et 
al., 2008). Collectively, data gathered from in vitro and in vivo studies demonstrate 
an inhibitory regulation of Kdr and Nrp1 expression and a stimulatory regulation of 
Flt1 expression by Notch (Figure 32B).  
In addition, Notch signalling regulates the expression of a third member of 
the  VEGF  receptor  family,  Flt4  (also  known  as  VEGFR3),  in  both  mouse  and 
zebrafish. In the zebrafish, tip cells of ISVs selectively express Flt4 during sprouting 
angiogenesis. Inhibition of Notch signalling by morpholino knockdown of rpbsuh 
results in an increase in flt4 expression and its continual expression even after ISV 
and DLAV are formed (Siekmann and Lawson, 2007). Similarly in the mouse, Flt4 
expression is high in endothelial cells of sprouting blood vessels of the retina and its 
expression is negatively regulated by Notch activity (Figure 32B; Tammela et al., 
2008). 
Although  I  have  not  shown  any  evidence  for increased  Kdr  activity  after 
DAPT treatment, it seems likely that this may occur for the several reasons. Firstly, 
Flt1 acts as a ‘decoy’ receptor by restricting the accessibility of VEGF-A for Kdr 
since it has a higher affinity for VEGF-A (Hiratsuka et al., 2005). Because Flt1 
undergoes weak autophosphorylation in response to VEGF (Seetharam et al., 1995; 
Waltenberger et al., 1994), its activity is not essential for transmitting a mitogenic 
response.  The  decrease  of  Flt1  expression  observed  after  DAPT  treatment  may 
translate to a down-regulation of endothelial Flt1 protein expression, and thereby 
increase the availability of VEGF-A for Kdr, whose level remained unchanged after 
DAPT  treatment.  Secondly,  the  increase  in  Nrp1  expression  (and  consequent 
increase  in  Nrp1  protein)  may  potentiate  Kdr  activity  since  Nrp1  stabilizes 
VEGF164/Kdr signalling complex and therefore enhances Kdr signalling.  
There is experimental evidence demonstrating that the inhibition of Notch 
signalling increases VEGF signalling. In the zebrafish, inhibition of VEGF signalling 
pharmacologically by SU5416, an inhibitor of Kdr tyrosine kinase activity, blocked 
the excessive sprouting observed in dll4 mutants (Leslie et al., 2007). Furthermore, 
co-injection of rbpsuh and flt4 morpholinos led to a partial rescue of the rbpsuh 
morphant phenotype (Siekmann and Lawson, 2007) and in the mouse, blocking Flt4 
activity in the retina partially rescues the effect of DAPT treatment (Tammela et al., 
2008). These experiments suggest that the excessive sprouting observed in dll4   101   mutants and  rbpsuh  morphants may be caused by increased VEGF signalling and  that,  in  zebrafish,  Notch  activation  normally  represses  flt 4   expression  to  limit  angiogenic behaviour in developing ISVs.    3.3.3   C ROSS - TALK  BETWEEN  VEGF  AND  N OTCH  SIGNALLING  PATH WAYS  REGULATES SPROU TING ANGIOGENESIS .   The complexity between Notch and VEGF signalling pathways is further increased  by the discovery that VEG F induces  Dll4  expression in the retina  (Lobov et al.,  2007;  Noguera - Troise  et  al.,  2006;  Suchting  et  al.,  2007)   and  in  human  arterial  endothelial cultures ( Figure  32 A,  Liu et al., 2003; Patel et al., 2005) . This presents a  situation where in regions of high VEGF - A expression (see  Figure  33 ), such as at the  migrating front of the retinal vascular plexus,   Dll4  expression is induced through  VEGFR  signalling  (although  the  mechanism  is  currently  unclear)  on  endothelial  cells. This Dll4 - expressing cell then triggers Notch signalling in adjacent cells so that  the ability of these cells to respond to VEGF is dam pened due to downregulation of  Kdr/Flt4   expression  and  increase  in  Flt1   and  sFlt1   expression.  The  decrease  in  Kdr/Flt4 activity has two consequences. The first is that the endothelial cell becomes  quiescent i.e. it adopts a non - motile, non - invasive behavio ur so that it maintains a  connection to the patent blood vessel from which the sprout originally emanated, and  secondly,  Dll4  expression  decreases  since  there  is  down - regulation  in  Kdr/Flt4  activity. These phenotypic and molecular differences among endothe lial cells would  therefore lead to the selection of an endothelial cell to become a tip cell, a Dll4 - expressing cell that is highly motile with multiple filopodia. The stalk cell, however,    Figure  32 . Proposed interaction between VEGF and Notch signalling pathways.   
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is  less  motile  with  high  Notch  activity  and  low  Dll4  expression.  The  difference 
between  the  two  endothelial  cell  subpopulations  reinforces  the  establishment  and 
function of a tip cell in vessel guidance. Notch signalling therefore limits the number 
of tip cells formed by the activation of Notch on neighbouring cells via Dll4. 
  The  model  proposed  above  illustrates  the  regulation  of  Notch-VEGF 
signalling in endothelial cells by Dll4. However, endothelial cells also express other 
DSL ligands. In the mouse retina, there are overlapping as well as spatial differences 
in the expression of Dll4, Jag1 and Dll1 (Hofmann and Luisa Iruela-Arispe, 2007). 
Endothelial tip cells selectively express Dll4, but not Jag1 or Dll1. Endothelial cells 
located at arterial junctions express Jag1, but not Dll1 and Dll4 endothelial cells. 
However, Dll1, Dll4 and Jag1 are all expressed in endothelial cells of capillaries and 
arteries (Hofmann and Luisa Iruela-Arispe, 2007). However, it is unclear whether all 
DSL ligands activate the same Notch receptors and also, some Jagged and Delta-like 
ligands have been reported to have opposing activities on Notch receptor binding 
(D'Souza  et  al.,  2008).  Endothelial  cells  may  therefore  have  varying  degrees  of 
Notch activity, depending on the number and type of ligand they are exposed to. 
Given that blood vessels are composed of multiple cell types and are exposed to 
basement  membrane  components,  it  is  likely  that  Notch  signalling  in  endothelial 
cells can also be regulated by Notch ligands expressed by non-endothelial vascular 
cells. For example, vascular smooth muscle cells around mature arteries in the retina 
express Jag1 (Hofmann and Luisa Iruela-Arispe, 2007). Also, extracellular matrix 
components may contain non-canonical DSL ligands and one example is MAGP2, 
which inhibits Notch signalling in endothelial cells (Albig et al., 2008). Although 
this was demonstrated in vitro, it may be possible that this can occur in vivo since 
this  gene  (Mfap5)  is  expressed  in  early  post-natal  retinas  (microarray  data  not 
shown).  The  regulation  of  endothelial  Notch  signalling  during  angiogenesis  is 
therefore very complex, consistent with our observation of a heterogeneous pattern 
of Notch signalling among endothelial cells in the developing vascular plexus of the 
mouse retina (Figure 19A and B). 
   103   Figure  33 . Proposed model for VEGF - Notch signalling in regulating angiogenic  sprouting.   The combination of a graded VEGF - A expression in the extracellular milieu and  endothelial Notch signalling faci litates the formation of endothelial tip cells  (Bentley  et al., 2008; Gerhardt et al., 2003) . (1) Selected tip cells become motile and extend  many filopodia protrusions ahead of the vessel plexus. (2) VEGF - A ahead o f the  migrating  vascular  plexus  binds  to  Kdr  expressed  on  tip  cell  filopodia,  thereby  triggering  VEGF  receptor  signalling  in  tip  cells.  Through  an  uncharacterized  mechanism, VEGF receptor activation induces the expression of  Dll4  in tip cells. Tip  cells th erefore have high Dll4 expression, which bind to Notch receptors on adjacent  stalk cells. (3) Stalk cells subsequently have higher Notch activity than tip cells.  Notch activation represses the transcription of  Kdr ,  Flt4  and  Nrp1  but induces the  transcripti on of  Flt1 . Notch activation also increases the expression of soluble Flt1, a  splice variant of Flt1. Stalk cells have low VEGF receptor activity due to decreased  Kdr expression and sequestering actions of Flt1 and sFlt1, and in turn, express less  Dll4 . (4 ) It is likely that the endothelial cells in the perfused “mother” vessel have  low Notch activity, due to their proximity to a high Notch/low Dll4 expressing stalk  cell, and low VEGF receptor activity because of low VEGF - A stimulation. However,  
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upon high VEGF stimulation, a cell of this state can become activated and turned 
into a tip cell.  
 
3.3.4  FUTURE PERSPECTIVES 
The  data  presented  in  this  chapter,  as  well  as  those  published  in  recent  years, 
illustrate that endothelial cells of sprouting blood vessels are heterogeneous in their 
behaviour.  The  collective  behaviour  of  each  endothelial  cell  culminates  in  the 
formation of an organized, functional vascular plexus. How does a population of 
endothelial cells become different in their response to the same stimulus such as 
VEGF-A?  As  presented  above,  endothelial  cells  exhibit  varying  levels  of  Notch 
signalling and since Notch activity modulates VEGF receptor expression, endothelial 
cells of a vessel plexus would respond differently to the same stimulus. This can 
arise from several factors. The first is that different VEGF receptors trigger different 
cellular  responses.  Due  to  its  weak  tyrosine  phosphorylation  activity,  Flt1  only 
weakly stimulates endothelial cell proliferation (Shibuya, 2008). Activation of Kdr, 
however, results in a multitude of endothelial cell behaviours such as cell migration, 
survival, permeability, proliferation and regulation of gene expression (Figure 34; 
Olsson et al., 2006; Shibuya, 2008; Siekmann et al., 2008). The function of the third 
VEGF  receptor,  Flt4,  was  previously  thought  to  be  selective  for  lymphatic 
endothelial cell function; however, there is now evidence demonstrating a role of 
Flt4 in blood endothelial cells during sprouting angiogenesis (Siekmann and Lawson, 
2007;  Tammela  et  al.,  2008).  Furthermore,  the  activities  of  VEGF  receptors  are 
modulated by co-receptors such as Neuropilins and heparan sulphate proteoglycans 
(HSPGs). The VEGF signalling output is therefore in part dictated by the type and 
level of VEGF receptor(s) expressed by the endothelial cell. It has been documented 
that endothelial tip cells express high levels of Kdr (Gerhardt et al., 2003). However, 
it would be of interest to investigate the spatial expression of the different receptors 
and co-receptors in relation to each other during retinal angiogenesis at the protein 
level. This study would confirm the hypothesis that endothelial stalk cells express 
higher levels of Flt1. Presently, the data gathered to support this hypothesis does not 
provide  spatial  information  on  receptor  expression  and  is  also  based  on  mRNA 
expression.  
   The second factor that determines endothelial cell biological output is the 
downstream   signalling   pathways  triggered   after   receptor   activation  and    105     Figure  34 . The VEGF signalling pathways in endothelia l cells.   Upon VEGF binding, VEGF receptors dimerize, leading to the phosphorylation of  different tyrosine residues. In human Kdr, these include Y951, Y1175 and Y1214.  Phosphorylation elicits differential downstream signalling events. Y951 influences  actin  remodelling by binding to TSAd (T - cell - specific adaptor)  (Matsumoto et al.,  2005)  therefore affecting endothelial cell migration. Phosphorylation of Y1214 has  similar effects on migration, but acts via the activatio n of p38/MAPK. The most  important tyrosine residue on Kdr is Y1175, which directly affects PLC γ 1 signalling  and thereby influences gene expression and cell proliferation. Y1175 also binds to  Shb, which in turn activates PI3K and Akt. The PI3K/Akt pathway r egulates vessel  permeability, endothelial cell survival and migration. From  (Siekmann et al., 2008) .       phosphorylation  of specific tyrosine residues ( Figure   34 ). Differential occupancy of  single  phosphorylated  residues  within  activated  Kdr  can  lead  to  distinct  cellular  outputs  (Siekmann  et  al.,  2008) .  For  example,  phosphorylation  of  Y1175  in  endothelial  cells  activates  the  PI3K/Akt  and  RAF/Mek/Erk  pathways.  However,  these two signalling pathways promote different endothelial functions. The  PI3K/Akt  pathway generally promotes angiogenesis by driving endothelial cell migration and  survival while the RAF/Mek/Erk pathway promotes maturation and differentiation of  blood vessels  (Harrington et al., 2008; Ho ng et al., 2006) . Interestingly, these two  pathways have opposing roles during arterial - venous differentiation. In the zebrafish,  
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activation of Akt antagonizes signalling through the PLCγ1/PKC/ERK pathway to 
block arterial endothelial differentiation (Figure 34; Hong et al., 2006). Even more 
interestingly, in vitro studies using endothelial cells demonstrate that VEGF-induced 
phosphorylation of Erk is inhibited by Dll4 (Harrington et al., 2008), suggesting that 
Notch signalling suppresses the RAF/Mek/ERK pathway. In light of this finding, one 
may ask whether endothelial tip cells have higher RAF/Mek/ERK activity than stalk 
cells. To address this, it would be necessary to examine phosphorylated Erk protein 
localization  by  immunohistochemistry  during  retinal  angiogenic  sprouting.  Notch 
signalling may also modulate the balance between PI3K/Akt and PLCγ1/PKC/ERK 
pathways  by  regulating  the  expression  of  PTEN,  a  negative  regulator  of  PI3K 
(Palomero et al., 2008; Whelan et al., 2007). However, it is still unclear whether this 
mode of regulation also occurs in endothelial cells and whether Notch up- or down-
regulates PTEN. Again, it would be of interest to investigate the spatial expression of 
PTEN among endothelial cells during angiogenesis. 
 
3.4  SUMMARY 
In this chapter, I have shown that Notch signalling negatively regulates endothelial 
tip formation during sprouting angiogenesis. Also, I have presented data suggesting 
that Notch modulation of tip and stalk cell formation is mediated through Notch 
regulation of VEGF receptor expression. 
   107  4   Nrarp stabilizes nascent blood vessel during  angiogenesis   4.1   I NTRODUCTION   This chapter of the thesis is devoted to the study of a less well - known Notch effector,  the  Notch - regulated ankyrin repeat protein or Nrarp. At the start of this project, there  was  no thing known about the function of Nrarp in angiogenesis. We therefore sought  to  investigate  a  role  of  Nrarp  in  vascular  development  in  the  mouse  and  the  zebrafish.   4.1.1   N RARP  IS A  N OTCH TARGET GENE THA T NEGATIVELY REGULAT ES  N OTCH  SIGNALLING .   In the mouse, the  N rarp  gene encodes a small protein of 114 amino acids with two  ankyrin repeat domains. In the zebrafish, two  nrarp  paralogues,  nrarp - a  and  nrarp - b ,  encode proteins of 112 and 111 amino acids, respectively  (Topczewska et al., 2003) .  Nrarp is also expre ssed in human, rat, Xenopus, Fugu and Tetraodon. The human,  mouse  and  rat  sequences  are  identical,  suggesting  an  evolutionarily  conserved  function for Nrarp proteins in vertebrates. Sequence alignment reveals an 80% amino  acid sequence identity between Nra rp proteins of mouse, zebrafish, Xenopus, Fugu  and Tetraodon  (Topczewska et al., 2003) .   The expression of  Nrarp  is directly induced by Notch signalling through the  CSL - dependent pathway  (Krebs et al., 2001; Lam ar et al., 2001; Pirot et al., 2004;   the CSL pathway is described in Chapter  1.3.1 ) .  During mouse and zebrafish        Figure  35 . Alignment of deduced amino acid of Nrarp proteins fr om various  species.   (Topczewska et al., 2003)   
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embrygenesis, Nrarp is expressed in several tissues such as the presomitic mesoderm 
in which cellular differentiation is regulated by Notch signalling (Krebs et al., 2001; 
Topczewska et al., 2003). In Notch1 null mice, Nrarp expression is downregulated 
(Krebs  et  al.,  2001).  Similarly,  mindbomb  zebrafish  mutants,  in  which  Notch 
signalling is abrogated, have reduced nrarp-a and nrarp-b expression (Topczewska 
et al., 2003). These findings indicate that Nrarp expression is positively regulated by 
Notch signalling in vivo. Studies in Xenopus revealed that Nrarp forms a ternary 
complex with NICD and CSL and, in doing so, disrupts the NICD/CSL complex to 
suppress  CSL-dependent  transcription  (Lamar  et  al.,  2001).  Furthermore, 
overexpression of Nrarp destabilizes NICD in  Xenopus (Lamar et al., 2001) and 
zebrafish (Ishitani et al., 2005) embryos. Thus, Nrarp is a negative regulator of Notch 
signalling. 
There are currently few known functions of Nrarp. By overexpressing Nrarp 
in  mouse  haematopoietic  stem  cells,  it  was  discovered  that  Nrarp  blocks  T  cell 
lineage commitment and progression through early stages of thymocyte maturation 
(Yun  and  Bevan,  2003).  In  the  zebrafish,  knockdown  of  nrarp-a  expression  by 
antisense morpholino oligonucleotide revealed that nrarp-a is required for migratory 
activity and pigment-cell fate specification of neural crest cells (NCCs) (Ishitani et 
al., 2005). Interestingly, the authors of this study showed that the regulation of NCC 
development by nrarp-a is conducted through the Wnt signalling pathway. This is 
mediated by the ability of Nrarp to bind to Lef1, a transcription factor in the Wnt 
signalling pathway. This interaction prevents Lef1 ubiquitination and degradation, 
thereby stabilizing Lef1 to positively regulate Wnt signalling (Ishitani et al., 2005). 
 
4.1.2  WNT SIGNALLING. 
The  Wnt  signalling  pathway  is  evolutionarily  conserved  in  metazoans  where  it 
regulates  many  cellular  and  biological  processes  such  as  cell  adhesion,  polarity, 
migration and proliferation, as well as differentiation of multiple cell lineages and 
stem cell self renewal (van de Schans et al., 2008). Proteins from the Wnt family are 
therefore essential in a wide range of developmental and physiological processes.  
  Wnts  are  secreted  lipid-modified  glycoproteins  of  several  hundred  amino 
acids in size (Willert et al., 2003). At least 19 Wnt proteins have been identified in 
mammals and they bind to at least two types of receptors: the serpentine receptors of  
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the Frizzled (Fz) family (10 members in mammals) and members of the low-density-
lipoprotein-related  protein  (LRP)  family  at  the  plasma  membrane.  In  addition, 
proteins from the Ror and Ryk family, both tyrosine kinase receptors, have also been 
identified as receptors for Wnt proteins (Kikuchi et al., 2007). Wnt proteins induce 
several pathways that include the Wnt/β-catenin pathway, which is also known to as 
the “canonical” Wnt pathway. In this pathway, signalling is achieved through the 
stabilization  of  β-catenin  or  Ctnnb1.  Wnt  proteins  also  activate  other  signalling 
pathways and these are referred to as “non-canonical Wnt signalling”. These include 
the Wnt/JNK pathway, which involves activation of small GTPases such like Rac, 
Rho and Cdc42 (Kikuchi et al., 2007) and the Wnt/Ca
2+ pathway, which requires 
intracellular increase of Ca
2+ (Kikuchi et al., 2007). 
  In the canonical Wnt pathway, β-catenin acts as a second messenger of Wnt 
signalling. When Frizzled receptors are not engaged by Wnt, a β-catenin degradation 
complex consisting of adenomatous polyposis coli (APC), Axin, Glycogen Synthase 
Kinase-3β  (GSK-3β)  and  Casein  Kinase-1  (CK-1)  bind  to  newly  synthesized  β-
catenin (Hinoi et al., 2000). Axin facilitates the phosphorylation of serine/threonine 
residues 33, 37 and 41 at the amino terminus of β-catenin by CK-1 and GSK-3β. The 
resulting phosphorylated footprints recruit a β-TrCP-containing E3 ubiquitin ligase, 
which targets β-catenin for proteasomal degradation (Kimelman and Xu, 2006). The 
level of free β-catenin in the cytoplasm therefore remains low. β-catenin-mediated 
Wnt  signalling  is  initiated  when  a  Wnt  ligand  binds  to  a  complex  formed  by  a 
Frizzled receptor and an LRP co-receptor. Frizzled receptor occupancy inhibits the 
kinase activity of the β-catenin degradation complex by an incompletely understood 
mechanism involving the direct interaction of Axin with the Axin-binding molecule 
Dishevelled (Dsh, (Cliffe et al., 2003)). As a consequence, β-catenin accumulates in 
the cytoplasm and translocates to the nucleus, where it binds to the N-terminus of 
DNA-binding  proteins  of  the  T-cell  factor  (Tcf)/Lymphoid  enhancer  factor  (Lef) 
family of high mobility group (HMG)-box proteins (Behrens et al., 1996; Reya and 
Clevers, 2005). In vertebrates, there are four Tcf genes (Tcf1, Lef1, Tcf3 and Tcf4) 
and each gives rise to a variety of specialized isoforms. In the absence of β-catenin, 
Tcf/Lef assemble alternative complexes with transcriptional co-repressors such as 
CBP and Groucho and become transcriptional (Hoppler and Kavanagh, 2007). The 
binding of β-catenin to Tcf/Lef facilitates the assembly of multimeric complexes    110   Figure  36 . Canonical Wnt pathway.   In the absence of Wnt ligand, the cells are in the “off” state. GSK - 3 β  is constitutively  active and cells maintain low cytoplasmic and nuclear levels of  β - catenin. In the  presence of extracellular Wnt signalling, a combination of L RP - axin interaction and  Dvl  phosphorylation  blocks  the  APC - axin - GSK - 3 β - CKI  complex  from  phosphorylating  β - catenin.  The  accumulated  β - catenin  then  enters  the  nucleus,  where  it  converts  Tcf/Lef1  into  a  transcriptional  activator.    Adapted  from  (Eisenmann, 2005) .       containing  transcriptional   co - activators  such  as  Pygo   (Stadeli  and  Basler,  2005) ,  thereby converting Tcf/Lef to transcriptional activators of target genes.       4.1.3   A IMS OF  P ROJECT .   The  aims  of  this  project  were:  i)  analysis  of  Nrarp  expre ssion  during  sprouting  angiogenesis and ii) investigate whether Nrarp has an angiogenic function.       
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4.2  RESULTS 
4.2.1  NRARP  EXPRESSION  DURING  MOUSE  EMBYRONIC  DEVELOPMENT  AND  IN 
EARLY POSTNATAL RETINA. 
To determine whether Nrarp is expressed in endothelial cells during angiogenesis, 
we  studied  the  expression  pattern  of  Nrarp  mRNA  by  wholemount  in  situ 
hybridization  in  mouse  embryos  and  in  early  postnatal  mouse  retinas.  In  mouse 
E10.5 embryos, Nrarp is predominantly expressed in the central nervous system and 
in the presomitic mesoderm, as reported previously (Figure 37A; Krebs et al., 2001). 
It is also expressed in the intersomitic vessels (arrowheads in Figure 37B) and in 
vessels  of  the  limb  buds  (Figure  37C).  Counterstaining  of  blood  vessels  with 
Endomucin  indicated  the  strongest  signal  at  vascular  branchpoints  (Figure  37C’, 
inset).  Confocal  microscopy  of  the  double-labelled  limb  buds  confirmed  Nrarp 
mRNA localization to endothelial cells located at branchpoints (arrowheads in Figure 
37D). It is interesting to note that endothelial cells located between branchpoints do 
not express Nrarp (arrows in Figure 37D). 
  Nrarp  is  also  expressed  in  endothelial  cells  of  the  developing  retinal 
vasculature. In the early postnatal mouse retina, Nrarp expression is prominent in 
endothelial cells at the migrating front of the vasculature (Figure 38A-C). Strongest 
expression was regularly detected in the stalk cells (red arrowheads). The distribution 
of  Nrarp  expression  therefore  coincides  with  regions  of  high  Notch  activity,  as 
revealed by the transgenic Notch reporter mouse (TNR) and the nuclear localization 
of Notch1 intracellular domain (NICD1) in the previous chapter. Close observation 
of Nrarp expression in 200 Isolectin-B4 labeled sprouts in three P5 retinas revealed 
Nrarp mRNA in only 7%±2.6 of the leading tip cells. For comparison, 84%±10 of 
the tip cells were positive for Dll4 mRNA, consistent with the idea that tip cells 
signal through Dll4 to induce Notch signalling, and hence Nrarp expression, in stalk 
cells. Like in the embryonic limb bud vasculature, Nrarp expression is also highly 
expressed  by  endothelial  cells  located  at  vessel  branchpoints  (red  arrowheads  in 
Figure 38A-C). 
  However,  Nrarp  expression  is  not  confined  to  endothelial  cells  at  the 
migrating  front  of  the  vasculature.  As  angiogenesis  progresses,  Nrarp  expression 
becomes more widespread within the proximal vascular plexus (Figure 38D and D’).    112     Figure  37 .  Nrarp  is expressed in endothelial cells of developing blood vessels in  mouse embryos.   A - D ,  Nrarp  ISH in E10.5 mouse embryos. The embryos were counterstained with  anti - endomucin antibody (red) to visualize blood vessels.  Nrarp  is predominantly  expressed  in  the  central  nervous  system  including  the  neural  tube  (NT)  and  the  presomitic mesoderm (arrow in A, PSM).  Nrarp  is expressed in mouse embryonic  (E10.5) intersomitic vessels (arrowheads in B) and limb bud vessels ( C ). In t he limb  bud,  Nrarp  expression is prominent at vessel branchpoints. D is a 3D reconstruction  of confocal images of limb bud blood vessels (outlined in dotted red line) showing  Nrarp   (blue)  expression  in  endothelial  cells  (green)  located  at  branchpoints  (arr owheads in D). Endothelial cells between branchpoints lack  Nrarp  expression  (arrows in D).    113     Figure  38 .  Nrarp  is expressed in endothelial cells of retinal blood vessels.   Nrarp   ISH  (blue)  of  early  mouse  postnatal  retinas  (P3  to  P7 ).  Retinas  were  counterstained  with  Isolectin - B4  to  visualize  blood  vessels  (green).  Nrarp   is  expressed by ECs at various regions of the developing vascular plexus: the migrating  vascular  front  (A - C)  and  the  capillary  plexus  (D).  White  arrows  indicate  Nrar p   expression in endothelial tip cells; red arrows indicate stalk cells that express  Nrarp ;  and  red  arrowheads  indicate  endothelial  cells  of  vessel  branchpoints  that  express  Nrarp .   
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4.2.2  NRARP EXPRESSION IN ZEBRAFISH EMBRYOS. 
In the zebrafish, the two paralogues nrarp-a and nrarp-b are highly expressed in the 
neural  tube  and  in  the  presomitic  mesoderm  (Figure  39A,B).  Additionally,  we 
observed  nrarp-a  expression  in  the  dorsal  aorta  at  24hpf  (Figure  39C’,  E).  By 
analyzing wholemounts and sections at higher magnification, nrarp-a expression is 
also  detected  in  some  endothelial  cells  of  the  intersegmental  vessels  (arrows  in 
Figure 39D), but appears absent from the posterior cardinal vein. However, we were 
not able to detect nrarp-b expression in blood vessels in the zebrafish embryos at 
24hpf  or  48hpf.  Nevertheless,  we  cannot  exclude  that  nrarp-a  and  nrarp-b  are 
expressed  in  other  vascular  segments  albeit  at  lower  levels.  Furthermore,  its 
detection may be undetectable by the in situ hybridization procedure.  
 
 
 
 
 
 
 
 
 
Figure 39. Expression of nrarp-a and nrarp-b in the zebrafish embryo. 
ISH of nrarp-a (A, C-E) and nrarp-b (B) in 24hpf (hours post-fertilization) zebrafish 
embryos. Like mouse Nrarp, nrarp-a and -b are predominantly expressed in the CNS 
and also in the PSM (arrowheads in A and B). C and C’ are transverse images of the 
same region of the zebrafish trunk taken at different focal planes. In C, nrarp-a 
expression  is  detected  in  some  cells  (white  arrows)  between  somite  boundaries. 
These cells may be neural crest cells. Boxed area in C is magnified in D, which 
shows nrarp-a expression in ECs of ISV (arrows). The somite boundary is outlined 
by a dotted line. nrarp-a is expressed in the dorsal aorta (arrow in C’). E is a cross-
section of zebrafish trunk showing nrarp-a expression in the dorsal aorta (circled) 
and the neural tube (arrows). NT, neural tube; NC, notochord; DA, dorsal aorta; CV, 
cardinal vein. nrarp-a ISH in C-D were produced by Jonathan D. Leslie.   115      116   4.2.3   N RARP PROTEIN EXPRESS ION  –   ATTEMPTS TO  GENERATE  AN  ANTI - N RARP  ANTIBODY .   At the start of this project, no known antibodies against Nrarp protein had been  generated. We ther efore proceeded to produce one.      In one attempt, a recombinant mouse Nrarp protein was generated and used  to raise an anti - Nrarp antibody (Nrarp Ty32). Unfortunately, the antibody generated  was unspecific. The Nrarp protein is predicted to be 12.5kDa. Whe n used in Western  Blotting, a band of about 17kDa was detected (arrow in  Figure  40 ). However, many  unspecific  and  stronger  bands  of  higher  molecular  weight  were  also  detected.  Furthermore,  the  17kDa  protein  band  was  als o  detected  in  Nrarp  null  retinas,  indicating that this antibody is not specific.         Figure  40 . Antibody raised against recombinant Nrarp protein.   Antibody raised against the recombinant Nrarp protein (Nrarp Ty32) was tested on  pr otein lysates of P5 retinas from  Nrarp +/+ ,  Nrarp +/ -  and  Nrarp - / -  by Western Blot.  Arrow points to a protein band that may be that of Nrarp. However, this band is also  present in the  Nrarp - / -  sample.     In  another  attempt  to  generate  an  anti - Nrarp  anitbody,  w e  designed  three  peptides that corresponded to distinct regions of the mouse Nrarp protein. Of these,  the antibody raised against the amino acid residues 16 - 29 of Nrarp (Nrarp 16 - 29c)  showed  potential  as  an  antibody  against  the  protein  ( Figure  41 ).  By  doing  immunofluorescence  on  a  mouse  brain  endothelial  cell  line  (bEND5),  strong  labelling was detected in the nuclei of cells ( Figure  41 B). This staining pattern was  barely detectable in  the negative control sample, where cells were only incubated  with secondary antibody ( Figure  41 A). However, no specific staining was observed   117   when  the  same  antibody  was  used  on  wholemount  retina  preparations  (data  not  shown). The antibody was also tested by Western Blotting to detect Nrarp expression  in bEND5 cells as well as P5 retinas. In the Western Blotting, a band of about 20kDa  that may be Nrarp was observed in both bEND5 cells and in the retina ( Figure  41 C).  However, this antibody also recognized other proteins of higher molecular weight.  Hence, to determine the specificity of this antibody for Nrarp, we need to test it on  protein lysates isolated from Nrarp null cells or tissu es.    In summary, we have not been able to detect Nrarp protein expression in  retinas  using  the  two  anti - Nrarp  antibodies  generated.  Thus,  the  only  available  technique available to localize  Nrarp  expression is  in situ  hybridazation.       Figure  41 . Antibody raised against peptide 16 - 29c of Nrarp protein.     The antibody that recognizes a peptide corresponding to residues 16 - 29 of mouse  Nrarp  protein  (Nrarp  16 - 29c)  was  tested  on  bEND5  cells  by  immunostaining.  Incubation of the antibody a t 2µg/ml produced a strong nuclear staining (B) that was  absent in the negative control (A). A protein of ~20kDa was detected by Western  Blotting (arrow in C).     
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4.2.4  ENDOTHELIAL NRARP EXPRESSION IS REGULATED BY NOTCH SIGNALLING. 
There  is  published  evidence  that  Notch  signalling  directly  regulates  Nrarp  gene 
promoter activity in a CSL-dependent manner (Pirot et al., 2004). However, it is 
unknown whether endothelial Nrarp expression is regulated by Notch signalling in 
vivo. We therefore investigated endothelial Nrarp regulation by Notch using three 
methods. Firstly, Notch signalling was inhibited by the administration of DAPT in 
P5 C57Bl6/J mice. Retinas were isolated from mice 6 hours after treatment and were 
processed for Nrarp ISH and qPCR experiments. By ISH, we detected a significant 
reduction  in  Nrarp  mRNA  expression  in  endothelial  cells  after  DAPT  treatment 
(Figure 42B) when compared to vehicle-treated mice (Figure 42A). qPCR analysis of 
Nrarp expression in whole retina lysates revealed a significant decrease of 70% in 
DAPT-treatment animals (p < 0.0001; Figure 42C). In the second approach, human 
Dll4-Fc protein was used to inhibit Notch signalling specifically in endothelial cells. 
Dll4-Fc  is  a  soluble  version  of  Dll4  that  acts  to  block  endogenous  Dll4/Notch 
interactions (Lobov et al., 2007). P5 mice were injected once intravitreally with Dll4-
Fc and retinas were analyzed for Nrarp expression 24 hours later by qPCR. There 
was  a  significant  decrease  of  30%  in  Nrarp  expression  when  compared  to  mice 
treated  with  a  human-Fc  (p  =  0.0004;  Figure  42C).  These  two  experiments 
demonstrate  that  Notch  signalling  positively  regulates  Nrarp  expression  in 
endothelial cells. 
  In  the  third  experiment,  we  stimulated  Notch  signalling  using  the  Jag1 
peptide (described in 3.2.6) and examined Nrarp expression by qPCR. There was no 
change  in  Nrarp  expression  after  3  hours  of  Jag1  treatment  as  compared  to 
scrambled peptide treatment. Longer treatment of Jag1 peptide for 6 hours led to a 
significant  decrease  of  ~60%  in  Nrarp  expression  when  compared  to  scrambled 
peptide treatment (p < 0.0001; Figure 43C). By wholemount retina ISH, we observed 
a decrease in blood vessel density at the vascular front, which is a Notch gain-of-
function phenotype, as well as a decrease in endothelial Nrarp expression (Figure 
43B).  In  contrast,  the  same  peptide  has  been  demonstrated  to  induce  significant 
increases in Nrarp expression in retinas from mice treated for 6, 12 and 24 hours 
(Tammela et al., 2008). The disparity between the published data and mine is hard to 
explain and may well be due to different experimental conditions.   119     Collectively,  data  from  my  own  experiments  and  from  published  works  indicate that  Nrarp  expression is positively regulated by Notch signalling  in vivo .            Figure  42 . Endothelial  Nrar p  expression is suppressed after DAPT and Dll4 - Fc  treatment.   P5 C57Bl6/J mice were injected once with DAPT at 100 µ g/g subcutaneously (A - C)  or with 4µg Dll4 - Fc or hFc (control) intravitreally (C).  Nrarp  expression in retinas  was analyzed by whole - mount ISH  (A,B) or by qPCR (C).  Nrarp  ISH revealed a  significant decrease in endothelial  Nrarp  expression after 6h DAPT (B) compared to  vehicle - treated animals (A). qPCR analyses showed a significant decrease in  Nrarp  expression  after  6h  DAPT  and  after  24h  Dll4 - Fc  t reatment  compared  to  their  respective controls. ***, p  ≤  0.0004. Vehicle and DAPT treatments, n  ≥  7; hFc, n =  4; Dll4 - Fc, n = 6. Values represent mean  ±  S.E.M.         120         Figure  43 .  Nrarp  expression is suppressed after Jag1 peptide tre atment.   P5 C57Bl6/J mice were injected subcutaneously once with 0.5mg/g Jag1 or scJag1  peptide. Retinas were analyzed 3 hours (C) or 6 hours (A - C) later. 6h Jag1 treatment  revealed a decrease in vessel density at the migrating front of the vessel plexus (B )  compared  to  scJag1  treatment  (A).  Nrarp   ISH  showed  a  decrease  in  endothelial  Nrarp  expression (B).  C , qPCR result of  Nrarp  expression in retinas 3 or 6 hours  after scJag1 or Jag1 treatment. There is a significant decrease in  Nrarp  expression  after 6 hour s Jag1 treatment compared to control. ***, p < 0.0001. 3h treatment:  scJag1, n = 3; Jag1, n = 5. 6h treatment: scJag1, n = 11;  Jag1, n  = 12. Values  represent mean  ±  S.E.M.     
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4.2.5  MICE DEFICIENT IN NRARP EXHIBIT RETINAL VASCULAR DEFECTS. 
We next investigated whether Nrarp has a function in angiogenesis. To examine this 
in  the  mouse,  we  obtained  an  Nrarp  mutant  mouse  line  that  was  generated  by 
Regeneron  using  the  Velocimouse  technology.  The  breeding  of  Nrarp
+/-  mice 
produced offspring of the appropriate Mendelian ratio. Nrarp
-/- newborn mice had 
normal  physical  appearance  and  had  a  similar  weight  to  wildtype  littermates. 
Furthermore, mice null for Nrarp survive until adulthood and we have not observed 
any striking or overt physical or behavioural abnormalities in these mice. Because 
these mice survive, we were able to analyze their retinas for vascular abnormalities. 
  Nrarp  mutants  displayed  a  defect  in  the  radial  expansion  of  the  vascular 
plexus from the optic nerve head to the periphery (Figure 44). At P3, there was no 
difference in the distance of vessel migration, indicating that initial migration of 
endothelial cells into the retina was normal. However, from P5 onwards, there was a 
dose-dependent delay in radial expansion when compare to wildtype littermates; the 
loss  of  two  alleles  of  Nrarp  resulted  in  a  greater  decrease  in  vessel  migration 
compared to the loss of one Nrarp allele (Figure 44B-D). The decrease in radial 
expansion in Nrarp
-/- mice was still significantly decreased compared to wildtype 
littermates  at  P7.  However,  radial  expansion  still  continued  so  that  by  P14,  the 
formation  of  the  primary  vascular  plexus  covering  the  surface  of  the  retina  was 
completed  Figure  45A,B).  Furthermore,  sprouting  of  new  blood  vessels  into  the 
deeper layers of the retina to form the middle and lower vascular capillary beds 
proceeded normally and the plexuses formed were comparable to those of wildtype 
littermates (Figure 45C-J). 
  There was also a reduction in the overall vessel density in both Nrarp
+/- and 
Nrarp
-/-  retinas  at  P4  to  P7,  the  developmental  stages  that  we  have  focused  on. 
Quantification of vessel density during the formation of the primary vascular plexus 
at P5 revealed a significant reduction in Nrarp
-/- and Nrarp
+/- retinas compared to 
Nrarp
+/+ littermate controls (Figure 46). In the migrating vascular front, there was a 
marked reduction in vessel branchpoints in P5 Nrarp
+/- and Nrarp
-/- retinas when 
compared  to  wildtype  littermates.  Nrarp
+/-  retinas  exhibited  a  27%  reduction  in 
vessel density (p < 0.0001) and Nrarp
-/- a 45% reduction (p < 0.0001; Figure 46D). 
The reduction in vessel density was also observed in the more mature plexus of the 
retinal vasculature. In the capillary regions between the veins and arteries, there were  
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significant  reductions  of  16%  and  36%  in  vessel  branchpoints  in  the  capillary 
plexuses of P5 Nrarp
+/- (p = 0.0079) and Nrarp
-/- (p < 0.0001) retinas, respectively, 
when  compared  to  wildtype  littermates  (Figure  46E).  The  analyses  of  vessel 
branchpoints a revealed a dose-dependent effect of Nrarp expression in regulating 
vessel density. 
At  higher  magnification,  vessels  of  Nrarp
+/-  and  Nrarp
-/-  retinas  were 
conspicuously narrow at branchpoints and appeared unstable and poorly lumenized. 
This is in marked contrast to vessels of wildtype animals, whose vessels were regular 
in diameter and appeared lumenized (Figure 47A). Also, vascular sprouts of Nrarp
-/- 
and Nrarp
+/- mice were generally more slender compared to those of Nrarp
+/+ mice 
(arrowheads in Figure 47B,C). We next examined whether there was a defect in tip 
cell  filopodia  formation  since  loss  of  Notch  signalling  induces  ectopic  filopodia 
protrusion by endothelial cells (Hellstrom et al., 2007; Lobov et al., 2007; Suchting 
et al., 2007). However, by counting the number of filopodia per 100µm of leading 
endothelial  membrane,  we  discovered  that  filopodia  formation  was  not  affected 
(Figure 47D), suggesting that loss of Nrarp does not regulate endothelial sprouting 
activity.  
   123             Figure  44 . Loss of  Nrarp  results in delayed radial expansion of retinal blood  vessels.   A - C , Overviews of retinas from P5 Nrarp +/+ , Nrarp +/ -  and Nrarp - / -  animals that have  been stained with anti - Collagen IV antibody.  D , Graph displays blood vessel radial  expansion (µm) from the optic nerve head. Loss of  Nrarp  results in a delay in the  vascularization of the superficial layer of the retina from  P5 to P7. *, p < 0.05; *, p <  0.01. P3: Nrarp +/+ , n = 8; Nrarp +/ - , n = 5; Nrarp - / - , n= 4. P5: Nrarp +/+ , n = 6; Nrarp +/ - , n  = 15; Nrarp - / - , n= 4. P6: Nrarp +/+ , n = 3; Nrarp +/ - , n = 4; Nrarp - / - , n= 4. P7: Nrarp +/+ , n  = 3; Nrarp +/ - , n = 4; Nrarp - / - , n= 5. Va lues represent mean  ±  S.E.M.    124     Figure  45 . Retina vascularization in  Nrarp - / -  mice is normalized by P14.   P14  Nrarp +/+  and  Nrarp - / -  retinas were stained with Isolectin - B4 (white or green).  A  and  B , overview images of retinas.  C  and  D , confocal Z - stack of  Nrarp +/+  and  Nrarp - / -  retinas  revealing three vessel plexuses in the retina. The primary vessel plexus on the superficial  layer of the retina ( E , F ), the middle vessel plexus ( G , H ) and the lower plexus ( I , J ) of  wildtype and  Nrar p - / -  are shown. Vessel density in  Nrarp - / -  retinas appears similar to  wildtype littermates in the three vascular plexuses. However, the vessels of the primary  plexus of  Nrarp - / -  (F) appear tortuous compared to that of wildtype retina (E). A, artery;  V, vei n.    125     Figure  46 . Loss of  Nrarp  leads to decreased vessel density in the retina.   There is a decrease in vessel density in P5  Nrarp  mutants.  A - C , representative images of  P5  Nrarp +/+ ,  Nrarp +/ -  and  Nrarp - / -  retinas that have been sta ined with Isolectin - B4. Box - and - whisker  graphs  show  the  number  of  vessel  branchpoints  per  100 µ m 2   in  the  migrating vascular front ( D ) and capillary plexus ( E ) of  Nrarp +/+ ,  Nrarp +/ -  and  Nrarp - / -   retinas. ***, p <0.0001; ** p = 0.0079. Vascular front:  Nrarp +/ + , n=21;  Nrarp +/ - , n=29;  Nrarp - / - , n=18. Capillary plexus:   Nrarp +/+ , n=41;  Nrarp +/ - , n=30;  Nrarp - / - , n=15.      126     Figure  47 . Normal filopodia protrusion in  Nrarp - deficient endothelial tip cells.   A - C , Confocal images of tip cells of  P5  Nrarp +/+ ,  Nrarp +/ -  and  Nrarp - / -  retinas stained  with Isolectin - B4. Arrowheads indicate narrow vessels in  Nrarp - deficient animals.  D,   box - and - whisker graph shows number of filopodia extended per 100µm vessel length.  There are similar numbers of filopodia  protrusions in P5  Nrarp +/+ ,  Nrarp +/ -  and  Nrarp - / -   retinas.  Nrarp +/+ , n=20;  Nrarp +/ - , n=23;  Nrarp - / - , n=19. m, microglia.     
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4.2.6  ZEBRAFISH  EMBRYOS  WITH  DECREASED  NRARP-A  AND  NRARP-B 
EXPRESSION DISPLAY ABNORMAL ISVS. 
The zebrafish expresses two nrarp paralogues, nrarp-a and nrarp-b. As their roles in 
angiogenesis have not been evaluated, we sought to determine whether, like in the 
mouse, the zebrafish also requires the function of nrarp during angiogenesis. The 
expression of nrarp-a and nrarp-b was knocked-down in Tg(fli1:EGFP)
y1 zebrafish 
using morpholinos that block their protein translation (Ishitani et al., 2005) and the 
formation of ISVs in the morphants was examined 48-56 hours post fertilization 
(hpf). 
  At  56hpf,  control  morpholino-injected  embryos  had  developed  ISVs  that 
extended dorsally between somite boundaries on both sides of the notochord and had 
formed  the  dorsal  longitudinal  anastomotic  vessel  (DLAV)  (Figure  48A,  A’).  In 
addition,  parachordal  vessel  (PAV)  formation  indicating  the  second  wave  of 
angiogenesis had commenced. nrarp-a and nrarp-b morphants also developed ISVs 
that  reached  the  dorsal  roof  of  the  neural  tube  (Figure  48B’,C’).  However,  the 
morphology of the ISVs that formed was abnormal; ISVs were irregular in diameter 
and do not appear lumenized (Figure 48B’-D’). In addition, we also observed loss of 
vessel continuity in nrarp-a and –b morphants (yellow arrowheads in Figure 48B-D). 
Analyses  of  80  ISVs  from  10  embryos  revealed  that  ~18%  of  ISVs  of  nrarp-a 
morphants  displayed  vessel  disconnection;  12.5%  occurred  between  the  ISV  and 
dorsal aorta, 1.25% within the ISV and 5% were at the ISV-DLAV junction (Figure 
48E). In nrarp-b morphants, 15% of ISVs display disconnections; 3.75% were at the 
ISV-DA junction, 2.5% within the ISVs, and 8.75% at the ISV- dorsal aorta junction 
(Figure  48E).  In  contrast,  we  rarely  observed  ISV  disconnection  in  control 
morphants  (2.5%).  These  observations  indicate  that  reduced  nrarp-a  and  nrarp-b 
function  resulted  in  unstable  interendothelial  contacts,  especially  at  vessel 
branchpoints. Knockdown of both nrarp-a and nrarp-b expression by injection of 5ng 
of each morpholino resulted in deformed ISV formation, vessel disconnections as 
well as misguidance in vessel patterning, a phenotype that was only observed upon 
knockdown of both proteins (Figure 48D). 
The observation that ISVs frequently disconnected from the dorsal aorta led 
us  to  ask  whether  there  was  ectopic  vessel  regression  when  nrarp-a  or  nrarp-b 
function  was  decreased.  To  address  this,  we  performed time-lapse  confocal  laser  
128 
scanning microscopy of the morphants from 48hpf onwards for 4 to 8 hours (Figure 
49A-C).  The  movies  acquired  revealed  that  a  decrease  in  nrarp-a  or  nrarp-b 
expression resulted in unusual endothelial cell retraction and consequent regression 
from  the  dorsal  aorta  as  well  as  from  the  DLAV.  In  the  movie  of  the  control 
morphant, the ISVs remained connected with the dorsal aorta and the DLAV during 
the  period  of  4  hours  of  movie  acquisition  (Figure  49A).  nrarp-a  knockdown 
however, resulted in the gradual regression of the dorsal part of the ISV from the 
existing DLAV (arrowhead in Figure 49B). The movie also shows that the ISV on 
the far left had very poor connection with the dorsal aorta and the DLAV and failed 
to form a lumenized vessel (arrows in Figure 49B). On the other hand, the ISV on the 
far  right  of  the  image  appeared  patent  and  a  secondary  sprout  from  the  PCV  is 
observed adjacent to this ISV, indicating that secondary angiogenesis proceeded in 
nrarp-a morphants. In the movie of nrarp-b morphant, the ventral end of the middle 
ISV had already disconnected from the dorsal aorta at the 48hpf (Figure 49C). As 
imaging  continued,  the  vessel  regressed  even  farther  from  the  dorsal  aorta 
(arrowhead  in  Figure  49C).  Furthermore,  the  tip  cell  of  this  vessel  failed  to 
anastomose with the adjacent tip cell to form the DLAV. Instead, the cell regressed 
away from the adjacent tip cell (arrowhead in Figure 49C).  
These movies provide evidence that reduction in nrarp-a and nrarp-b function 
results in dynamic vessel regression during sprouting angiogenesis. The observed 
regression explains the disconnection of blood vessels and also some missing ISVs 
that are occasionally observed at 56hpf in nrarp-a and nrarp-b morphants (Figure 
50C). It is also interesting to note that the migration and formation of new vascular  
 
Figure 48. Knockdown of nrarp-a and nrarp-b in zebrafish embryos results in 
defective ISV formation. 
A-D, Tg(fli1:EGFP)
y1 zebrafish were injected with 10ng control (A), nrarp-a (B), 
nrarp-b  (C)  and  5ng  each  of  nrarp-a  and  -b  (D)  morpholinos  and  analyzed  at 
~56hpf. The anterior end of each embryo is to the left of the images. Defective ISVs 
were observed with reduced nrarp-a and -b function. Yellow arrows indicate very 
poor  connection  of  the  ISV  to  the  dorsal  aorta  (B’,D’).  Arrowheads  indicate 
disconnected  ISVs  (B’-D’)  and  *  indicate  ISVs  with  delayed  dorsal  migration 
(B’,D’). White arrows show misdirected ISV formation (D’). E, Graph illustrates the 
percentage of ISVs in morphants that display disconnections between ISV and dorsal 
aorta, within ISV or between ISV and DLAV at 56hpf. 10 embryos (8 ISVs/embryo) 
were analyzed for each morphant. DLAV, dorsal longitudinal anastomotic vessel; 
ISV,  intersegmental  vessel;  PAV,  parachordal  vessel;  DA,  dorsal  aorta;  PCV, 
posterior cardinal vein.   129          130       
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Figure 49. There is abnormal ISV regression in nrarp-a and nrarp-b morphants.  
Confocal time-lapse movies of Tg(fli1:EGFP)
y1 zebrafish embryos that have been 
injected  with  10ng  control  (A),  nrarp-a  (B)  or  nrarp-b  (C)  morpholino.  Image 
acquisition  began  at  48hpf  and  continued  for  4  to  8  hours.  The ISVs  of  control 
morphants remained connected to the DA and DLAV (A). Note that the middle and 
right ISVs of the control morphant is out-of-focus. Knockdown of nrarp-a and nrarp-
b resulted in ectopic vessel regression. Arrowheads in B and C indicate ISVs that 
have regressed. Yellow arrows point to abnormally thin and non-patent vessels with 
weak connections to the DA or DLAV.  
 
 
sprouts  were  not  affected  upon  decrease  in  nrarp-a  and  nrarp-b  activity.  This 
conclusion is based on the finding that the DLAV was formed, albeit poorly, in the 
presence of vessel regression (Figure 48C’, Figure 49B) indicating that the tip cell of 
each ISV continued to migrate dorsally even after losing adhesion with the adjacent 
endothelial cell.  
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4.2.7  THE DEFECT IN ISV FORMATION IN NRARP-A AND NRARP-B MORPHANTS IS 
INDEPENDENT OF SOMITE FORMATION. 
Malformation of ISVs is often a result of defective somite formation. To ascertain 
that this was not the cause of the ISV defects observed when nrarp-a and nrarp-b 
expression was knocked-down, we examined the formation of myotome boundaries 
in the morphants at 48hpf using an antibody against Collagen XII. Collagen XII is 
expressed  along  myotendinous  junctions  at  myotome  boundaries  as  well  as 
boundaries between the neural tube and notochord, the notochord and the dorsal 
aorta, and also along the developing PAVs (Figure 50A). We observed myotome 
boundary  formation  in  nrarp-a,  nrarp-b  and  double  nrarp-a  and  -b  morphants 
(Figure 50B-D) at 48hpf, indicating that the ISV malformations in these morphants 
are independent of myotome formation. The collagen XII staining also revealed that 
neural tube formation in nrarp-a morphants is slightly defective. The border between 
the  neural  tube  and  notochord  is  more  irregular  than  that  in  uninjected  embryos 
(Figure 50A and B). 
 
 
 
 
 
 
 
 
 
Figure  50.  Defects  in  ISVs  formation  in  nrarp-a  and  nrarp-b  morphants  are 
independent of somite formation. 
Wholemount  anti-Collagen  XII  (red)  staining  of  48hpf  fli1:(EGFP)
y1  zebrafish 
embryos that were uninjected (A), injected with 10ng nrarp-a (B), 10ng nrarp-b (C) 
or 5ng nrarp-a and 5ng nrarp-b (D) morpholinos. Collagen XII is expressed along 
myotome boundaries (1 in A), boundaries between the neural tube and notochord (2), 
the notochord and dorsal aorta (DA, 4) and also along the developing parachordal 
vessels (PAVs, 3). There is unspecific staining in the yolk stalk. Arrows in B-D 
indicate absence of or regressing ISVs in the presence of myotome boundary. 
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4.2.8  LOSS  OF  NRARP  EXPRESSION  ALSO  RESULTS  IN  ECTOPIC  VESSEL 
REGRESSION IN THE RETINA. 
The observations made from zebrafish time-lapse movies prompted us to examine 
Nrarp-deficient mice for excessive vessel regression. As dynamic imaging of mouse 
retina is not yet possible, we resorted to immunostaining retinas for the basement 
membrane component, collagen IV, and endothelial cell junction proteins such as 
Claudin 5 and VE-cadherin. Collagen IV is produced by endothelial cells as they 
mature so that its expression regularly co-localizes to endothelial markers such as 
Isolectin-B4 (Figure 51) and endomucin (not shown). However, during the process 
of  vessel  pruning  or  regression,  empty  basement  sleeves  often  remain  after 
endothelial cells have regressed. In the retina, pruning is a physiological component 
of network remodeling and is most prominent in areas where there is high oxygen 
tension, such as areas in close proximity to arteries (Figure 51; Claxton and Fruttiger, 
2005). Empty collagen IV sleeves are frequently observed in proximal regions of the 
artery closest to the optic nerve head (arrowheads in Figure 51A), indicating the 
previous  existence  of  vessels  that  were  connected  to  the  artery  but  have  since 
regressed.  This  method  of  detecting  vessel  regression  has  previously  been  used 
(Baffert  et  al.,  2006).  Another  means  of  determining  regressing  vessels  is  by 
examining endothelial cell junction expression. Junction proteins such Claudin 5 are 
often localized to interendothelial junctions in a continunous manner (Figure 51B). 
An exception to this localization is during vessel regression when Claudin 5 is no 
longer confined to intermembrane junctions but is instead internalized to vesicular 
structures  (yellow  arrows  in  Figure  51B).  Also,  the  loss  of  junctional  continuity 
between two connecting vessels is also an indicator of vessel regression (white arrow 
in Figure 51B). These changes in junctional arrangement were frequently detected 
before  complete  vessel  disconnection  has  occurred,  suggesting  that  this  event 
precedes  vessel  regression.  Therefore,  by  triple  staining  retinas  with  antibodies 
against Collagen IV, Claudin 5 and Isolectin-B4, we were able to assess whether 
there was increased vessel regression by increased empty Collagen IV sleeves and 
abnormal endothelial cell junction staining in Nrarp-deficient retinas.  
At the sprouting vascular front of P5 Nrarp
+/+ retinas, Collagen IV regularly 
co-localized  with  endothelial  Isolectin-B4  staining,  suggesting  that  newly  formed 
vessels in    135     Figure  51 . Vessel regression profiles along the artery in the retina.   P6 wildtype retinas were immunostained with antibodies against Claudin 5 (red),  Collagen  IV  (green)  and  Isolectin - B4  (blue).  Empty  Collagen  IV  sleeves  (arrowheads  A,  C  and  E)  were  o ften  detected  along  the  length  of  the  artery,  especially towards the optic nerve head (bottom of image).  B - E , high magnification  of boxed area in A, where vessel pruning is on - going as indicated by redistribution of  Claudin 5 (yellow arrows and * in B) and  remnants of Collagen IV (arrowheads). In  the artery, Claudin 5 is localized along the length of the vessel at interendothelial  junctions.  However,  in  regressing  vessels,  it  is  accumulated  in  vesicular - like  structures (yellow arrows in B) and there is a lo ss of junctional connection between  the smaller vessel and the artery (white arrow in B). Another common feature in  regressing vessels is the jagged appearance of Claudin 5 staining (* in B).    136     Figure  52 . Increased vessel regres sion in the sprouting front of retinal vessels of  Nrarp - / -  mice.   Vascular  front  of  P5  Nrarp +/+   ( A )  and  Nrarp - / -   ( B  ,C )  retinas  that  have  been  immunostained with antibodies against Claudin  5 (green), Collagen IV (red) and  Isolectin - B4 (blue). In  Nrarp +/+  re tinas, vessel regression occurs behind the sprouting  front (dots in A). However in  Nrarp - / -  retinas, vessel regression is observed at, as  well as behind, the sprouting front (dots in B). Endothelial junctions in  Nrarp +/+   retinas are frequently in continuum  with junctions of adjacent vessels (A’). In  Nrarp - / -  retinas, there are regions where there is a loss of continuum so that endothelial  junctions in the same vessel appeared segregated or constricted (yellow arrows, B’).  In C’, three consecutive vessels ha ve lost junctional connection with the adjacent  vessel (yellow arrows).       137     
138 
Figure 53. Increased vessel regression and loss of endothelial junctional stability 
in capillary plexus of Nrarp-deficient mice. 
A-H, Capillary plexuses of P6 Nrarp
+/+ (A-D) and Nrarp
-/- (E-H) retinas that have 
been stained with for Claudin 5 (green), Collagen IV (red), and Isolectin-B4 (blue). 
In Nrarp
+/+ retinas, there is some vessel regression in the capillary plexus (dots in B) 
and  tight  junctions  are  continuous  between  endothelial  cells  that  form  adjacent 
vessels (A, C, D). C and D are magnified images of boxed regions in A and B. 
However,  in  Nrarp
-/-  retinas,  there  is  increased vessel  regression  (dots  in  F)  and 
discontinuous endothelial junctions (arrows and arrowheads in E, G, and H). G and 
H are magnified images of boxed region in E and F, illustrating discontinuity of 
endothelial junctions between vessels. Yellow  arrows indicate punctate claudin 5 
staining whereas white arrows point to loss of claudin 5 continuity between vessels. 
I, box-and-whisker graph shows the ratio of Isolectin-B4-positive vessels to collagen 
IV-positive vessels. Values below 1 indicate increased vessel regression. Nrarp
+/- 
and Nrarp
-/- mice undergo significantly more vessel regression in the capillary plexus 
compared to Nrarp
+/+ mice. ***, p < 0.0005. Nrarp
+/+, n=13; Nrarp
+/-, n=8; Nrarp
-/-, 
n=20. 
 
the vicinity of high VEGF production rarely regress (Figure 52A). However, some 
vessel regression is observed behind the vascular front (dots in Figure 52A). In P5 
Nrarp
-/-  retinas,  we  detected  vessel  regression  profiles  at,  as  well  as  behind,  the 
vascular front, where sprouting occurs (dots in Figure 52B). Additionally, there are 
regions along vessels where endothelial junctions are not continuous but appeared 
segregated  from  each  other  (Figure  52B’)  and  in  some  regions,  there  is  loss  of 
junctional  connectivity  between  adjacent  vessels  (Figure  52C’).  Such  junctional 
staining suggests that nascent vessels in Nrarp
-/- retinas are unstable. 
Vessel regression occurs in the capillary plexus of wildtype retinas (dots in 
Figure 53 B). By quantifying vessel regression, we discovered a significant increase 
in vessel regression in the capillary plexus of Nrarp
+/- (p = 0.0004, Figure 53I) and 
Nrarp
-/-  retinas  (p  =  0.0001,  Figure  53I;  dots  in  Figure  53F)  when  compared  to 
wildtype littermates. This is accompanied by a marked change in endothelial junction 
arrangement.  In  the  capillary  plexus  of  Nrarp
+/+  mice,  we  observed  continuous 
interendothelial  junctions  along  vessels  and  between  vessels  (Figure  53A,C). 
However,  in  Nrarp
-/-  mice,  there  were  many  areas  where  junctions  within  and 
between vessels have become discontinuous so that junctions appear isolated (white 
arrows in Figure 53E, G and H) and often all that remained were punctate Claudin 5 
staining (yellow arrows in Figure 53E, G and H).  
These  observations  suggest  that  excess  vessel  pruning  occurred 
concomitantly with sprouting even in regions of strong growth factor stimulation in  
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Nrarp-deficient retinas. Such an event would favour vessel regression rather than 
vessel growth. The observed increase in vessel regression in the sprouting region 
could  very  well  explain  both  the  delayed  retinal  vascularization  and  the  reduced 
vascular density in Nrarp deficient retinas.  
Likewise  in  the  zebrafish,  we  observed  a  change  in  the  stability  of 
interendothelial  junctions  between  ISVs  and  dorsal  aorta  in  zebrafish  nrarp-a 
morphants. To visualize cellular junctions, zebrafish embryos were stained with anti-
ZO1 antibody (Blum et al., 2008) and analyzed by confocal microscopy. At 48hpf in 
uninjected embryos, the base of ISV was composed of 2 endothelial cells that formed 
a firm, ring-shaped interendothelial junction with the dorsal aorta (Figure 54A). In 
nrarp-a  and  –b  morphants,  interendothelial  junctions  are  formed;  however,  the 
formation of firm junctions between the ISVs and the dorsal aorta was frequently lost 
in nrarp-a morphants (Figure 54B) and also in nrarp-b morphants (data not shown). 
Instead, interendothelial junctions frequently appeared detached from the dorsal aorta 
(arrows in Figure 54). The connection between ISV and dorsal aorta of nrarp-a and –
b morphants were frequently lost (12.5% and 8.75%, respectively; Figure 54E). The 
observation that nrarp-a and –b morphants display poorly formed interendothelial 
junctions suggest that vessel regression is preceded by a loss of endothelial junction 
integrity.   140         Figure  54 .  nrarp - a  morphants display abnormal endothelial juncti ons.   A   and  B ,  Zona  occludens  1  (ZO1,  red)  staining  in  uninjected  and  nrarp - a   morpholino - injected  Tg(fli1: EGFP ) y1  (green) zebrafish embryos at 48hpf. A’ and B’  are  magnified  Z - stack  images  of  the  boxed  regions  in  A  and  B,  respectively.  Endothelial junctions  are illustrated by red tracing in A” and B”. Arrow points to  poor interendothelial junction between ISV and dorsal aorta in  nrarp - a  morphants.        141   4.2.9   L OSS OF  N RARP  FUNCTION DOES NOT L EAD TO ECTOPIC  A POPTOSIS .   Hyaloid vessel regression is triggered by endotheli al cell apoptosis  (Lobov et al.,  2005) . We therefore examined whether ectopic vessel regression observed in  Nrarp - deficient  mice  and  in  nrarp - a   and  – b   zebrafish  morphants  was  also  a  result  of  endothelial apoptosis.      In mammalian cells, caspase 3 is a key mediator of apoptosis. We therefore  investigated  whether  there  was  aberrant  apoptosis  in  Nrarp   mutants  by  immunostaining  for  active  caspase  3.  In  wildtype  P5  retinas,  active  caspase  3  staining was observed in some n euronal cells of the retina but not in any endothelial  cells of the developing vasculature ( Figure  55 A). Similarly in  Nrarp - / -  retinas, we  were not able to detect apoptotic endothelial cells ( Figure  55 B).              Figure  55 . Active caspase 3 staining in the retina.   P5 retinas were stained with anti - active caspase 3 antibody (red) and Isolectin - B4  (green).  In  wildtype  retinas,  some  neuronal  cells  (arrowheads)  an d  macrophages  (arrow) are apoptotic (A). However, apoptosis was not detected in endothelial cells.  In  Nrarp +/+  retinas, we did not observe endothelial cells undergoing apoptosis (B).     142       Figure  56 . TUNEL staining in zebrafish emb ryos.   A - F ,  uninjected  (A,B),  nrarp - a   (C,D)  and  nrarp - b   (E,F)  morpholino - injected  Tg(fli1:EGFP) y1  embryos were processed for wholemount TUNEL (red) staining at  48hpf. Arrows in D and F indicate ISVs that have regressed from the DA. There is  no ectopic endot helial apoptosis.     
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To  assess  apoptosis  in  the  zebrafish,  wholemount  TUNEL  (Terminal 
deoxynucleotidyl  transferase  dUTP  nick  end  labelling)  assay  was  performed  at 
48hpf. At this developmental stage, apoptosis is observed in some cells at the very 
end of the tail Figure 56A). Some apoptotic cells were also observed in the trunk 
region of the embryo (Figure 56B); however, none of these cells were endothelial. In 
zebrafish embryos that have been injected with 10ng nrarp-a morpholino, there was 
an  expansion  in  apoptosis  in  the  tail  bud  region  so  that  apoptosis  is  no  longer 
confined to the tail end (Figure 56C). There was also a slight increase in the TUNEL 
staining in the trunk region of the embryos (Figure 56D). However, we were not able 
to detect apoptosis in endothelial cells, even in ISVs that have regressed from the 
dorsal aorta (arrows in Figure 56D). We also did not observe an increase in apoptosis 
in nrarp-b morphants (Figure 56E, F).  
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4.2.10  NORMAL  ASTROCYTE  NETWORK  AND  PERICYTE  COVERAGE  IN  NRARP 
MUTANTS. 
The proper development of blood vessels in the retina requires tight interaction with 
two other cells types: astrocytes and pericytes. The astrocytic network guides vessel 
patterning  (Gerhardt  et  al.,  2003)  as  well  as  stimulating  blood  vessel  growth  by 
secreting VEGF-A (Fruttiger, 2002; Zhang and Stone, 1997). Although we detected 
Nrarp expression predominantly in endothelial cells in the superficial layer of the 
retina, other cell types in the inner nuclear layer of the retina also express Nrarp 
(Blackshaw et al., 2004). It was therefore important to examine whether other cell 
types in the retina developed normally in Nrarp
-/- animals and to ensure that the 
vascular  phenotype  we  observed  was  not  a  secondary  effect  from  abnormal 
development of other retinal cells.  
  Astrocytes were visualized by staining the retinas for glial fibrillary acidic 
protein (GFAP). GFAP expression is strongest when astrocytes are mature and this is 
observed in regions where they are associated with blood vessels (Gariano, 2003; 
West et al., 2005). Immunostaining of both P4 Nrarp
+/+ and Nrarp
-/- retinas showed 
strong  GFAP  expression  in  the  central regions  of  the  retina  that  became  weaker 
towards the periphery of the retina (Figure 57A and B). The density of the astrocytic 
network developed in Nrarp
-/- retinas (Figure 57B,D) was similar to that in wildtype 
littermates (Figure 57A,C). In wildtype retinas, astrocytes were often associated with 
blood vessels (Figure 57C’). However, in Nrarp
-/- retinas, there were many regions 
where astrocytes were not associated with blood vessels (Figure 57D’). This can be 
explained  by  the  reduction  in  vessel  density  in Nrarp
-/-  retinas  (Figure  46).  This 
finding indicates that there is normal astrocyte density in Nrarp
-/- retinas and that the 
vascular phenotype in Nrarp mutants is independent of astrocyte development. 
During vessel maturation, the supportive functions of pericytes contribute to 
vessel stability (Hoffmann et al., 2005; Holash et al., 1999). Accordingly, inhibition 
or  genetic  inactivation  of  PDGF-B  signalling  or  alteration  of  the  Ang-1/Ang-2 
balance promotes loss of pericytes followed by selective vessel regression (Enge et 
al., 2002; Hammes et al., 2004; Sennino et al., 2007). We therefore investigated 
whether the excess vessel regression in Nrarp-deficient mice is caused by a decrease 
in pericyte coverage of blood vessels. In P7 wildtype retinas, pericytes were tightly 
associated with blood vessels at the vascular front (Figure 58A) and in the capillary   145   plexus ( Figure  58 C). An exception is at sprouting  vessels, which were not covered  by  pericytes.  In  Nrarp - / -   retinas,  vessels  at  the  vascular  front  ( Figure  58 B)  and  capillary  plexus  ( Figure  58 D)  were  also  associated  with  pericytes.  This  finding  indicates  that  the  ectopic  vessel  regression  that  occurs  in  the  absence  of  Nrarp   expression is independent of pericyte recruitment.       Figure  57 . Normal astrocyte network in  Nrarp - / -  retinas.   P4  Nrarp +/+   and  Nrarp - / -   retinas  were  stained  with  anti - GFAP  antibody  (red)  to  visualize astrocytes and Isolectin - B4 (green) to visualize blood vessels. Astrocytic  networks formed in the retinas are similar in both wildtype and  Nrarp - / -  animals.  Arrows point to astrocytes that are  not associated with blood vessels. This is more  frequent in  Nrarp - / -  retinas (D’). OpN, optic nerve.     146               Figure  58 . Normal pericyte coverage of blood vessels in  Nrarp - / -  mice.   Antibody  against  chondroitin  sulfate  proteoglyca n  4,  more  commonly  known  as  NG2, was used to detect pericytes (red) in the retina. Apart from endothelial tip cells  at the migrating front of the vasculature, pericytes are associated with blood vessels  (green,  Isolectin - B4)  of  P7  Nrarp +/+   (A,C)  and  Nrarp - / -   (B,D)  mice.  Arrowheads  indicate cell bodies of pericytes.       
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4.2.11  LOSS  OF NRARP EXPRESSION RESULTS IN DECREASED ENDOTHELIAL CELL 
PROLIFERATION. 
Notch  signalling  regulates  endothelial  cell  proliferation.  In  the  absence  of  Notch 
signalling, more endothelial cells proliferate and adopt the explorative migrating tip 
cell behaviour, leading to excessive numbers of endothelial cells in the ISVs (Leslie 
et al., 2007; Siekmann and Lawson, 2007). In the mouse, loss of Notch signalling 
also leads to an increase in  endothelial cell proliferation (Hellstrom et al., 2007; 
Lobov et al., 2007; Suchting et al., 2007). We therefore investigated whether Nrarp 
has a role in regulating endothelial proliferation by BrdU incorporation. 
  Nrarp
+/+, Nrarp
+/- and Nrarp
-/- mice were treated with BrdU intraperitoneally 
at P5 and retinas were analyzed for BrdU incorporation 3 hours later.
 There was a 
significant decrease in endothelial cell proliferation in Nrarp
-/- retinas at P5 (p = 
0.0328;  Figure  59C,D)  when  compared  to  wildtype  littermates  (Figure  59A,D). 
Proliferation was normal in Nrarp
+/- retinas (Figure 59B,D). 
In the zebrafish, endothelial cells undergo controlled proliferation during ISV 
formation. To study proliferation in the zebrafish, embryos were exposed to BrdU 
from 19hpf, when endothelial cells began to migrate from the dorsal aorta, until 
48hpf, when the ISVs and DLAV have formed. During this period, any cells within 
the  ISV  that  have  divided  were  detectable  by  BrdU  staining.  In  the  control 
morphants, all endothelial cells within the ISV showed BrdU incorporation (99%; 
Figure  60A,D).  We  found  a  clear  reduction  in  the  number  of  BrdU-positive 
endothelial cells in both nrarp-a and nrarp-b morphants (nrarp-a MO, 17.5%, p = 
0.0003; nrarp-b MO, 19%, p = 0.0086; Figure 60B-D). In some ISVs, no endothelial 
cell had undergone division, indicating that these ISVs formed solely by migrating 
endothelial cells from the dorsal aorta. In addition, wholemount BrdU staining of the 
zebrafish embryos revealed that other cell types in the neural tube, notochord and 
myotome had proliferated during the period of BrdU incorporation. However, we 
noticed proliferation in some cells in the dorsal fin of control zebrafish (Figure 60A) 
that were absent in nrarp-a (Figure 60B) and nrarp-b (Figure 60C) morphants. 
The significant decrease in endothelial cell proliferation offers an explanation 
for the decrease in the number of endothelial cells that composed the ISVs in nrarp-a 
and nrarp-b morphants. In control embryos, the number of endothelial cell nuclei  148           Figure  59 . Decreased endothelial cell proliferation in  Nrarp - / -  mice.   P5  Nrarp +/+ ,  Nrarp +/ -  and  Nrarp - / -  mice were injected with BrdU intraperitoneally and  retinas were analyzed fo r BrdU incorporation 3 hours later. There is a significant  decrease in endothelial cell proliferation in  Nrarp - / -  retinas.  A - C , retinas were stained  with anti - BrdU antibody (red) and Isolectin - B4 (green). BrdU - positive endothelial  cells are circled. Other  BrdU - positive nuclei are those of astrocytes and pericytes.  D ,  bar  graphs  show  number  of  proliferated  endothelial  cells  in  10,000µm 3   retinal  vessels after 3 hours of BrdU incorporation. *, p=0.0328.  Nrarp +/+ , n=17,  Nrarp +/ - ,  n=8;  Nrarp - / - , n=14. Values rep resent mean  ±  S.E.M.    149       
150 
Figure  60.  Decreased  endothelial  cell  proliferation  and  number  in  ISVs  of 
nrarp-a and nrarp-b morphants. 
Control,  nrarp-a  and  nrarp-b  morpholino-injected  Tg(fli1:EGFP)
y1  zebrafish 
embryos  were  exposed  to  BrdU  (red)  from  19  to  48hpf.  There  is  a  decrease  in 
endothelial cell proliferation upon knockdown of nrarp-a and nrarp-b expression. In 
A-C, all endothelial cells along ISVs at 48hpf have been circled, and arrows indicate 
endothelial cells that have proliferated. D, graph shows the percentage of endothelial 
cells  composing  ISVs  that  are  BrdU-positive:  control  MO,  99.5%;  nrarp-a  MO, 
82.5% and nrarp-b MO, 81%. **, p = 0.0086; ***, p = 0.0003. Control MO, n = 8 
(31 ISVs); nrarp-a MO, n = 6 (47 ISVs); nrarp-b MO, n = 14 (66 ISVs). Values 
represent mean ± S.E.M. There is a decrease in the number of endothelial cell nuclei 
that  composed  ISVs  in  nrarp-a  and  nrarp-b  morphants.  E,  bar  graph  shows  the 
percentage of ISVs containing x number of endothelial cell nuclei per ISV at 48hpf. 
Control MO, n=17; nrarp-a MO, n=16; nrarp-b MO, n=21. At least 8 embryos were 
analyzed and 8 ISV/embryo were counted. 
 
 
within ISVs varied from 1 to 6, with the largest percentage (35.5%) of vessels having 
four nuclei (Figure 60E). However, in both nrarp-a and nrarp-b morphants, there 
was a decrease in endothelial cell nuclei within the ISVs. Most ISVs contained only 
two endothelial cell nuclei (nrarp-a MO, 43%; nrarp-b MO, 41%; Figure 60E).  
 
 
 
 
   151   4.2.12   L OSS OF  N RARP  EXPRESSION ALTERED  VEGF  RECEPTOR EXPRESSION .   As  described  in  the  previous  chapter,  Notch  signalling  negatively  and  positively  regulate s  Kdr  and  Flt1  expression, respectively. We therefore investigated whether  the expression of VEGF receptors were altered in  Nrarp  mutant retinas by qPCR. It  was also important to address whether there was a decrease in VEGF - A expression  in  Nrarp  mutants si nce withdrawal of VEGF - A rapidly leads to loss of blood vessel  connections in adult mice  (Baffert et al., 2006 ;  Inai et al., 2004) . Thus, reduction of  VEGF - A  levels  appears  s ufficient  to  induce  vessel  pruning.  We  therefore  also  investigated  whether  there  was  a  decrease  in  Vegfa   expression  in  Nrarp   mutant  retinas.   We observed increases in  Vegfa  and  Kdr  mRNA expression levels in  Nrarp - / -   when  compared  to  Nrarp +/+   retinas;  howeve r,  these  increases  were  statistically  insignificant  ( Figure  61 ).  There  was  also  a  dramatic  increase  in  Flt1   mRNA  expression in  Nrarp - / -  compare to  Nrarp +/+  retinas. However, this increase was again  insignificant because  of the big variance in the  Flt1  mRNA expression from  Nrarp - / -   retinas.       Figure  61 .  Vegfa ,  Flt1   and  Kdr   expression  in  P5  retinas from  Nrarp  mutant  mice.   Graph illustrates the relative expression levels of  Vegfa ,  Flt1  and  Kdr  mRN A in  wildtype,  Nrarp +/ -   and  Nrarp - / -   P5  retinas.  t - test  analysis  revealed  no  significant  difference in the expression between animals of different genotypes.  Nrarp +/+ , n = 5;  Nrarp +/ - , n = 6;  Nrarp - / - , n = 6. Values represent mean  ±  S.E.M.     
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4.2.13  LOSS OF NRARP EXPRESSION INCREASED NOTCH SIGNALLING. 
Nrarp has been reported to act as a negative regulator of Notch signaling (Ishitani et 
al., 2005; Lamar et al., 2001). A mechanism for this negative regulation is through 
destabilization of the Notch intracellular domain (NICD) by Nrarp, which has been 
shown in Xenopus and zebrafish (Ishitani et al., 2005; Lamar et al., 2001). However, 
the negative regulatory role of Nrarp in Notch signalling has not been demonstrated 
in the mouse.  
  We initially planned to determine the regulation of Nrarp on Notch signalling 
at  a  cellular  resolution  in  the  developing  mouse  retinal  vasculature  by  breeding 
Nrarp-deficient mice with the TNR Notch reporter mouse. Unfortunately, these mice 
no longer expressed GFP in the retina nor in other tissues examined e.g. embryonic 
neural tube. We were therefore unable to determine whether there was an increase in 
GFP signal in Nrarp
-/-;TNR
+ mice and if there was, where the increase was within 
the different endothelial cell populations in the retinal vasculature. 
We  therefore  resorted  to  investigating  Notch  activity  using  whole  retinal 
lysates. Firstly, analysis of NICD1 in the retina by Western Blotting revealed a slight 
increase of 22% in NICD1 protein level in P5 Nrarp
-/- retinas when compared to 
Nrarp
+/+ (Figure 62A). This finding confirms previous reports that Nrarp destabilizes 
NICD1  so  that  NICD1  is  degraded  (Ishitani  et  al.,  2005;  Lamar  et  al.,  2001). 
Secondly, qPCR analyses revealed significant increases in the expression of Notch 
target genes Hey2 (p = 0.0426) and Lunatic fringe (Lnfg, p = 0.0025) in Nrarp
-/- 
retinas when compared to Nrarp
+/+ retinas (Figure 62B). There was also a slight but 
significant increase in Lnfg expression in  Nrarp
+/- retinas (Figure 62B, p=0.015), 
suggesting a dose-dependent negative regulation of Notch signalling through Nrarp. 
  We next investigated whether the negative regulation of Notch signalling by 
Nrarp also occurs in endothelial cells, since the experiments described above used 
whole retina lysates. To address this, endothelial cells were isolated from lungs of 
adult Nrarp
+/+ and Nrarp
-/- mice and cultured on plates coated with recombinant Dll4 
to  stimulate  Notch  signalling.  The  expression  of  Hey2  in  endothelial  cells  from 
Nrarp
+/+ and Nrarp
-/- were subsequently compared by qPCR. As shown in Figure 
62C, loss of Nrarp in endothelial cells resulted in a significant increase of 146% in 
Hey2 expression (p = 0.0004) when compared to Nrarp
+/+ endothelial cells.   153     The experiments described here show, as we ll as support existing data, that  Nrarp  negatively  regulates  Notch  signalling  in  the  mouse.  Furthermore,  we  have  demonstrated that this regulation also exists in endothelial cells.     Figure  62 . Loss of  Nrarp   leads to increase in  Notch  signalling  in  the  mouse  retina  and  in  isolated  endothelial cells.   A ,  NICD1  level  in  P5  retinas  of  Nrarp +/+ .  Nrarp +/ -  and  Nrarp - / -  mice  were examined by Western  Blotting.  There  is  an  increase  of  22%  in  the  NICD1  level  when  Nrarp   expression  is  lost.  Ho wever, this difference is  not  significant  after  t   test  analysis.    B , the expression of Notch  target  genes  Hey1 ,  Hey2   and  Lnfg   in  P5  retinas  were  investigated  by  qPCR. There are increases  in  Hey1 ,  Hey2   and  Lnfg   expression  in  Nrarp - / -   retinas.  Only  Lnfg   expr ession  is  increased  in  Nrarp +/ -   retinas.  **,  p<0.01;  *,  p<0.05.  Nrarp +/+ ,  n=5;  Nrarp +/ - ,  n=6;  Nrarp - / - ,  n=6.  C ,  relative  Hey2  expression in  endothelial  cells  isolated  from adult lungs by qPCR.  There  is  a  significant  increase  in  Hey2   expression in  Nrarp - / -   ECs.  ***, p = 0.0004. n = 6 for  each genotype. Values in B and C show mean  ±  S.E.M.       
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4.2.14  DAPT TREATMENT PARTIALLY RESCUED NRARP
-/- VASCULAR DEFECT. 
We subsequently asked whether the increase in Notch signalling is the cause of the 
observed vascular phenotype in Nrarp
-/- mice. If so, inhibition of Notch signalling in 
Nrarp-deficient retinas would rescue the vascular phenotype. To test this hypothesis, 
we inhibited Notch  signalling in  vivo pharmacologically by administrating the γ-
secretase inhibitor, DAPT, subcutaneously once every 24 hours for 48 hours from P5 
onwards.  At  the  end  of  the  treatment  (P7),  the  retinas  were  stained  with  anti-
Collagen IV antibody and Isolectin-B4.  
  DAPT  treatment  resulted  in  an  increase  in  vessel  density  in  retinas  of 
Nrarp
+/+ (Figure 63A) and Nrarp
+/- (Figure 63B) mice, especially in the plexus that 
underwent sprouting angiogenesis during the period of treatment. Although not as 
obvious, there was also an increase in vessel sprouting in Nrarp
-/- (Figure 63C) that 
is  clearly  evident  at  the  vascular  front  (Figure  63K).  This  increase  in  sprouting 
restored vessel density in Nrarp
-/- to normal wildtype density. We next investigated 
whether there was a reduction in vessel regression in the capillary plexus after DAPT 
treatment  by  measuring  the  ratio  of  Isolectin-B4-positive  vessel  to  Collagen  IV-
positive vessels in P7 retinas. Firstly, this analysis revealed that at P7, the extent of 
vessel regression is similar in both Nrarp
+/+ and Nrarp
-/- retinas (Figure 63F). This is 
in contrast to the significant increase in vessel regression at P5 in Nrarp
-/- compared 
to wildtype retinas of the same age (Figure 53I). This observation suggests that the 
ectopic increase in vessel regression upon loss of Nrarp is transient during retinal 
angiogenesis so that by P7, the extent of vessel regression is similar to wildtype 
animals. In fact, some regions in the capillary plexus of P7 Nrarp
-/- retinas have an 
Isolectin/Collagen IV ratio of > 1 (Figure 63F), suggesting that there is increased 
sprouting  in  Nrarp
-/-  retinas.  This  analysis  also  showed  that  DAPT  treatment 
significantly increased vessel sprouting in Nrarp
+/+ retinas (p = 0.0024, F). However, 
there is no significant change in vessel regression in the capillary plexus of DAPT-
treated Nrarp
-/- retinas when compared to untreated Nrarp
-/- retinas (Figure 63F). 
Nevertheless, we did observe an increase in vessel sprouting in some regions of the 
capillary plexus by immunostaining (arrows in Figure 63E). This increase in vessel 
sprouting  may  “mask”  empty  collagen  IV  sleeves,  so  that  it  is  not  possible  to 
ascertain whether there is a difference in vessel regression between untreated and   155         
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Figure 63. DAPT treatment restored vessel density but not vessel morphology in  
Nrarp
-/- mice.  
A-E, P5 Nrarp
+/+. Nrarp
+/- and Nrarp
-/- mice were injected with DAPT for 48 hours. 
Retinas were stained with anti-Collagen IV antibody (red) and Isolectin-B4 (green) 
at  P7.  A-C,  overviews  of  retinas  from  48h  DAPT-treated  Nrarp
+/+.  Nrarp
+/-  and 
Nrarp
-/- mice. Double-ended arrows indicate an increase in vessel density in Nrarp
+/+ 
and Nrarp
+/- retinas (A,B). D and E, capillary plexuses of DAPT-treated Nrarp
+/+ 
and  Nrarp
-/-  retinas,  respectively,  displaying  anti-Collagen  IV  and  Isolectin-B4 
staining.  There  is  increased  vessel  sprouting  in  both  images  (arrows).  F, 
quantification of vessel regression or vessel sprouting in P7 Nrarp
+/+ and Nrarp
-/- 
retinas with or without DAPT treatment. **, p = 0.0024. untreated Nrarp
+/+, n = 11; 
DAPT Nrarp
+/+, n = 8; untreated Nrarp
-/-, n = 10; DAPT Nrarp
-/-, n = 18. G, relative 
expression  of  Flt1,  Kdr,  Hey2  and  Lnfg  in  48h  DAPT-treated  Nrarp
-/-  retinas 
compared  to  untreated  Nrarp
-/-  retinas.  There  is  no  significant  difference  in 
expression. Untreated, n = 3; DAPT, n = 5. Values show mean ± S.E.M. H-J, high 
magnification  of  sprouting  front  of  P7  Nrarp
+/+,  Nrarp
-/-  and  48h  DAPT-treated 
Nrarp
-/-  retinal  vasculature.  There  is  increased  filopodia  protrusion  and  vessel 
formation in DAPT-treated Nrarp
-/- retinas (J) compared to untreated Nrarp
-/- retinas 
(I). Arrowheads indicate thin and poorly connected blood vessels in untreated and 
DAPT-treated Nrarp
-/- retinas.  
 
 
DAPT -treated Nrarp
-/- retinas.  
  In the previous chapter, I have shown that DAPT treatment for 3 or 6 hours 
inhibits  Notch  signalling  in  the  retinal  blood  vessels  (Figure  24).  We  therefore 
examined whether DAPT treatment for 48 hours reduced the increases in Hey2, Lnfg 
as well as Flt1 and Kdr expression in Nrarp
-/- retinas by qPCR (Figure 63G). The 
expression  of  all  four  genes  was  not  significantly  different  from  vehicle-treated 
Nrarp
-/-  retinas  (Figure  63G).  One  way  of  interpreting  this  result  is  that  DAPT 
treatment for 48 hours failed to decrease Notch signalling. However, it is premature 
to state this since, firstly, we have not assessed the transcriptional changes in Notch 
target genes after 48h DAPT treatment in wildtype retinas. We therefore do not know 
whether this length of DAPT treatment inhibits expression of Notch target genes. 
However, a Notch loss-of-function vascular phenotype was obtained, suggesting that 
48h DAPT treatment did inhibit Notch signalling even though we did not detect a 
decrease in Notch transcriptional activity by qPCR. Secondly, we previously showed 
that there was significant increase in Hey2 and Lnfg in P5 Nrarp
-/- retinas, when 
compared to Nrarp
+/+ retinas. The animals that we have used for the DAPT rescue 
experiments  were  P7  at  the  time  of  qPCR  analysis.  There  may  therefore  be 
developmental stage differences in Notch activity at P5 and P7 wildtype retinas. In  
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addition,  we  do  not  know  whether  the  increase  in  ectopic  Notch  signalling  still 
occurs at P7 in Nrarp
-/- retinas. Thus, further experiments need to be performed to 
investigate the expression of Notch target genes in wildtype P7 retinas and compare 
that to those in wildtype P5. Furthermore, absolute quantitative PCR may be a better 
choice for the PCR analysis as apposed to relative quantitative PCR. Additionally, a 
more  specific  inhibitor  of  Notch  signalling  such  as  Dll4-Fc  should  be  used  in 
conjunction  with  DAPT  in  the  attempt  to  decrease  ectopic  endothelial  Notch 
signalling in Nrarp
-/- retinas. 
High magnification of the sprouting vessels in DAPT-treated Nrarp
-/- (Figure 
63J)  revealed  an  increase  in  filopodia  protrusion  by  endothelial  tip  cells  when 
compared to untreated Nrarp
-/- (Figure 63I). In addition, there was also an increase in 
the formation of blood vessels (Figure 63J); however, the vessels that formed were 
still thin and poorly connected like those found in untreated Nrarp
-/- (arrowheads in 
Figure  63I).  Thus,  DAPT  treatment  did  not  normalize  Nrarp
-/-  blood  vessel 
morphology to those of Nrarp
+/+ animals (Figure 63H).  
In summary, 48h DAPT treatment of Nrarp
-/- retinas did not normalize the 
abnormally thin and poorly connected vessels that form when Nrarp expression is 
lost  (Figure  63I).  This  finding  suggests  that  the  vascular  phenotype  in  Nrarp-
deficient mice may not be a result of increased Notch signalling.  
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4.2.15  LOSS OF NRARP EXPRESSION DECREASED WNT SIGNALLING. 
We  next  investigated  whether  Nrarp  can  function  through  the  Wnt  signalling 
pathway to regulate blood vessel morphogenesis. Ishitani et al reported that zebrafish 
nrarp-a binds to and stabilizes the Lymphoid enhancer factor 1 (Lef1) by preventing 
its  degradation  (Ishitani  et  al.,  2005).  In  human  umbilical  vein  endothelial  cells 
(HUVECs),  endogenous  LEF1  protein  co-immunoprecipated  with  Myc-tagged 
mouse Nrarp, confirming the interaction between Nrarp and LEF1 in endothelial 
cells  (Figure  64A).  We  next  examined  the  level  of Lef1  protein  in  the  retina  of 
Nrarp
-/- mice by Western blotting. We observed a reduction in Lef1 in Nrarp
+/- and 
Nrarp
-/- retinas when compared to wildtype littermates (Figure 64B), suggesting that 
Nrarp also regulates Lef1 stability in the mouse. 
  In order to determine whether Nrarp regulates Wnt signalling in endothelial 
cells, two approaches were undertaken. The first was isolation of endothelial cells 
from  adult  lungs  of  Nrarp
+/+  and  Nrarp
-/-  mice.  Isolated  endothelial  cells  were 
cultured on recombinant mouse Dll4-coated plates and the expression of CyclinD1, 
whose expression is directly regulated by the β-catenin/Tcf/Lef1 complex (Shtutman 
et  al.,  1999;  Tetsu  and  McCormick,  1999)  was  compared  between  wildtype  and 
Nrarp
-/- endothelial cells by qPCR. Indeed, there was a significant decrease of 42% 
in CyclinD1 expression in Nrarp
-/- endothelial cells (p = 0.0190; Figure 64B). The 
same cells also displayed an increase in Hey2 expression (p = 0.0004; Figure 64B). 
These  data,  therefore,  show  that  Nrarp  differentially  regulates  Notch  and  Wnt 
signalling in endothelial cells. 
The  second  method  employed  to  investigate  Nrarp  regulation  of  Wnt 
signalling  in endothelial cells was the use of the TOPFlash luciferase reporter in 
HUVECs  combined  with  knockdown  of  NRARP  expression  by  siRNA.  The 
TOPFlash reporter contains eight Tcf/Lef1 binding sites in the promoter that drives 
the transcription of luciferase (Veeman et al., 2003). Stimulation of HUVECs with 
Wnt3a, a Wnt ligand, resulted in an increase in TOPFlash activity when compared to 
unstimulated HUVECs (Figure 64D). Knockdown of NRARP suppressed the increase 
in TOPFlash activity that was induced to basal level (p = 0.0002; Figure 64D). We 
also  investigated  whether  stimulation  of  both  Wnt  and  Notch  signalling  would 
potentiate  TOPFlash  activity.  Stimulation  by  rhDll4  alone  did  not  stimulate 
TOPFlash activity (Figure 64D). However, co-stimulation with Wnt3a and Dll4 led   159       Figure  64 . Nrarp promotes Wnt signalling in endothelial cells.   A ,  Coimmunoprecipitation  experiment  in  HUVECs  transfected  with  Nrarp - Myc.  Endoge nous LEF1 coimmunoprecipitated with Nrarp - Myc (arrow). An empty vector  (pcDNA) was used as a control.  B , Immunoblot of Lef1 protein in P5  Nrarp +/+ ,  Nrarp +/ -  and  Nrarp - / -  retinas. There is a decrease in Lef1 protein level in  Nrarp +/ -  and  Nrarp - / -   retinas.  C ,  fold  differences  in  expression  of  Hey2   and  CyclinD1   in  endothelial  cells  of  Nrarp - / -   compared  to  Nrarp +/+   mice.  There  is  a  significant  increase in  Hey2  expression and a significant decrease in  CyclinD1  expression in  Nrarp - / -  ECs. *, p = 0.019; ***, p = 0 .0004. n = 6.  D , TOPFlash reporter activity in  HUVECs after  NRARP  siRNA treatment. Knockdown of  NRARP  suppressed Wnt3a - induced TOPFlash activity.  NRARP  siRNA treatment for 24 hours resulted in a 70 - 80% reduction  NRARP  mRNA expression compared to scrambled  siRNA (data not  shown). *, p = 0.0014; ***, p = 0.0002. n = 3 for each condition. Data in A and D  were produced by Michael Potente.     
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to  a  slight  potentiation  in  Wnt  signalling (Figure  64D),  which  was  abolished  by 
NRARP knockdown (p = 0.0114; Figure 64D). 
Together, the data show that Nrarp positively regulates Wnt signalling under 
Wnt stimulatory conditions.  
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4.2.16  HETEROGENEOUS  ENDOTHELIAL  WNT  ACTIVITY  IN  RETINAL 
VASCULATURE. 
We next investigated where Wnt signalling is active in the vasculature in vivo, and 
whether Wnt activity co-localizes with Notch activity. To do this, we crossed the 
BATlacZ  Wnt  reporter  mouse  with  the  TNR  Notch  reporter  mouse  that  was 
described in the previous chapter. In the BATlacZ mouse, a siamois promoter with 8 
Tcf/Lef binding sites drives the expression of LacZ-NLS (Nakaya et al., 2005). Thus, 
the  BATlacz  mouse  has  been  designed  to  detect  Wnt/β-catenin-regulated 
transcriptional activation that is mediated by Tcf/Lef proteins i.e. it is a reporter of 
canonical Wnt signalling. Indeed, this mouse shows expression in the embryonic 
node and primitive streak that is partially lost in Wnt3a
-/- embryos (Nakaya et al., 
2005).  
Several problems arose in the attempt to visualize Wnt and Notch activity in 
the retina. First of all, we were unable to detect LacZ expression in the retina by X-
Gal staining (a process whereby X-Gal is hydrolyzed by beta-galactosidase to yield a 
blue precipitate) or by anti-β-Galactosidase antibody staining. However, the failure 
to detect Wnt activity in the BATlacZ does not translate to lack of Wnt signalling in 
the retina. In fact, it has been documented that several Tcf reporters fail to label sites 
of known Wnt/β-catenin signalling (reviewed in (Barolo, 2006)). We subsequently 
examined the retinas of another Tcf reporter mouse called BAT-gal, which differs 
from the BATlacZ mouse by having one less Tcf/Lef binding site in the promoter 
(Maretto et al., 2003). In this case, β-galactosidase activity was detected successfully 
in the retinal vasculature by immunofluorescence (Figure 65). Wnt signalling was 
prominent in endothelial cells situated behind the migrating front (Figure 65A) and 
in  the  vascular  plexus  (Figure  65B).  The  strongest  reporter  activity  regularly 
localized to endothelial cells situated at vessel branchpoints. The second problem 
that arose in this experiment was that the TNR Notch reporter mouse had lost its 
GFP expression for unclear reasons. Hence, we were unable to colocalize Wnt and 
Notch  activity  using  this  approach.  In  another  bid  to  colocalize  Wnt  and  Notch 
signalling in the retina, we attempted Nrarp mRNA ISH in BAT-gal mice followed 
by anti-β-galactosidase antibody staining. Unfortunately, the conditions for ISH were 
not suitable for anti-β-galactosidase antibody staining. 
   162     Figure  65 . Wnt activity in a subpopulation of endothelial cells in the retina of  BAT - gal TCF reporter mouse.   A  and  B , P4 retinas of BAT - gal mice that have been immunostain ed with anti - β - galactosidase antibody (green) and Isolectin - B4 (red). Wnt activity is prominent at  branchpoints at arterial and veinous ends (A) and also at branchpoints of capillary  vessels (B). This experiment was performed by  Daniel Nyqvist .     
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4.2.17  LEF1-DEFICIENT  MICE  DISPLAY  INCREASED  VESSEL  REGRESSION  IN  THE 
RETINA. 
Given that Nrarp modulates the Wnt signalling pathway by stabilizing Lef1 ((Ishitani 
et al., 2005), Figure 64B) and that Wnt signalling is downregulated upon reduction in 
Nrarp expression and function (Figure 64C, D), we next investigated whether mice 
deficient in Lef1 also display ectopic vessel regression. Wholemount staining with 
Isolectin-B4 of retinas from P4 to P5 mice revealed a significant decrease of ~40% in 
blood vessel density in Lef1
-/- (p < 0.0001; Figure 66B,D,E) that is accompanied by a 
reduction  in  radial  expansion  of  the  retina  plexus  when  compared  to  wildtype 
littermates (Figure 66A,C). However, there was no difference in blood vessel density 
between wildtype and Lef1
+/- mice (Figure 66E).  
  We next examined whether the decrease in vessel density was also the result 
of increased vessel regression, which was observed in Nrarp-deficient mice. Indeed, 
co-staining of retinas with anti-Collagen IV antibody revealed a significant increase 
in empty Collagen IV sleeves in Lef1
-/- mice when compared to wild-type littermates 
(Figure 67 and Figure 68). We observed ectopic vessel regression in the migrating 
front (Figure 67B), in arterial regions (Figure 67C) and in capillary regions (Figure 
67D,  Figure  68B)  of  the  vascular  plexus.  Quantification  revealed  a  significant 
increase  of  ~14%  in  vessel  regression  in  the  capillary  regions  of  Lef1
-/-  retinas 
compared to the same vascular region in wildtype (p = 0.0002; Figure 68C) and 
Lef1
+/- (p = 0.048; Figure 68C) littermates. In addition, vessels of Lef1
-/- animals 
appeared  narrower  compared  to  wildtype  littermates  and  staining  for  Claudin  5 
showed an increase in discontinuous endothelial junctions in Lef1
-/- vessels (Figure 
68D). 
 
 
 
 
 
 
 
 
   164     Figure  66 . Reduced vessel density in  Lef1 - / -  mice.   P5  Lef1 +/+  ( A , C ) and  Lef1 - / -  ( B , D ) were stained with Isolectin - B4. There is a decrease  in vessel density (D, E) and radial expansion (B) in  Lef1 - / -  mice.  E , graph illustrates  the  number  of  vessel  branchpoints/100µm 2   area  in  Lef1 +/+ ,  Lef1 +/ -   a nd  Lef1 - / -   P5  retinas. There is a significant decrease in vessel density in  Lef1 - / -  animals. *, p =  0.0150; ***, p < 0.0001.  Lef1 +/+ , n = 41;  Lef1 +/ - , n = 8;  Lef1 - / - , n = 8. Values represent  mean  ±  S.E.M.       165     Figure  67 . Blood ves sel regression profiles in  Lef1 - / -  retinas.   P5  Lef1 - / -  retinas were stained with anti - Collagen IV antibody (green) and Isolectin - B4 (blue). Ectopic vessel regression (arrows) is observed at the vascular front (B),  arterial end (C) and capillaries (D) of th e vascular plexus.      166     Figure  68 . Increase in vessel regression in  Lef1 - / -  retinas.   A  and  B  are images of capillary regions of  Lef1 +/+  and  Lef1 - / -  retinas, respectively,  that have been stained with anti - Collagen IV antibody (red)  and Isolectin - B4 (green).  Arrows highlight regression profiles. There is significantly more vessel regression in  Lef1 - / -   retinas  (B  and  C).  C ,  Quantification  of  vessel  regression  in  the  capillary  plexus  of  Lef1 +/+ ,  Lef1 +/ -   and  Lef1 - / -   P5 retinas. **,  p  =  0 .048;  ***,  p  =  0.0002.  Lef1 +/+ , n = 13;  Lef1 +/ - , n = 9;  Lef1 - / - , n = 9.  D ,  Lef1 - / -  retinas stained with anti - Claudin 5 antibody (red), anti - Collagen IV antibody (green) and Isolectin - B4 (blue).  Discontinuous  junctions  are  observed  in  capillary  plexus  of  mu tant  retinas  (arrowheads in D’).   
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4.2.18  MORPHOLINO KNOCKDOWN OF LEF1 IN THE ZEBRAFISH. 
We next returned to the zebrafish to investigate whether we could recapitulate the 
nrarp-a  and  –b  morphant  vascular  phenotype  when  lef1  expression  is  knocked-
down. At 56hpf, the dorsal aorta, posterior cardinal vein, ISVs and DLAV were well 
formed  and  patent  in  the  control  morphant  (Figure  69A  and  A’).  Preliminary 
experiments  show  that  knockdown  of  lef1  expression  resulted  in  vessel  defects 
ranging from mild (Figure 69B and B’) to severe (Figure 69C and C’). In the mild 
morphants, vessels with irregular diameter and poor ISV connections to the dorsal 
aorta  and  DLAV  were  observed  (arrows).  In  addition,  the  dorsal  aorta  appeared 
poorly formed with a lack of lumen (* in Figure 69B’). In the more severe morphant, 
the dorsal aorta, posterior cardinal vein and ISVs were severely deformed. The dorsal 
aorta was disintegrated along its length and is separated from the posterior cardinal 
vessel (indicated by double-ended arrows in C and C’). The ISVs were also very 
fragmented so that endothelial cells were no longer adhered to each other within 
ISVs and between ISV and the dorsal aorta (Figure 69C). Cross-section of the severe 
lef1 morphant revealed an enlarged axial vessel (* in Figure 69C’).  
  Thus, knockdown of lef1 expression and function in the zebrafish resulted in 
a vascular phenotype that is similar to that of decreased of nrarp-a and –b function. 
Furthermore, decreasing lef1 expression led to a more severe vessel defect compared 
to decreasing nrarp-a or –b. However, because loss of lef1 results in tail truncations 
and loss of paraxial mesoderm (Dorsky et al., 2002), more thorough analysis needs to 
be more performed to examine the cell autonomous role of lef1 in endothelial cell 
function during ISV formation in the zebrafish. 
 
 
 
 
 
 
 
   168     Figure  69 . Knockdown of  lef1  expression in the zebrafish.   Tg(fli1:EGFP) y1  zebrafish were injected with 2ng control ( A, A’ ) or  lef1  (B, B’, C,  C’)  morpholinos  and  analyzed   at  ~56hpf.  A - C  are  lateral  views  of  ISVs  at  the  zebrafish  trunk.  A’ - C’  are  cross - sections  of  the  trunk  showing  the  3D  vascular  network. B and C are images of different  lef1  morphants showing mild and severe  vascular defects, respectively. Arrows indicate  poor vessel connections. Arrowhead  indicates vessel disconnection. Double - ended arrows indicate vessel segregation e.g.  between DA and PCV. * indicate poorly formed dorsal aorta and posterior cardinal  vein.  DLAV,  dorsal  longitudinal  anastomotic  vessel;  ISV ,  intersegmental  vessel;  PAV, parachordal vessel; DA, dorsal aorta; PCV, posterior cardinal vein.   
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4.2.19  INDUCIBLE  ENDOTHELIAL-SPECIFIC  DELETION  OF  CTNNB1  LEADS  TO 
EXCESSIVE VESSEL REGRESSION. 
We  next  examined  whether  β-catenin  activity  regulates  vessel  stability  during 
angiogenesis in the postnatal retina. To investigate this, we genetically deleted the 
gene that encodes β-catenin, Ctnnb1, in endothelial cells in an inducible manner by 
crossing the Ctnnb1
lox/lox mouse, where the Ctnnb1 gene is flanked by two lox sites 
(Brault et al., 2001) with the tamoxifen-inducible Pdgfb-iCreER line that expresses 
EGFP  (Claxton  et  al.,  2008).  We  first  examined  Cre-mediated  recombination 
efficiency in endothelial cells by crossing Pdgfb-iCreER mouse with the Cre-reporter 
line Rosa26R-EYFP (Srinivas et al., 2001). Single bolus injection of 4OH-tamoxifen 
for 48 or 72 hours resulted in widespread endothelial-specific recombinase activity, 
as  observed  by  the  nuclear  EFYP  staining  in  P6  retinas  (arrows  Figure  70). 
Furthermore, the use of Pdgfb-driven Cre activity is prominent in endothelial cells of 
the vascular front.  
We  next  crossed  the  Pdgfb-iCreER  mice  with  Ctnnb1
lox/lox  mice  and 
examined β-catenin protein levels in blood vessels. There was a marked reduction in 
junctional β-catenin in Ctnnb1
lox/lox; Pdgfb-iCreER
+/- mice compared to Cre-negative 
littermates (Figure 71B). Staining for other junctional proteins such as ZO-1 and VE-
cadherin revealed normal junctional localization of these proteins in the absence of 
endothelial Ctnnb1 expression (Figure 71), indicating that loss of β-catenin does not 
cause endothelial cell junctional disassembly. The redundant activity of γ-catenin and 
the  increased  incorporation  of  desmoplakin  in  adhesion  junctions  are  possible 
explanations for intact endothelial cell junctions in the absence of endothelial β-
catenin (Cattelino et al., 2003). 
Deletion of endothelial Ctnnb1 for 72 hours resulted in a significant reduction 
in  vascular  density  in  Pdgfb-iCreER-positive  mice  (Figure  72E).  There  was  a 
significant  decrease  of  ~40%  in  the  number  of  capillary  vessel  branchpoints  in 
Ctnnb1-deficient mice compared to littermates expressing Ctnnb1 (p = 0.0279). High 
magnification  analysis  indicated  that  sprouting  occurred  normally  (Figure  72B). 
However, anti-Collagen IV staining revealed excessive empty basement membrane 
sleeves and vessel regression at the vascular front and venous regions of Ctnnb1-
deficient  mice  (dots  in  Figure  72B,  D).  Thus,  loss  of  endothelial  Ctnnb1 
recapitulated the phenotype observed in Nrarp-and Lef1-deficient mice, suggesting   170   that  endothelial  Wnt   signalling  controls  vascular  stability.  Because  we  observed  intact endothelial junctions in the absence of endothelial  β - catenin, the excessive  vessel regression observed upon reduction in  canonical Wnt signalling may be a  result of changes in Wnt - regulated transcriptional events.        Figure  70 . Endothelial specific Cre - mediated recombination using the  Pdgfb - iCreER  conditional line.   P3  Pdgfb - iCreER +/ - ; Rosa26R - EYFP   m ice  were  given  a  single  dose  of  4OH - tamoxifen intraperitoneally. Retinas were analyzed 48 hours later at P5. The  Pdgfb - iCreER  mouse also carries an  EGFP  gene, whose expression is specific to blood  vessels in the retina, especially in endothelial cells of t he migrating front (green in A  and B). Its expression is predominantly localized to endothelial cell membrane. After  4OH - tamoxifen  injection,  we  observed  nuclear  EYFP  (red)  in  endothelial  nuclei  (arrows  in  A’’  and  B),  indicating  that  recombination  persiste d  48  hours  after  induction  by  4 - OH  tamoxifen  injection.  This  experiment  was  conducted  by  Jane  Babbage and Holger Gerhardt.    171               Figure  71 . Endothelial - specific deletion of  Ctnnb1  leads to a specific loss of  β - catenin from endot helial cell junctions.   Ctnnb1 lox/lox  mice were bred with  Ctnnb1 lox/lox ; Pdgfb - iCre ER +/ -  mice. The offspring  were all injected once with 4OH - tamoxifen at P3. Eyes were harvested 72 hours later  at P6.  A  and  B , retinas were triple - stained with anti - β - catenin ( green), anti - ZO1 (red)  and anti - VE - cadherin (blue) antibodies. There is a specific loss of  β - catenin from  endothelial  cell  junctions  of  retinal  blood  vessels  of  Ctnnb1 lox/lox ; Pdgfb - iCre ER +/ -   mice  (B)  compared  to  Ctnnb1 lox/lox ; Pdgfb - iCre ER - / -   littermates  (A ).  Tight  junction  protein  ZO1  and  adherens  junction  protein  VE - cadherin  remained  localized  to  endothelial cell junctions (B). This experiment was conducted by Jane Babbage and  Holger Gerhardt.    172       Figure  72 . Deletion of endothelia l  Ctnnb1  postnatally results in decreased vessel  density due to increased vessel regression.   A - D , confocal images of retinas stained with anti - Collagen IV antibody (red) and  Isolectin - B4  (blue).  There  is  increased  blood  vessel  regression  (dots)  at  both  the   vascular front (B) and the venous regions (D) of retinas from  Ctnnb1 lox/lox ; Pdgfb - iCreER +/ -  mice when compared to  Ctnnb1 lox/lox ; Pdgfb - iCreER - / -  littermates. Graphs  illustrate the number of branchpoints/100µm 2  ( E ) and the extent of vessel regression  ( F ) in  the capillary plexuses of  Cre  negative and  Cre  positive littermates. *, p =  0.0279; ***, p = 0.0005. n  ≥  8 for each group. Jane Babbage and Holger Gerhardt  performed the experiment; I conducted the quantification of vessel regression.       
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4.2.20  ENDOTHELIAL-SPECIFIC  ACTIVATION  OF  CTNNB1  FAILED  TO  RESCUE 
VESSEL   REGRESSION IN NRARP MUTANT MICE. 
Given that loss of Lef1 and endothelial Ctnnb1 resulted in ectopic vessel regression 
during angiogenesis in the retina, we hypothesized that over-expression of Ctnnb1, 
and therefore canonical Wnt signalling, specifically in endothelial cells would rescue 
the increased vessel regression observed in Nrarp-deficient mice. To address this 
hypothesis,  we  crossed  Nrarp-deficient  mice  with  the  Ctnnb1
lox(ex3)  mice,  whose 
exon3 is flanked by loxP sequences (Harada et al., 1999). Exon3 of the β-catenin 
protein contains many serine/threonine residues that are phosphorylated by the APC-
axin-GSK3β complex, an event that signals β-catenin for proteosomal degradation. 
Therefore, the deletion of exon 3 (Ctnnb1
Δex3) confers β-catenin enhanced stability 
and  activity  of  β-catenin  within  the  cell.  Again,  we  used  the  Pdgfb-iCreER 
conditional mouse line to induce endothelial-specific activation of β-catenin in Nrarp 
mutant  mice.  P3  pups  born  from  Nrarp
+/-;Ctnnb1
lox(ex3)/lox(ex3)  or  Nrarp
+/-
;Ctnnb1
+/lox(ex3)  mice  crossed  with  Nrarp
-/-;  Ctnnb1
lox(ex3)/lox(ex3);  Pdgfb-iCreER
+/- 
were treated with 4OH-tamoxifen once and retinal blood vessels were examined 72 
hours later at P6. 
  The  gain  of  one  or  two  alleles  of  Ctnnb1
ΔEx3  failed  to  decrease  vessel 
regression in Nrarp-deficient mice. We still observed an excessive amount of vessel 
regression profiles in the capillary plexus and arterial regions of Nrarp
-/-;Ctnnb1
+/ΔEx3 
retinas  (dots  in  Figure  73B  and  D).  Furthermore,  the  gain  of  two  alleles  of 
Ctnnb1
ΔEx3 appeared to increase the range of vessel regression in Nrarp-deficient 
mice  so  that  the  minimum  data  point  in  Ctnnb1
ΔEx3/ΔEx3  is  lower  than  that  of 
Ctnnb1
+/+ mice (compare plot 3 to 1 in Figure 73). In other words, there were some 
regions in Nrarp
+/-; Ctnnb1
ΔEx3/ΔEx3 that have a higher degree of vessel regression 
than in Nrarp
+/-;Ctnnb1
+/+ mice. However, there were no significant differences in 
the extent of vessel regression among the animals of different genotypes. 
  The  failure  to  observe  a  reduction  of  vessel  regression  in  Nrarp-deficient 
mice  in  the  presence  of  constitutive  β-catenin  may  be  due  to  the  fact  that  Lef1 
protein level was still decreased. Wnt-induced transcription requires the formation of 
a complex comprising β-catenin and a member of the Tcf/Lef family. As β-catenin 
alone  is  unable  to  bind  to  DNA,  overexpression  of  β-catenin  is  insufficient  to 
increase the transcription of Wnt target genes if the level of Tcf/Lef is limiting. This   174     Figure  73 .  Overexpression  of  Ctnnb1   in  endothelial  cells  failed  to  normalize  vessel regression in  Nrarp - deficient retinas.   Nrarp +/ - ; Ctnnb1 lox(ex3)/lox(ex3)   or  Nrarp +/ - ; Ctnnb1 +/lox(ex3)   mice  were  crossed  with  Nrarp - / - ;  Ctnnb1 lox(ex3)/lox(ex3) ;  Pdgfb - iCreER +/ - . The offspring were all  injected once  with 4OH - tamoxifen at P3. Eyes were harvested 72 hours later at P6. Retinas were  subsequently stained with anti - Collagen IV antibody (red) and Isolectin - B4 (green).  A  is a representative image of  Nrarp - / - ; Ctnnb1 +/+  retinas.  B  and  D  are image s of  Nrarp - / - ; Ctnnb1 + / Δ ex3  retinas that show the range of vessel regression after gaining  one allele of constitutive  β - catenin. In B, there appears to be an increase in vessel  density after ectopic activation of  β - catenin when compared to  Nrarp - / -  retinas.  In D,  there appears to be a decrease in vessel density and increase in vessel regression after  ectopic activation of  β - catenin. Dots in the images indicate vessel regression profiles.  D , quantification of vessel regression in the capillary plexus of mice  from various  genotypes.  All  animals  are  Pdgfb - iCreER +/ - . There  is  no  significant  difference  in  vessel regression between  Nrarp +/ -  or  Nrarp - / -  with or without endothelial  Ctnnb1   overexpression.  Nrarp +/ - ; Ctnnb1 +/+ ,  n = 6;  Nrarp +/ - ;  Ctnnb1 + / Δ ex3 , n = 16;  Nra rp +/ - ;   Ctnnb1 Δ ex3/ Δ ex3 , n = 8;  Nrarp - / - ;  Ctnnb1 +/+ , n = 19;  Nrarp - / - ;  Ctnnb1 + / Δ ex3 , n = 19; and   Nrarp - / - ; Ctnnb1 Δ ex3/ Δ ex3 , n = 5.   
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may be a possible scenario in Nrarp-deficient animals, where there is a decreased 
Lef1  protein  level.  However,  it  would  be  necessary  to  determine  the  lack  of  an 
increase  in  canonical  Wnt  signalling  in  Nrarp
-/-;  Ctnnb1
ΔEx3/ΔEx3  to  confirm  this 
speculation.  
 
4.3  DISCUSSION 
4.3.1  NRARP MODULATES THE NOTCH AND WNT PATHWAYS 
Previous studies have shown that Nrarp inhibits Notch signalling by disrupting the 
NICD/CSL transcriptional complex (Ishitani et al., 2005; Lamar et al., 2001). In our 
study, we confirmed the negative regulatory function of Nrarp in Notch signalling in 
Nrarp mutant mice. There was a significant increase in the expression of Hey1, Hey2 
and Lnfg in retinas and of Hey2 in endothelial cells of Nrarp null mice. Nrarp
+/- mice 
also  displayed  a  slight  increase  in  Lnfg  expression.  Intriguingly,  this  increase  in 
Notch signalling in Nrarp mutant mice did not produce the same phenotype obtained 
from ectopic activation of Notch signalling by systemic injection of Jag1 peptide 
(Hellstrom et al., 2007). In Jag1-treated retinas, there was significantly less filopodia 
formation at the sprouting front of the vessel, supporting the conclusion that Notch 
signalling suppresses endothelial tip cell formation (Figure 31). Similarly, ectopic 
activation of Notch signalling in the zebrafish using an inducible Gal4/UAS system 
blocks  sprouting  of  intersegmental  vessels  (Leslie  et  al.,  2007;  Siekmann  and 
Lawson,  2007).  However,  Nrarp  deficiency  does  not  affect  sprouting  activity  or 
filopodia  formation  (Figure  47).  Also,  we  could  not  find  evidence  for  increased 
vessel regression following Jag1 peptide injection in the mouse retina and regression 
of existing vessels has not been observed in zebrafish in which Notch signalling is 
ectopically activated.   
Why, then, are there different phenotypic outcomes from ectopic increase in 
Notch signalling? Conceptually, the loss of an intrinsic negative regulator of NICD 
such as Nrarp should give rise to a cell-autonomous increase in Notch signalling, 
whereas  a  general  genetic  or  pharmacological  activation  of  Notch  signaling  will 
affect the entire endothelial cell population independent of their position in the tip or 
stalk. Study of Nrarp expression by ISH revealed strong Nrarp expression in stalk 
cells and endothelial cells at vessel branchpoints (Figure 37D and Figure 38). Thus, 
the loss of Nrarp should only lead to an increase in Notch signalling in a    176     Figure  74 . Nrarp different ially modulates Notch and Wnt signalling.   In endothelial cells, Dll4 stimulates Notch  signalling and positively regulates the  expression of  Nrarp  in a CSL - dependent manner. Nrarp negatively regulates Notch  signalling by disrupting the formation of NICD and  CSL transactivation complex  and by promoting the degradation of NICD. Stimulation of endothelial cells by Wnt  ligands such as Wnt3a induces canonical Wnt signalling.  β – catenin is stabilized and  binds  to  a  member  of  the  Tcf/Lef1  transcription  factor  family .  Nrarp  positively  modulates Wnt signalling by binding to and stabilizing Lef1 protein by preventing its  degradation. Consequently, there is increased  β – catenin/Lef1 formation to activate  expression of Wnt - target genes.       subpopulation of cells that already received Notch signaling, leaving the sprouting  tip cells  and their filopodia formation unaffected.   Another explanation for the phenotypic difference is that the stabilizing role  of  Nrarp on blood vessels is mediated via Wnt signalling. We have shown that   i)    Nrarp  binds  to  LEF1  in  HUVECs,  ii)   loss  of  Nrarp  function  leads  to  decreased  expression of a Lef1 target gene,  CyclinD1 , in endothelial cells isolated from  Nrarp - / -   lungs,  and  iii)  by  using  the  TOPFlash  Wnt  reporter  to  examine  Wnt  activity,  knockdown of  NRARP  expression by siRNA significan tly decreased Wnt activity in  HUVECs in the presence of Wnt3a ( Figure  64 ). Furthermore, genetic deletion of  Lef1  and endothelial  Ctnnb1  resulted in a very similar vascular phenotype: increased  vessel regression during d evelopment of the retinal vasculature. Analysis of BAT - gal  
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retinas  revealed  strong  Wnt  activity  in  endothelial  cells  at  vessel  branchpoints 
(Figure  65),  which  is  also  where  Nrarp  is  strongly  expressed.  It  is  tempting  to 
speculate that Nrarp integrates with canonical Wnt signalling especially at vessel 
branchpoints to stabilize nascent vessels during angiogenesis. We have shown that 
the  controlled  endothelial  cell  proliferation  during  angiogenesis  is  important  in 
stabilizing nascent vessels in Nrarp null retinas and it is likely that both Notch and 
Wnt signalling regulate this process in endothelial cells. Ex vivo, activation of Notch 
signalling in endothelial cells induces cell cycle arrest through retinoblastoma protein 
de-phosphorylation and down-regulation of p21
CIP expression (Noseda et al., 2004). 
In  contrast,  activation  of  Wnt  signalling  promotes  endothelial  cell  proliferation 
(Masckauchan  et  al.,  2006;  Masckauchan  et  al.,  2005)  and  the  β-catenin/Lef1 
complex has been demonstrated to directly activate the transcription of CyclinD1 to 
induce  cell  cycle  progression  (Shtutman  et  al.,  1999).  Thus,  Nrarp  could  drive 
endothelial stalk cell proliferation by reducing Notch-dependent cell cycle arrest and 
increasing Lef1/Wnt signaling-dependent CyclinD1 levels. 
 
4.3.2  WNT SIGNALLING STABILIZES NASCENT BLOOD VESSELS 
The analysis of the Nrarp vascular phenotype has also generated insight into the 
cellular  mechanism  of  vessel  regression  during  vessel  morphogenesis  in  retinal 
vasculature.  
In adult mice, reduction in VEGF-A signalling rapidly leads to loss of vessel 
connections (Baffert et al., 2006; Inai et al., 2004). However, in Nrarp
-/- retinas, 
excessive  vessel  regression  occurs  in  regions  of  high  VEGF-A  expression 
concomitant with sprouting, suggesting that the loss of Nrarp disables a molecular 
pathway that normally stabilizes vessels under VEGF-A stimulation. Several groups 
have  reported  that  Notch  signalling  regulates  VEGF  receptor  expression.  Kdr2 
expression is induced by VEGF-A and down-regulated in endothelial cells through 
Notch signaling (Harrington et al., 2008). Suchting et al proposed that increased 
vessel density and tip cell activity in DAPT-treated or Dll4 heterozygous retinas is 
caused  by  up-regulation  of  Kdr  (Suchting  et  al.,  2007).  Conversely,  vascular 
regression in Nrarp
-/- retinas could be mediated by Notch-dependent repression of 
Kdr. However, we observed slightly increased levels of Vegfa and Kdr expression in 
Nrarp
-/-  retinas  (Figure  61).  Although  pharmacological  inhibition  of  VEGF-Kdr  
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signalling leads to vascular regression (Baffert et al., 2006), it is unclear whether 
reduced Kdr expression levels would have similar effects. Flt1, which functions as a 
high  affinity  decoy  receptor  for  VEGF-A,  is  up-regulated  by  Notch  signalling 
(Harrington et al., 2008). Consistent with the observed increase in Notch signalling, 
Nrarp
-/- retinas express higher levels of Flt1 mRNA (Figure 61), suggesting that 
enhanced  Flt1-mediated  sequestration  of  VEGF-A  may  contribute  to  the  vessel 
regression. 
In the introduction of the thesis, I described the importance of pericytes in 
stabilizing blood vessels. Inhibition or genetic inactivation of PDGF-B signalling or 
alteration of the Angiopoietin-1/Angiopoietin-2 balance promotes loss of pericytes 
followed by selective vessel regression (Enge et al., 2002; Hammes et al., 2002; 
Hammes et al., 2004; Rao et al., 2007; Sennino et al., 2007; Uemura et al., 2002). In 
Nrarp
-/-  retinas,  vessel  regression  occurs  despite  apparently  normal  pericyte 
recruitment (Figure 58). Furthermore, we have not been able to detect significant 
expression of Nrarp in retinal pericytes. We therefore conclude that the vascular 
phenotype in Nrarp
-/- retinas reflects an endothelial cell-autonomous role of Nrarp in 
vessel stabilization. 
Published work on the study of hyaloid vessel regression demonstrated that 
this process requires the induction of endothelial cell apoptosis mediated by Wnt 
signalling  in  a  Fzd4-  and  Lrp5-dependent  manner  (Lobov  et  al.,  2005). In  these 
vessels, Wnt signalling functions to promote endothelial cell cycle entry but in the 
absence of survival factors like VEGF-A or Angiopoietin-1 or in the presence of 
inhibitors of these survival factors, endothelial cells of hyaloid vessels receiving Wnt 
signalling  undergo  apoptosis.  However,  we  did  not  find  evidence  for  apoptosis-
induced  vessel  regression  in  Nrarp-deficient  endothelial  cells  in  the  retinal 
vasculature.  Therefore,  in  the  context  of  retinal  blood  vessels,  endothelial  Wnt 
signalling is required for vessel maintenance rather than regression.  
Instead,  we  discovered  that  reduced  endothelial  cell  proliferation  and 
excessive junctional rearrangement contribute to vessel regression in retinal vessels. 
Analyses of Nrarp null mice and nrarp-a and –b zebrafish morphants revealed a 
decrease in endothelial cell proliferation and consequently, endothelial cell number 
in nascent blood vessels. One can imagine that a decrease in endothelial cell number 
in growing vessels would cause junctional stress. This is exemplified in nrarp-a and 
–b morphants where the sprouting and migratory activities of endothelial cells were  
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unaffected.  The  combination  of  reduced  endothelial  cell  number  and  continuous 
dorsal  migration  of  endothelial  cells  would  impose  a  strain  on  the  endothelial 
junction  between  the  ventral  cells  of  the  ISV  and  the  dorsal  aorta.  This  was 
demonstrated by ZO-1 staining where we observed poorly formed junctions between 
ISVs and the dorsal aorta (Figure 54). Similarly in the postnatal mouse retina, there 
was an increase in junctional segregation and discontinuity when Nrarp expression 
was  lost  (Figure  53F,  H,  I).  These  junctional  rearrangements  are  also  observed 
during vessel remodelling when excess vessels are removed in a controlled manner 
by vessel regression to produce a refined vascular network (Figure 51). The finding 
that  similar  junctional  rearrangements  also  occur  in  Nrarp  mutants  suggests  that 
endothelial junctions do form in the mutants but become unstable when subjected to 
strain and subsequently culminate in vessel regression.  
  Our study of Lef1 and β-catenin function in angiogenesis points toward a role 
of canonical Wnt signalling in the regulation of vessel stability. A similar role has 
also been observed for Fzd5, a receptor for Wnt5a, Wnt10b and Wnt2, in yolk sac 
and placental angiogenesis in mouse (Ishikawa et al., 2001). Deletion of Fzd5 results 
in vascular phenotypes in the yolk sac that are similar to those found in Nrarp
-/- 
retinas: vessels are narrower and the network formed is less branched, and, these 
endothelial cells are frequently detached or degenerated (Ishikawa et al., 2001). In 
addition, the authors could not find evidence for increased endothelial apoptosis but 
did  observe  a  decrease  in  endothelial  cell  proliferation,  reminiscent  of  Nrarp-
deficient endothelial cells. Whether Fzd5 is also involved upstream of β-catenin/Lef1 
in the retinal endothelial Wnt signalling pathway that is modulated by Nrarp remains 
unclear, as embryonic lethality of these mutants precluded retinal analysis. A similar 
retinal phenotype, however, has been observed with the loss of Lrp5 in the mouse. 
Lrp5
-/-  retinas  have  significantly  reduced  blood  vessel  density  from  P5  to  P7 
compared to wildtype littermates (Phng et al, submitted). Recent work identified a 
mouse mutation in the Lrp5 gene (Lrp5
r18) that caused a truncation in the C-terminal 
interaction  domain  required  for  Wnt/β-catenin  signalling  (Xia  et  al.,  2008).  The 
authors reported retinal vascular defects including collapsed lumen, decrease in tight 
junction formation between endothelial cells and attenuated vascularization, leading 
to  incomplete  development  of  the  retinal  vasculature.  A  similar  retinal  vascular 
phenotype was also observed in the Lrp5 null mouse (Xia et al., 2008). Previous 
study has demonstrated that mutant LRP5 proteins without the last three PPP(S/T)P  
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motifs in the C-terminal intracellular domain are unable to bind to Axin, a process 
that is required to prevent degradation of β-catenin, and failed to activate LEF1 (Mao 
et al., 2001). In the Lrp5
r18 mutant, the last three PPP(S/T)P motifs in the C-terminus 
are disrupted, which would probably eliminate the docking site for Axin binding to 
Lrp5 (Xia et al., 2008). Thus, Lrp5 truncated mutant proteins are probably unable to 
stabilize β-catenin, leading to decreased β-catenin/Tcf/Lef1 transcriptional complex 
formation and activation of canonical Wnt target genes that are essential for the 
development of the retinal vasculature (Cao et al., 2007). Another line of evidence 
indicating  Wnt  signalling  in  retinal  vascular  development  is  Norrin-dependent 
activation of Fzd4 (Xu et al., 2004). Loss of Fzd4 activity also results in a delay in 
retinal vascularization {Xu, 2004 #233). However, whereas Norrin, Fzd4 or Lrp5 
deficiency leads to severe and persistent attenuation of retinal vascularization, most 
of the defects caused by the loss of Nrarp resolve after the first post-natal week. 
 
4.3.3  FUTURE PERSPECTIVES 
Much  remains  to  be  explored  with  the  phenotypes  of  the  Nrarp  mutant  mice. 
Although we have not performed experiments to address lumen formation in Nrarp 
null mice, immunofluorescent staining of endothelial cells by Isolectin-B4 suggests 
that lumen formation in these mice may be defective. To examine this process, one 
would have to do vessel perfusion experiments as well as electron microscopy to 
analyze the ultrastructure of Nrarp null blood vessels. Electron microscopy would 
also allow us to study the formation of adherens and tight junctions in the mutants. 
Although Claudin 5, and therefore tight junctions, was observed in Nrarp null mice 
by immunofluorescence, such a method does not reveal the integrity of the junctions 
formed.  
Although we have only documented vascular defects in the retina, it may be 
possible that there are vascular abnormalities in other tissues and also in certain 
physiological processes where angiogenesis is re-initiated, such as during pregnancy. 
The latter theory is based on the frequent inability of Nrarp
-/- females to produce 
offspring and also on published literature describing the roles of Fzd4 and Norrin in 
reproductive angiogenesis. Fzd4 null females are infertile due to failure of embryos 
to implant (Hsieh et al., 2005). Examination of the corpus luteum of these mutant 
mice revealed defective arborisation of blood vessels and degeneration of the tissue,  
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consequently  resulting  in  infertility  (Hsieh  et  al.,  2005).  In  Norrin  null  mice, 
implantation of the foetus occurs but bleeding is observed at the implantation site 
and the chorioallantois fails to develop, depriving the embryo of placental support 
(Luhmann et al., 2005). It would therefore be interesting to see whether Nrarp null 
female mice also display defects in reproductive angiogenesis. 
There are 19 Wnt ligands known to date in the mouse genome, and of these, 
only  a  few  e.g.  Wnt3a  and  Wnt7b  are  recognized  to  have  angiogenic  effects. 
Similarly, there are a large number of Frizzled receptors (10 in mammals) and co-
receptors of the Wnt pathway whose angiogenic functions are unknown. To further 
understand the angiogenic function of Wnt signalling in vivo, such as in the retina, it 
is  important  to  analyze  the  expression  pattern  of  different  Wnt  ligands,  Frizzled 
receptors,  such  as  Fzd4  and  Fzd5,  and  co-receptors  including  Lrp5  and  Lrp6,  at 
different stages of retinal vascular development. The Gerhardt laboratory already has 
preliminary data indicating that loss of Lrp5, Fzd4 and Norrin result in decreased 
vessel  density  in  the  retina.  However,  it  is  unclear  how  the  loss  of  these  Wnt 
components  resulted  in  decreased  vessel  density.  Is  it  through  increased  vessel 
regression, as in Nrarp mutants?  
Another fundamental question that has yet to be answered is the mechanism 
underlying  vessel  regression.  A  possible  mechanism  is  through  regulation  and 
stabilization of endothelial junctions. As well as being a transcriptional activator, β-
catenin is also a component of adherens junctions. However, the loss of endothelial 
β-catenin  did  not  prevent  the  formation  of  adhesion  junctions  since  intact  VE-
cadherin immunostaining in interendothelial junctions in bctnn1
lox/lox;Cre
+/- mice was 
observed  (Figure  67B).  The  canonical  Wnt/β-catenin  pathway  also  regulates  the 
expression of tight junction molecules Claudin 3 and Claudin 5 in endothelial cells 
(Liebner et al, 2008, in press). Conditional inactivation of β-catenin in endothelial 
cells  resulted  in  an  impairment  of  blood-brain-barrier  in  mice,  highlighting  the 
importance of the transcriptional regulatory role of the canonical Wnt signalling in 
maintaining tight junction integrity (Liebner et al, 2008, in press). One can therefore 
ask whether canonical Wnt signalling also stabilizes endothelial junctions of nascent 
vessels  by  up-regulating  the  expression  of  “stabilizing  genes”  to  promote  vessel 
homeostasis.  If  so,  does  physiological  pruning  of  blood  vessels  during  vessel 
network maturation involve loss of Wnt signalling? Or is it an active process that 
requires remodelling of junctional and cytoskeletal components? The mechanism(s)  
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underlying vessel regression is still elusive and much work needs to be done to solve 
the question. Whatever the mechanism is, it will likely be transient and dynamic in 
nature to prevent excessive vessel regression.  
4.4  SUMMARY 
Ishitani  et  al  first  showed  Nrarp  regulation  of  Wnt  signalling  in  the  zebrafish 
(Ishitani  et  al.,  2005).  Here,  we  also  demonstrate  that  Nrarp  modulates  Wnt 
signalling in the mouse as well as in human endothelial cells. There is therefore a 
conserved role of Nrarp in integrating Notch and Wnt signalling pathways across 
different species. The function of Nrarp, however, is not essential since Nrarp null 
mice are healthy and viable. Instead, we believe that Nrarp modulates and integrates 
Notch  and  Wnt  signalling  to  fine-tune  vessel  patterning  at  a  specific  phase  of 
angiogenesis, as shown in the postnatal retina, to stabilize nascent blood vessels.  
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5  Conclusion 
The research I have conducted during the course of my studies has contributed to 
understanding the role of Notch signalling in regulating blood vessel formation and 
patterning  during  angiogenesis.  Prior  to  the  commencement  of  my  projects,  the 
Notch pathway was implicated in arterial-venous and vascular smooth muscle cell 
differentiation.  However,  as  we  have  discovered  very  recently,  this  signalling 
pathway has a more diverse role in vascular development. 
  At the start of my studies, one of the many unanswered questions in vessel 
guidance is how endothelial tip cells are regulated. Gerhardt et al showed that a 
graded VEGF-A expression in the extracellular milieu is essential for polarization of 
tip cells and guidance of blood vessels (Gerhardt et al., 2003). However, it is still 
unknown  how  endothelial  tip  cells  form  although  we  know  that  both  Notch 
signalling and a gradient of VEGF-A expression are required for robust selection and 
formation  of  tip  cells.  In  Chapter  3,  I  presented  data  demonstrating  that  Notch 
regulation  of  tip  cell  formation  is  important  for  regulating  vessel  density. 
Suppression of Notch signalling in endothelial cells by genetically deleting one allele 
of Dll4 or endothelial Notch1 or by pharmacological inhibition of γ-secretase all 
resulted  in  an  increase  in  vessel  sprouting  (Hellstrom  et  al.,  2007).  Conversely, 
ectopic activation of Notch signalling in endothelial cells by the Jag1 peptide led to a 
decrease in vessel sprouting and consequently, a decrease in vessel density. These 
experiments demonstrate that tip cell formation requires tight regulation; too many 
tip cells create a hyperdense, non-functional vessel network and too few tip cells 
create a sparse network that may not be sufficient to support tissue growth. 
There  is  an  accumulation  of  data  supporting  a  regulatory  role  of  Notch 
signalling in VEGF receptor expression. The expression of Kdr, Flt4 and Nrp1 are 
down-regulated by Notch signalling whereas Flt1 is up-regulated (Harrington et al., 
2008; Siekmann and Lawson, 2007; Tammela et al., 2008; Figure 75). Thus, the 
changes  in  the  level  and  type  of  VEGF  receptor  expression  induced  by  Notch 
signalling  may  contribute  to  the  phenotypic  differences  in  subpopulations  of 
endothelial cells. For example, a decrease in VEGF receptor activity decreases the 
expression of Dll4 and suppresses cell motility, thereby producing a non-sprouting 
endothelial cell such as the stalk cell, which is capable of switching into a tip cell 
under the right stimulatory conditions.   184       Figure  75 . Proposed model showing integration of Notch and Wnt signalling in  promoting  non - sprouting endothelial cells.   An  endothelial  cell  such  as  the  tip  cell  with  high  Kdr  activity  and  high  Dll4  expression triggers Notch activation in the adjacent cell. Notch receptor activation  triggers expression of  Nrarp ,  Hey1 ,  Hey2  and  Lunatic fringe  in a CSL - dependent  manner.  Nrarp  negatively  regulates  Notch  signalling  by  disrupting  NICD - CSL  complex and promoting the degradation of NICD. In an unidentified mechanism,  Notch  activation  represses  the  expression  of  p21 cip1 ,  Kdr   and  Nrp1   and  induces  expres sion of  Flt1 , leading to a decrease VEGF receptor activity, decreased  Dll4   expression and decreased endothelial cell proliferation in this cell, characteristics of a  stalk cell. In the presence of Wnt ligand e.g. Wnt3a, the canonical Wnt/ β - catenin  pathway  is  activated.  Formation  of  the  β - catenin/Tcf/Lef1  complex  leads  to  the  
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transcriptional activation of Wnt-target genes such as CyclinD1 to induce endothelial 
cell  proliferation.  Wnt  signalling  may  also  have  a  role  in  maintaining  junctional 
integrity. Nrarp integrates Notch and Wnt signalling by its ability to bind to and 
stabilize Lef1 protein. Stabilization of Lef1 sustains and/or promotes canonical Wnt 
signalling. Note that it is unclear where interaction between Nrarp and Lef1 occurs in 
the cell. Together, Notch and Wnt signalling promote the acquisition of a stable, non-
sprouting endothelial cell. 
 
 
In Chapter 4, I demonstrated that the downstream Notch effector, Nrarp, also 
has a role in regulating vessel density. Interestingly, the mechanism for regulating 
vessel density appeared to be different from manipulating upstream components of 
the Notch pathway where receptor activity or NICD generation was compromised. 
We discovered that Nrarp regulates vessel density by modulating vessel stability and 
regression, and not by regulating endothelial tip cell formation. Genetic deletion of 
Nrarp resulted in a transient increase in vessel regression during angiogenesis so that 
a  decreased  vascular  density  developed.  We  further  showed  that  Nrarp functions 
through  the  Wnt  signalling  pathway  to  maintain  vessel  stability.  There  was  a 
decrease in Lef1 protein level in Nrarp null retinas, a decrease in the expression of 
the Ctnnb1/Lef1 target gene CyclinD1 in Nrarp null endothelial cells and, by using 
the  TOPFlash  Wnt  reporter  assay,  Nrarp  knockdown  by  siRNA  inhibited  Wnt 
activation after stimulating HUVECs with rWnt3a. Thus, Nrarp integrates Notch and 
Wnt pathways to regulate vessel patterning (Figure 75).  
Importantly, these experiments tell us that the process of vessel patterning is 
tightly regulated at many time-points during the process of angiogenesis. Angiogenic 
sprouting, which is considered the initiation phase of angiogenesis, depends on the 
formation of endothelial tip cells. In recent years, a wealth of studies has shown that 
the formation of tip cells is regulated in time, space and number, and perturbation of 
tip cell formation results in anomalous vessel network that may lead to embryonic 
death, as in the case of Dll4
+/- haploinsufficient mice. Furthermore, growing vessels 
require proliferation of endothelial cells. This process has to be tightly regulated as a 
proliferation rate that is too high culminates in increased vessel area for example, 
through increased vessel diameter, and one that is too low results in decreased vessel 
area. In addition, the nascent network that forms needs to be stabilized for a patent, 
functional network to develop. It is assumed that stabilization of vessels occurs after 
formation  of  new  vessel  sprouts.  However,  during  the  course  of  my  studies,  we 
discovered that stabilizing mechanisms work concomitantly with sprouting since in  
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Nrarp-deficient mutants, vessel regression is observed at the sprouting front of the 
migrating  vessels.  Thus,  many  cellular  processes  need  to  be  integrated  for  an 
organized blood vessel network to form and Notch the pathway serves as one such 
regulator of vessel patterning. 
  The Notch pathway has pleiotropic roles during development of tissues and 
organs. How does one signalling pathway produce such morphological complexity at 
different stages of development? A key to this achievement is the ability of Notch 
signalling to integrate with other signalling pathways, thus forming a larger, more 
complex signalling system known as the hyper-network (Hurlbut et al., 2007). It is 
through  such  an  interconnected  system  that  an  extraordinarily  diverse  output  is 
generated by one signalling pathway. As illustrated in this thesis, Notch signalling is 
able to integrate with two distinct signalling pathways, the VEGF receptor tyrosine 
kinase  family  and  the  Wnt  pathway,  to  regulate  blood  vessel  patterning  during 
angiogenesis  through  different  mechanisms.  The  cross-talk  between  Notch  and 
VEGF receptor signalling regulates endothelial tip cell formation while that between 
Notch and Wnt modulates vessel stability. It remains to be seen whether the Notch 
pathway  can  integrate  with  additional  pathways  in  the  temporal  and  spatial 
regulation of angiogenesis.  
In the past few years, we have begun to understand that different endothelial 
cells have specialized properties and functions. Through studying the regulatory role 
of Notch signalling in developmental angiogenesis, we have learnt that deregulation 
of specific endothelial cells results in different vascular abnormalities. For example, 
increased formation of tip cells results in an overgrown, chaotic vascular network. 
Although  such  a  network  is  unfavourable  during  development,  the  induction  of 
excessive tip cell formation and an increased vascular network by blocking Dll4-
Notch  signalling  is  therapeutically  beneficial  in  tumour  biology.  In  tumours,  the 
blood vessels induced by blocking Notch activity are non-functional, resulting in 
growth  inhibition  in  a  variety  of  established  human  and  rodent  tumour  models 
(Noguera-Troise  et  al.,  2006;  Ridgway  et  al.,  2006;  Scehnet  et  al.,  2007). 
Importantly, blockade of Dll4 can have potent antitumour effects on tumours that are 
resistant to VEGF inhibition (Noguera-Troise et al., 2006; Ridgway et al., 2006), 
raising the possibility of using combination antiangiogenic therapies against VEGF 
and Notch pathways.   
187 
Alternatively, a dysfunctional tumour vascular network can also be achieved by 
inducing vessel regression. As we have discovered, an established vessel network 
can  become  destabilized  especially  when  endothelial  cells  located  at  vessel 
branchpoints lose junctional integrity. In light of our recent finding that loss of Wnt 
signalling results in ectopic vessel regression during developmental angiogenesis, it 
is possible that inhibition of endothelial Wnt signalling will also have antiangiogenic 
effects  in  diseases  such  as  cancer.  It  is  tempting  to  speculate  that  a  combined 
inhibition of Notch and Wnt signalling could produce a more potent antiangiogenic 
effect  in  tumours.  These  are  interesting  avenues  to  explore  towards  finding  new 
targets for antiangiogenic therapy.  
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